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Extensive research has found glucose and caffeine to have beneficial effects on cognition 
and mood. Broadly, glucose has been found to improve memory and caffeine to improve 
attention and alertness. Relatively little research has investigated the effects of their 
combined consumption, although to date, similar effects on cognitive performance and 
mood have been found. The aim of this thesis was to systematically evaluate the 
behavioural effects of combined consumption of these substances and compare them with 
the effects of consuming either substance in isolation. Moderating factors, such as 
cognitive effort, were considered along with the evaluation of neural and neuroendocrine 
responses.   
The first study (chapter 2) found evidence of beneficial effects of caffeine, glucose and 
their combination on memory and mood, with individual effects varying across doses. 
However, concurrent measurement of the neuroendocrine response found no effects 
(chapter 3). Investigation into pre-retrieval administration of the substances memory 
performance (chapter 4) found no effects of any substance, in contrast to the beneficial 
effects found for pre-learning administration. A parallel assessment of glucose and 
caffeine on different attentional networks and systems (chapter 5) failed to find any effects 
on this aspect of cognitive performance. In chapter 6 the effects of the substances on 
participants who were in a sub-optimal state were examined. The findings were not able to 
show that effects of the substances can be more clearly elucidated when participants are 
not performing optimally. The final experimental study (chapter 7) investigated the effects 
of caffeine and glucose on neurocognitive processes, but no beneficial effects were found. 
Overall, the findings suggest that the effects of caffeine, glucose and their combination are 
modulated by dose and domain.     
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1.1 General Introduction 
 
Energy drinks are widely consumed beverages in Europe and North America (Woojae, 
2003). They are marketed as providing a ‘boost’ in performance and mood when needed, 
helping to increase alertness, energy and decrease drowsiness (Smit & Rogers, 2002). 
Much work has been done on two of the main ingredients usually contained in these 
drinks, glucose and caffeine when they are consumed in isolation. There is ample evidence 
to suggest that when consumed in isolation both of these substances have an effect on 
cognition and mood (Addicott & Laurienti, 2009; Brice & Smith, 2002; Durlach, 1998; 
Foster, Lidder, & Sünram, 1998; Haskell, Kennedy, Wesnes, & Scholey, 2005; Lorist & 
Tops, 2003; Martin & Benton, 1999; Owens & Benton, 1994; Scholey, Harper, & 
Kennedy, 2001; Smit & Rogers, 2000; Sünram-Lea, Foster, Durlach, & Perez, 2001; 
Sünram-Lea, Dewhurst, & Foster, 2008; Sünram-Lea, Owen, Finnegan, & Hu, 2011). In 
terms of the aspects of cognition affected, generally speaking glucose has been found to 
have most robust beneficial effects on verbal episodic memory (Foster et al., 1998; 
Meikle, Riby, & Stollery, 2005; Sünram-Lea et al., 2001), and caffeine has been found to 
increase alertness, ameliorate fatigue and have a beneficial effect on attention (Smith, 
2002). However relatively little work has been done on the effects of these substances 
when consumed in combination on cognition and mood. 
This chapter is going to provide an overview of the literature on the effects of caffeine and 
glucose on cognition and mood. Firstly the effects of glucose and caffeine in isolation will 
be examined. Then current research on the effects of caffeine and glucose when 
administered in combination, including in the form of energy drinks, i.e. in conjunction 






This section will examine the effects of glucose on behavioural measures. The optimal 
dose will be considered along with factors which may moderate the effects of glucose in 
individuals. Finally potential mechanisms of action will be discussed. 
 
1.2.1. Cognitive effects of glucose 
 
Glucose is the brain’s primary fuel. Since relatively little glucose can be stored, the brain is 
reliant on a continuous supply of glucose as its primary fuel, delivered via the bloodstream 
(Wenk, 1989). The effect of glucose on cognition has been extensively studied in an acute, 
short-term context in which a glucose load is administered and cognitive performance 
assessed shortly afterwards. Beneficial effects of glucose administration have been 
observed across different populations using this experimental paradigm. For example, 
glucose administration has been found  to enhance cognitive function in young and aged 
animals and humans (Benton, Owens, & Parker, 1994; Donohoe & Benton, 2000; Foster et 
al., 1998; Messier, 2004; Smith, Riby, Eekelen, & Foster, 2011; Sünram-Lea et al., 2001; 
Sünram-Lea et al., 2011), and clinical populations including Alzheimer’s Disease and 
Schizophrenia (Fucetola, Newcomer, Craft, & Melson, 1999; Newcomer, Craft, Fucetola, 
Moldin, Selke, Paras, & Miller, 1999; Stone, Seidman, Wojcik, & Green, 2003;). In 
addition, in patients with Diabetes Mellitus improved glycaemic control has been found to 
lead to improvements in cognitive function (Meneilly, Cheung, Tessier, Yakura, & 
Tuokko, 1993; Naor, Steingruber, Westhoff, Schottenfeld-Naor, & Gries, 1997; Ryan, 
Freed, Rood, Cobitz, Waterhouse, & Strachan, 2006). 
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It has been found that memory in particular is sensitive to enhancement by glucose, 
specifically verbal declarative memory (Foster, et al., 1998; Meikle, Riby, & Stollery, 
2005; Sünram-Lea et al., 2001). The evidence also suggests that the beneficial effects of 
glucose are enhanced when tasks have a high cognitive load, for example when they 
require an element of divided attention or are cognitively demanding (Foster, et al., 1998; 
Kennedy & Scholey, 2000; Sünram-Lea, et al., 2002b). This effect is found especially 
when looking at the performance of healthy young adults where it is generally considered 
that they are performing at an optimum level to begin with (Messier, 2004; Smith et al., 
2011). For example, using 25g glucose Kennedy & Scholey (2000); Scholey, Harper, and 
Kennedy, (2001); Sünram-Lea, Foster, Durlach, and Perez, (2002a); and Sünram-Lea, 
Foster, Durlach and Perez (2004) found significant effects on a difficult serial subtractions 
task (serial sevens). However glucose effects were not observed when using the less 
demanding serial threes task (Kennedy & Scholey, 2000; Scholey & Kennedy, 2004) with 
glucose loads of 25g and 37.5g respectively. Sünram-Lea et al., (2002b) investigated the 
effect of glucose under conditions of increased cognitive load by utilising a secondary task 
to divide participants’ attention. They found that compared to placebo, 25g glucose 
improved memory performance on a word recall task only when participants completed a 
secondary task during encoding , but not when participants encoded the list without a 
secondary task. They suggested that the additional cognitive task potentially ‘depletes’ 
episodic memory capacity and/or glucose–resources and is therefore critical to the 
observation of cognitive facilitation by glucose. 
 




The effects of glucose on mood are equivocal, some studies have found it has no effect on 
mood (Sünram-Lea et al., 2011), whilst others have found it to have effects (Benton & 
Owens, 1993; Owens, Parker & Benton, 1997). Benton and Owens (1993) conducted three 
experiments to examine the effect of glucose on mood. In the first they examined the short 
term effects of 50g glucose; in the second they examined the effects of sustained high 
blood glucose by administering 50g glucose initially, followed by two further 25g doses at 
45 and 75 mins (both studies utilised a placebo control); finally they examined 
consumption of 50g on participants’ negative responses to a frustrating situation. They 
found that both short term increases and sustained increases in blood glucose were 
associated with participants feeling less tense. Participants also exhibited less negative 
responses to a frustrating situation, as assessed by ethological descriptions of their 
behaviour, after consuming a glucose drink compared to placebo. Owens et al., (1997) 
examined the effect of 50g glucose across three different cognitively demanding tasks 
(Stroop; Rapid Visual Information Processing and a difficult hand-eye coordination test), 
and found falling blood glucose levels were associated with participants rating themselves 
as feeling less energetic. Two underlying physiological processes have been postulated for 
these effects of glucose on mood (Benton, 2002). Firstly that in an attempt to normalise 
blood glucose levels the autonomic nervous system is activated and this is responsible for 
the increase in self-reported tension; secondly that the feeling of decreased energy may be 
due to neuroglycopenia, i.e. a shortage of glucose in the brain (Benton, 2002). Indeed the 
result seen in Owens et al., (1997) may be due to the cognitively demanding tasks inducing 
localised neuroglycopenia (Benton, 2002). Sünram-Lea et al., (2011) found no mood 
effects of 15g, 25g, 50g or 60g glucose compared to a placebo as assessed by the Bond-
Lader visual analogue scales. However, when participants were divided into 3 different 
groupings based on an equal split of their BMI, they found that those with a high BMI 
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(25.60-31.80) rated themselves as significantly more alert following all of the active drinks 
compared with the low (17.8-21.90) and medium (22.70-24.90) BMI groups. These 
findings suggest that individual moderating factors may affect individuals’ mood in 




As with many substances affecting cognitive performance, research has shown that the 
dose-response for the enhancement of memory by glucose follows an inverted U shape 
(Gold, Vogt, & Hall, 1986, Sünram-Lea et al., 2011). In human populations, glucose has 
been shown to be effective at doses ranging from 25g-75g (Messier, 2004). Sünram-Lea et 
al., (2011) investigated the dose-response of glucose in memory facilitation and mood in 
healthy young adults. They found that whilst glucose improved performance on a range of 
memory tasks only the long-term memory task adhered to the previously observed the 
inverted U-shaped dose-response curve, whereby 25g was the optimal dose for improving 
performance. Improvements on the Serial 3’s Subtraction task (a numeric working 
memory task) followed a cubic trend, with improvements following the lowest and highest 
doses and those on the Spatial Working Memory task following a quartic trend, where 25g 
lead to a significant improvement in performance, but there were also improvements in 
performance following the highest dose (60g). This suggests that the optimal dose is 
dependent upon the cognitive domain under investigation.  
 




It has also been shown that individual differences in age, Body Mass Index (BMI) and 
glucoregulation among participants are important moderators of optimal dose and more 
general susceptibility to glucose facilitation of cognitive performance (Donohoe & Benton, 
1999a; Hall,  Gonder-Frederick, Chewning, Silveira & Gold, 1989; Messier, Tsiakas, 
Gagnon, Deorochers, & Awad, 2003; Riby, Meikle, & Glover, 2004; Sünram-Lea et al., 
2011).  With regards to age, in younger adults lower doses around 25g are generally more 
effective, whereas in older adults higher doses around 50-75g are more effective (Messier, 
2004). However, there is likely to be an interaction with glucoregulation as this declines 
with age. Older participants were found to have improved episodic memory following 25g 
glucose (Riby, et al., 2004). However, older adults with poorer glucose regulation have 
been found to perform worse on cognitive tasks following 50g glucose (Donohoe & 
Benton, 1999a; Messier, et al., 2003). A high BMI is also associated with poorer 
glucoregulation and Sünram-Lea et al., (2011) found that those with a high BMI (>25) 
showed impaired cognitive performance after 60g of glucose, compared to an 
improvement in performance following the same dose in those with low and medium BMI 
(<25). Whilst this research has found that a faster rate in decline in blood glucose levels 
i.e. a smaller area under the curve has been associated with better memory, Donohoe and 
Benton (2000) found that rather than improved memory being just the result of a more 
efficient glucoregulatory response, it was specifically related to participants’ ability to 
reach baseline again following nadir. ‘Nadir’ is the point at which, following the ingestion 
of glucose and subsequent rise in blood glucose levels, blood glucose levels slightly dip 






To summarise, glucose has been found to have its most robust effects at a dose of 25g on 
verbal declarative memory. There is evidence that the most facilitative dose is dependent 
on the cognitive domain, and the effects of glucose can only be evidenced when task 
demand is high. There are also several other moderating factors which augment the effect 
of glucose, for example; age, glucoregulation; BMI. 
 
1.3 Glucose Mechanisms of Action 
 
There are several proposed mechanisms of action for glucose. The precise mechanisms by 
which increased peripheral and/or central glucose availability affects cognitive processes 
are still unclear. Whilst there are two broad theoretical approaches to the potential 
mechanism: energetic demand and domain specific models, one does not necessarily 
exclude the other and they may both provide explanations depending on different 
parameters.  
It is suggested that a central mechanism of action is responsible for glucose enhancing 
effects because it is able to cross the blood-brain barrier and it has been shown that central 
and systemic administration of glucose produce similar behavioural effects (Stefani, 
Nicholson, & Gold, 1999). Therefore when it is administered only centrally it does not 
pass through the peripheral systems. Glucose exerts robust effects on long-term memory 
tasks, in particular declarative memory. The hippocampus is the brain region most strongly 
implicated in long-term memory performance (Aggleton and Brown, 1999). Consequently, 
the hippocampus has been postulated to play a critical role as the glucose enhancement 
effect is most reliably found on the domain of episodic memory and the hippocampus is a 
key structure in episodic memory functioning (Shastri, 2002; Wincour, 1995). One study 
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in support of this used the remember-know-guess paradigm (Sünram-Lea et al., 2008). 
Following the ingestion of a glucose drink participants recalled significantly more words 
as ‘remembered’ compared to placebo. No differences were found on the ‘know’ or 
‘guess’ responses. This supports the theory as the hippocampus is thought to be 
preferentially involved in ‘recollection’ based recognition memory but not ‘familiarity’ 
(Aggleton & Brown, 2006; Rugg & Yonelinas, 2003; Sünram-Lea, et al., 2008). The 
hippocampus is densely populated with insulin receptors compared to other brain regions 
(Lathe, 2001; Unger et al., 1989), and it is suggested that this might be the one of the 
potential underlying mechanism responsible for  the glucose enhancement effect on verbal 
declarative memory (Craft, Dagogo-Jack, Wiethop, Murphy, Nevis, Fleischman et al., 
1993). Indeed, both acute and chronic administration of intranasal insulin, a mechanism 
that enables the direct delivery of glucose to the central nervous system, has been shown to 
improve declarative memory without concomitant changes in plasma insulin and glucose 
levels (Benedict et al., 2004, 2007; Reger et al., 2008a,b). Messier (2004) however 
highlights that, as it is not possible to increase plasma glucose concentration in humans 
without a rise in blood insulin levels, it is not possible to be sure that insulin is the 
mediator between the ingestion of glucose and memory improvements. For example, Craft 
et al., (1999) found that using a euglycemic clamp to raise blood insulin levels, whilst 
blood glucose levels remained constant, improved memory in patients with Alzheimer 
disease. However additional glucose had to be administered to prevent blood glucose 
levels from failing whilst insulin levels were increased and so rather than showing that 
insulin is the mechanism of action, it only suggests that raised blood glucose levels are not 
necessary for the memory enhancement effect (Messier, 2004). It remains difficult to tease 
apart the relative effects of glucose and insulin on cognitive function, and whether they can 
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have effects independently or whether they have an interrelated function (Smith et al., 
2011). 
The availability of glucose as mere energy fuel, particularly in the brain may be behind the 
glucose enhancement effect (Scholey et al., 2001). A greater reduction in blood glucose 
has been observed after performing more cognitively demanding tasks (Scholey et al., 
2001). This could explain why beneficial effects are seen after the ingestion of glucose 
prior to these types of tasks, as without the additional glucose load glucose supply may 
become depleted which in turn might have a detrimental impact on cognitive performance 
(Scholey et al., 2001). However, the hippocampus in particular has evolved protection 
against temporary fluctuations in glucose supply by having higher stores of glycogen 
compared to other areas of the brain (Dalsgaard, Madsen, Secher, Laursen & Quistorff, 
2006). It is also unlikely that glucose uptake needed during a cognitively demanding task 
would be greater than the overall glucose demand of the brain and the amount of glucose 
produced is carefully matched to the glucose used in order to maintain consistent blood 
glucose levels (Messier, 2004). Messier (2004) suggested instead that it may be autonomic 
changes, arising from increased stress and physiological arousal, and caused by the 
emotions arising from the task such as experiencing difficulty, that lead to variations in 
blood glucose in more demanding tasks. There is also evidence that the memory 
enhancement effect of glucose is seen even after the increase in blood glucose following 
administration of glucose has subsided (Sünram-Lea, Foster, Durlach & Perez, 2002a). 
Sünram-Lea et al., (2002a) found enhanced recall on a memory task 24 hours after 
administration of a glucose drink, which demonstrates that the glucose memory 
enhancement effect does not depend on elevated plasma glucose levels per se. Therefore, 
other mechanisms which are facilitated by an increase in glucose are more likely to be the 
mechanism for the glucose enhancing effect rather than just the increase in glucose per se. 
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In addition, there is evidence indicating that glucose affects cognitive processes, in 
particular memory through an enhancement of brain acetylcholine synthesis and/or its 
release (see Messier 2004 for review). When glucose is metabolised via the Krebs cycle, it 
produces acetylcoenzyme A which is necessary, along with choline, for acetylcholine 
(ACh) synthesis (Messier, 2004). Kopf, Buchholzer, Hilgert, Löffelholz, & Klein, (2001) 
found that memory performance improved on a maze task when glucose and choline were 
administered individually and in combination. They suggested that increased hippocampal 
ACh synthesis lead to the memory improvement, and therefore the facilitation of memory 
by glucose could be mediated by increased ACh availability (Smith et al., 2011). 
Raggozzino, Pal, Unick, Stefani and Gold (1996) found that when rats explored a four-arm 
maze, the increase in hippocampal ACh output was dose dependently increased by 
peripheral glucose injections. A 50% increase in ACh synthesis was seen during the 
exploration of the four-arm maze and this was further increased by another 50% when 
250mg/kg peripheral glucose injection was administered. This was also the dose at which 
the animals exhibited better memory performance during the task. No effect on ACh 
synthesis was found when a higher dose of 1000mg/kg was administered. The pattern of 
ACh output increasing dose dependently following glucose injections up to a certain point, 
mirrors the dose-dependent effects of glucose seen on behavioural performance, whereby 
after a certain point administration of glucose does not result in further improvements 
(Sünram-Lea et al., 2011). 
It has also been suggested that glucose exerts its memory effects via potassium adenosine 
triphosphate (KATP) channel function. When glucose is metabolised it increases intra-
neural ATP levels and causes a KATP channel blockade, which in turn causes the neuron to 
become depolarised and this mediates neurotransmitter release by increasing the 
probability if stimulus-evoked neurotransmision (Stefani & Gold 2001; Stefani et al., 
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1999). Stefani et al., (1999) compared the effects of glucose, glibenclamide (a KATP 
channel blocker) and saline on spatial working memory performance in rats. They found 
that relative to the saline placebo, task performance was improved following both the 
glucose and glibenclamide individually and when administered in combination at lower 
doses. They concluded that given the similarity of the effects on task performance these 
results support the theory that glucose exerts its effects by modulating KATP channel 
function (Stefani et al., 1999). As with ACh, an important finding here is the dose-
dependent effects of this mechanism, as the effects of glucose have been found to be dose-
dependent (Messier, 2004). However, the effects of glucose on KATP channel function has 
not been examined directly, and therefore it is not possible to know if glucose and 
glibenclamide are exerting their effects via a common neurophysiological mechanism, or if 
each has a different underlying mechanism which are resulting in the same effects (Smith 
et al., 2011). 
Glucose may exert its cognitive effects on central mechanisms via peripheral mechanisms, 
specifically the liver and the vagus nerve have been implicated. The suggestion is that 
following high doses of glucose and fructose (>1000mg/kg), changes in the liver to the cell 
membrane transport are detected by the coeliac ganglion and transformed into neural 
signals and then carried to the brain by the vagus nerve (Messier & White, 1987, White, 
1991). This is supported by the finding that coeliac ganglion lesions, which block most of 
the efferents of the liver, have been found to abolish the glucose memory effect (White, 
1991). The main relay station for the vagal nerve fibres in the brain is the nucleous of the 
solitatory tract in the brainstem. The nucleus has projections into forebrain areas such as 
the amygdala and hippocampus and therefore the hippocampus could be involved with 
both central and peripheral actions of glucose on memory (White, 1991). Stimulation of 
the vagus nerve has also been found to modulate cognitive performance, both improving 
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(Clark, Naritoku, Smith, Browning & Jensen, 1999; Sackeim et al., 2001) and impairing 
(Helmstaedter, Hoppe & Elger, 2001). Whilst these results should be interpreted with 
caution due the participants having either epilepsy or treatment resistent depression 
(Messier, 2004), they still provide evidence of a potential mechanism. 
The evidence for one sole mechanism of action for glucose is not clear. Given the variation 
in the behavioural effects of glucose and the dose-dependent nature of these, it is likely 
that the faciliatative effect of glucose relies on a variety of underlying mechanism of action 
(Sünram-Lea & Owen, 2017). This may be further modulated by specific participant 




The following section will examine the behavioural effects of caffeine. Dose and time 
dependent effects as well as other moderating factors will be discussed. The potential 
underlying mechanisms will then be discussed. 
 
1.4.1 Cognitive effects of caffeine 
 
In terms of its behavioural effects, caffeine has been found to reduce simple reaction time 
(Chubley, Bye, Henson Peck & Riddington, 1979; Smith, Thomas, Perry & Whitney, 
1997; Smith, Maben, & Brockman, 1994); improve sustained attention (Smith, Kendrick, 
& Maben 1992; Brice & Smith, 2001b); improve concentration (Hindmarch, et al., 2000); 
improve performance on delayed memory tasks (Kelemen & Creeley, 2001; Smith et al., 
1999); and improve encoding of new information (Smith, Clark, & Gallagher, 1999).  
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In a review Smith (2002) concluded that following caffeine consumption the strongest 
effects are found on attention. Brice and Smith (2001a) investigated the effect of caffeine 
on a sustained attention task and a driving simulator task as a more naturalistic measure of 
attention. They administered 3mg/kg of caffeine and found that performance was 
improved on both tasks with greater accuracy on the sustained attention task and fewer 
steering wheel movements in the driving simulation task, which evidenced improved 
sustained attention during this task. Performance on a choice reaction time task which 
required focused attention was also improved in two studies, one with caffeine at the level 
of 40mg (Smith et al., 1999) and in the second with 1.5mg/kg and 3mg/kg of caffeine 
(approximately 105mg and 210mg respectively for a 70kg person) (Brice & Smith, 
2001b). In the second study there was no difference between the 1.5mg/kg or 3mg/kg dose 
in terms of performance on this CRT task (Brice & Smith, 2001b). 
Caffeine has also been found to have some beneficial effects on memory (Kelman & 
Creeley, 2001; Smith et al., 1999b). Smith et al., (1999b) found that whilst there was no 
beneficial effect of caffeine (40mg) on a free recall memory task, it did significantly speed 
up the response times in a delayed recognition task. Participants who received caffeine 
also completed significantly more trials in a semantic processing task, which consisted of 
sentence verification into ‘true’ or ‘false’ classifications, and measures speed of retrieval 
of information from general knowledge. However Kelman & Creeley (2001) suggested 
that caffeine’s memory benefit might be due to state-dependent memory effects as most 
studies administer the encoding and recall parts of the memory following a single dose of 
caffeine, and therefore caffeine is present during both phases of the task. They 
administered 4mg/kg of caffeine on either day 1 (encoding), day 2 (recall) or on both days. 
They found that when caffeine was administered on both days, recall was significantly 
better than when it was only administered on one, which supports their theory that it is 
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state-dependent memory effects rather than caffeine per se that is having an affect 
(Kelman & Creeley, 2001).  
 
1.4.2 Mood effects of caffeine 
 
Caffeine has predominantly been found to increase alertness and reduce fatigue (Brice & 
Smith 2001a; Haskell et al., 2005; Hindmarch, Rigney, Stanley, Quinlan, Rycroft & Lane, 
2000; Kennedy, Galloway, Dickau & Hudson, 2008; Smith, Sturgess & Gallagher, 1999). 
Negative mood effects such as anxiety and tension have been found at higher doses above 
500mg (Griffths, Juliano & Chausner, 2003; Sicard, Perault, Enslen, Chaufford, Vandel & 
Tachan, 1996). However doses of these amounts are unlikely to be commonly ingested 
(Smith, 2002). 
Haskell et al., (2005) found that following both 75mg and 150mg caffeine participants 
rated themselves as significantly more alert and significantly less mentally fatigued 
compared to placebo after they had completed a cognitively demanding battery. Doses as 
low as 12.5mg and up to 100mg were found to attenuate ratings of feeling bored following 
a similar cognitively demanding battery (Smit & Rogers, 2000). Additionally, the 100mg 
dose led to increased self-ratings of ‘energetic arousal’. Conversely, some research has 
found no mood effects of 100mg and 200mg of caffeine (Svensson, Persson & Sjoberg, 
1980; Swift & Tiplady, 1988). It has been proposed that mood effects follow from changes 
in cognitive performance and this may be an explanation for the lack of mood effects in 






Although previous research initially administered large doses of around 200-250mg to 
explore the effects of caffeine (Addicott & Laurienti, 2009), more recently research has 
focused on amounts of caffeine that may be consumed in one to two cups of coffee, which 
is approximately 75-150mg (Brice & Smith, 2002; Haskell, Kennedy, Wesnes, & Scholey, 
2005). Research has found that following doses of this level, caffeine can increase 
alertness and reduce fatigue (Glade, 2010; Smith, 2002). For example, Haskell et al., 
(2005) found that participants rated themselves as significantly more alert and less 
mentally fatigued after the completion of a battery of computerised cognitive tasks, 
following ingestion of both 75mg and 150mg of caffeine. Brice and Smith (2002) 
compared a more naturalistic pattern of caffeine consumption (65mg of caffeine consumed 
at four time-points); to a single large dose (200mg) to see if they had the same effects. The 
doses were chosen on the basis that there would be the same amount of caffeine in the 
system after 5 hrs from the first consumption of the 65mg dose. Both treatments led to 
improvements in attention; specifically better performance on reaction time tasks (faster 
simple reaction time and improved accuracy on a choice response task), improved 
accuracy on a vigilance task, faster self-paced responding a sustained response task, 
increased speed for encoding new information in a categoric search task and improved 
tracking accuracy on a dual tracking/detection task. These results suggest that results 
observed following administration of a large single dose, may actually be representative of 
more naturalistic consumption patterns (Brice and Smith, 2002).  
Doses of caffeine, below those found in a typical cup of tea or coffee, have also been 
examined; Smit and Rogers (2000) examined the effects of 0, 12.5, 25, 50 and 100mg of 
caffeine. The participants completed a battery of tasks consisting of a simple reaction time 
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task, a Rapid Visual Information Processing (RVIP) task and a mood questionnaire. All 
doses led to improvements in performance on both cognitive tasks and attenuated mood in 
terms of preventing an increase in feeling ‘bored’ which increased towards the end of the 
testing session after placebo. The 100mg also increased ‘energetic arousal’. The most 
notable element however is that there was a very flat dose response in terms of 
improvements on the performance tasks (Smit & Rogers, 2000), i.e. performance did not 
differ significantly following administration of the dosages ranging from 12.5mg dose to 
100mg (Smit & Rogers, 2000). 
 
1.4.4 Moderating factors 
 
It has been suggested that caffeine is most effective when alertness levels are low (Smith, 
2002). Lorist, Snel & Kok (1994) found that whilst administration of 200mg of caffeine, 
followed by a maintenance dose of 50mg caffeine, shortened participant’s reaction time, 
larger improvements were shown in participants who were fatigued compared to those 
who were well rested. Similarly, Schweitzer, Muehlbach and Walsh (1992) found that 
caffeine (4mg/kg) administered prior to a single night shift improved alertness and 
attenuated the decline in performance and alertness due to circadian rhythms in the early 
hours of the morning when participants were engaged in a Simulated Assembly Line Task 
(SALT). Research has also shown that caffeine can attenuate the dip in performance that is 
associated with the post-lunch period (Smith, Rusted, Eaton-Williams, Savory & 
Leatherwood 1990). Smith et al., (1990) examined the effects of caffeine both before and 
after lunch on a sustained attention task (Bakan vigilance task). Caffeine improved 
performance both before and after lunch, and removed the decline in performance that was 
seen after lunch following the decaffeinated drink. 
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Age appears to be another factor that has been shown to moderate the behavioural effects 
of caffeine (Hogervorst, Riedel, Schmitt, & Jolles, 1998; Lorist, Snel, Mulder, & Kok, 
1995; Swift & Tiplady, 1988). Swift and Tiplady (1988) found that 200mg improved more 
aspects of cognitive performance in elderly participants (attention and reaction time) 
compared to younger adults. However, whilst the younger participants rated themselves as 
significantly more alert, interested, calmer, and steadier following caffeine consumption, 
the elderly participants reported no such effects. Moreover, Hogervorst et al., (1998) found 
that 225mg caffeine improved performance on a word learning list in middle-aged 
participants (aged 46-54yrs), but not in younger (aged 26-34yrs) or older (aged 66-74yrs) 
participants. Lorist et al., (1995) examined the effect of 250mg caffeine on reaction time 
and event-related potentials (ERPs) in young (18-23yrs) and elderly (60-72yrs) 
participants. Following the placebo the results showed that elderly participants were 
slower in their identification of relevant information and the evaluation of the stimuli. 
However caffeine improved performance and ERPs on both young and elderly 
participants. Caffeine also ameliorated the deficits in the P3b latency (an indication of 
stimulus evaluation time) associated with ageing. 
One major controversy surrounding the behavioural effects of caffeine is whether caffeine 
consumption has any net benefits, or if the positive effects found are merely due to 
‘withdrawal reversal’; as much of the research uses participants who have abstained from 
caffeine prior to taking part in the research (James, 1994; James, 1998; James & Rogers, 
2005; Rogers & Dernoncourt, 1998; Yeomans, Ripley, Davies, Rusted & Rogers, 2002). 
For example, James (1998) found no evidence of improvement in participants’ 
performance after they had caffeine when they had consumed caffeine habitually prior to 
testing, but did find that performance on a short-term memory task was impaired when 
participants were withdrawn. Yeomans et al., (2002) also tested the withdrawal reversal 
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hypothesis using a methodology where they pre-loaded participants with 0, 1 or 2mg/kg 
caffeine at breakfast, followed 60 minutes later by a second drink containing either 0 or 
1mg/kg caffeine. They tested participants’ performance before and after the drinks and 
found that both initial doses of caffeine at breakfast improved self-rated alertness, 
decreased reaction time and the 1mg/kg dose also increased accuracy on the Rapid Visual 
Information Processing (RVIP) task. However, whilst the 1mg/kg dose 60 minutes post 
breakfast resulted in increased self-rated alertness and decreased reaction time, the 
subsequent dose had no effect on performance or mood in participants who had already 
received caffeine at breakfast. The researchers interpreted these results as supporting the 
caffeine reversal hypothesis as once participants were no longer caffeine deprived there 
was no additional benefit of subsequent caffeine administration (Yeomans et al., 2002). 
James and Rogers (2005) in their review of the literature suggest that the typical placebo-
controlled studies that are widespread in this research, by their design, fail to discern 
whether there are net benefits of caffeine administration or if the effects are solely due to 
withdrawal reversal. They suggest that only long-term withdrawal studies are able to 
investigate this question clearly and that the evidence from these studies suggest that any 
beneficial effects of caffeine can be explained by the effects of withdrawal reversal. 
However, other researchers have argued that these effects cannot be explained by 
withdrawal reversal (Addicott &Laurienti, 2009; Childs & de Wit, 2006; Haskell et al., 
2005; Smith, 2002; Smith, Christopher & Sutherland, 2013). Some of the studies which 
support the withdrawal reversal hypothesis have been criticised for their methodology. For 
example, James (1998) did not take any baseline measures, and therefore pre-existing 
differences prior to treatment could not be accounted for (Smith, 2002). Moreover, studies 
investigating the effect of caffeine in low or non-consumers found that caffeine has a 
positive effect on cognitive performance and mood (Childs & de Wit, 2006; Haskell et al., 
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2005; Smith et al., 2013). Childs and de Wit (2006) used participants who consumed less 
than 300mg caffeine per week, and examined the effects of 0, 50, 150 and 450mg caffeine 
on cognitive performance and mood. They found that caffeine improved attention, 
increased feelings of arousal, positive mood and self-rated feelings of high as assessed by 
Visual Analogue Scales used to detect drug effects. However impaired performance was 
found on a working memory task (Childs & de Wit, 2006). Haskell et al., (2005) compared 
habitual caffeine consumers (consumed tea/coffee more than 50mg caffeine/day), to non-
habitual caffeine consumers (didn’t consume tea/coffee and in total consumed less than 
50mg caffeine/day). They found no baseline differences between groups and caffeine 
significantly improved a number of cognitive tasks including simple reaction time, digit 
vigilance reaction time, numeric working memory reaction time, and sentence verification 
accuracy irrespective of the caffeine consumption status. Moreover, in both groups, 
reduced fatigue and increased alertness was observed following caffeine consumption 
(Haskell et al., 2005). Smith et al., (2013) also compared the effects of 2mg/kg caffeine in 
overnight-withdrawn and non-consumers. They analysed the baseline scores prior to 
caffeine administration and found no significant effects of caffeine withdrawal. In both 
groups caffeine improved mood and cognitive performance relative to placebo. The effects 
between groups only differed on ratings of alertness and anxiety and fewer lapses of 
attention, where caffeine had a larger effect compared to non-consumers. Evidence 
demonstrating effects in non-habitual consumers suggest that the effects are unrelated to 
withdrawal reversal (Childs & de Wit, 2006; Haskell et al., 2005; Smith, 2002, Smith et 
al., 2013).     
Whilst the issue of whether caffeine has any true net benefits rather than simply improves 
performance due to withdrawal reversal remains controversial; it has been shown that 
consumer status does alter caffeine’s effects (Haskell & Kennedy, 2011; Rogers, 
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Heatherley, Mullings & Smith, 2013). Rogers et al., (2013) compared the effects of 
overnight caffeine abstinence and subsequent caffeine administration in non to low 
(caffeine intake < 40mg per day) and medium to high (caffeine intake ≥ 40mg per day) 
caffeine consumers. They found that caffeine withdrawal was associated with negative 
effects at the earlier 10.30am testing session, these effects increased in the later afternoon 
testing sessions where participants reported themselves to be sleepier, less alert and had 
poorer performance on the cognitive tasks. In the medium-high participants who consumed 
caffeine in the morning, improvements in these outcome measures were seen. However, in 
non-low participants caffeine administration only decreased ratings of sleepiness. The 
authors suggest that the failure of caffeine to improve mental performance and increase 
mental alertness in these participants was due to caffeine increasing their ratings of 
anxiety/jitteriness. Caffeine did however improve the psychomotor performance of both 
groups (faster typing speed, simple and choice reaction time responses). The authors 
concluded that although caffeine has beneficial effects on performance and with regular 
consumption consumers become tolerant to its effects of increasing anxiety/jitteriness, this 
increase in tolerance also extends to its effects on sleepiness and therefore mental alertness 
and mental performance fail to be enhanced by subsequent caffeine administration. 
Differences in neurocognitive responses to caffeine have also been identified. Haskell and 
Kennedy (2011) examined the effects of 75mg caffeine at rest and during cognitive tasks 
on pre-frontal cerebral-haemodynamics using near infrared spectroscopy. They compared 
habitual consumers (≥ 3 cups of tea and/or coffee per day) to non-habitual consumers (no 
tea or coffee and ≤ 1 caffeinated soft drink per day). They found that whilst caffeine 
significantly decreased cerebral blood flow, there was a significant interaction with 
consumption status. There was an exaggerated effect in non-consumers and no significant 
effect in consumers. The authors suggest that this shows that modulation of cerebral blood 
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flow does occur with a typical single serving of caffeine, but that regular consumers 
develop a tolerance for this effect.  
 
1.4.5 Caffeine Summary 
 
To summarise, caffeine has been found to have its most robust effects on alertness and 
attention. This is particularly evident when sustained performance is required or the 
consumer is already in a fatigued state. There is some evidence that caffeine can improve 
memory performance, but overall the evidence remains equivocal. The beneficial effects of 
caffeine are seen at doses similar to a typical cup of tea or coffee (50-75mg), although 
doses as low as 12.5mg have been found to be equally effective. By contrast high doses, 
for example over 500mg have been found to lead to decrements in performance and 
increase anxiety. The effects of caffeine on an individual are also moderated by factors 
such as age and consumer status. 
 
1.5 Caffeine mechanisms of action 
 
After caffeine has been ingested it is rapidly absorbed by the gastrointestinal tract, with 
peak plasma levels occurring around 30-60 minutes post consumption, and the half-life 
being around 3-5 hours (Lorist & Tops, 2003). Whilst caffeine has been found to have a 
variety of different mechanism of action including activation of adenylate cyclase; 
mobilisation of calcium from the sarcoplasmic reticulum and inhibition of 
phosphodiesterase (Nehlig, Daval, & Debry 1992; Sawyok & Yaksh, 1993), the action of 
caffeine at levels that are achieved through usual human consumption are thought to be 
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mainly related to its actions in the antagonism of the adenosine receptors (Fredholm, 
Bättig, Holmén, Nehlig, & Zvartau, 1999). Adenosine triphosphate (ATP) is used for 
cellular energy and it is manufactured from glucose via the Krebs cycle. When ATP is 
broken-down cyclic adenosine monophosphate (cAMP) is formed and when cAMP is 
broken-down adenosine is formed (Fredholm et al., 1999). Adenosine then builds up 
throughout the day whilst the person is awake and signals tiredness in preparation for sleep 
(Fredholm et al., 1999). Caffeine is able to pass through the blood-brain barrier due to its 
hydrophobic properties (Nehlig, 2010). Its double-ringed molecular structure is similar to 
that of adenosine, and therefore caffeine is able to bind to the adenosine receptors in the 
brain acting as a competitive agonist (Poltev et al., 2010). As adenosine is A central 
nervous system depressant, through its’ antagonism of the adenosine receptors, caffeine 
removes the endogenous adenosinergic tonus and leads to an increase in neurotransmission 
(Nehlig, 1999; Nehlig et al., 1992). In particular caffeine’s effects are thought to be due to 
its competitive antagonistic actions at the A1 and A2A adenosine receptor subtypes (Garrett 
& Griffiths, 1997; Lorist & Tops 2003). Although present in almost all brain areas, 
adenosine A1 receptors have the greatest concentration in the hippocampus, cerebral and 
cerebellar cortex and certain thalamic nuclei (Goodman & Snyder, 1982; Fastbom, Pazos 
& Palacios, 1987). Adenosine A2A receptors are found to be concentrated in the dopamine-
rich regions of the brain (Fredholm et al., 1999), namely the striatum, nucleus accumbens 
and olfactory tubercle (Javis & Williams, 1989; Ongini & Fredholm, 1996). Moreover, 
adenosine receptors are found on many central neurons including noradrenergic, 
dopaminergic, cholinergic and glutaminergic systems (Daly and Fredholm, 1998). 
Consequently, through its action on adenosine receptors located in these pathways, 
caffeine exerts its effects on numerous neurotransmitter systems.  
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The neuronal effects of caffeine in inhibiting adenosine can directly explain the beneficial 
behavioural effects seen from caffeine consumption, specifically improvements in 
alertness and vigilance and a reduction in fatigue (Liberman et al., 2002). Of particular 
interest to the observed behavioural effects appears to be an increase in  dopaminergic 
activity (Garrett & Griffiths, 1997), which has been suggested to mediate caffeine’s 
stimulating effects (Ferré, Fuxe, von Euler, Johansson, & Fredholm, 1992). It is interesting 
to note, however that baseline arousal appears to be an important moderating factor of its 
effect on different neurotransmitter systems (Smith, Brice, Nash, Rich and Nutt, 2003). For 
example, the behavioural effects of caffeine proposed to pertain to increased cholinergic 
activity (including faster encoding of information, improved vigilance performance) have 
been observed in both alert and fatigued participants , whereas those pertaining to 
noradrenergic effects (including faster simple reaction time and fewer ‘attentional lapses’) 
have mainly been observed in fatigued participants (Smith, Sutherland & Christopher, 
2005).  The beneficial effects of caffeine in low arousal states may therefore be because it 
counteracts the reductions in central noradrenaline turnover (Smith et al., 2003). 
 
1.6 Glucose and caffeine in combination 
 
Whilst there is a paucity of studies which have examined the effects of glucose and 
caffeine consumed together on cognition and mood, those that have been conducted have 
included a wide range of behavioural and physiological measures. As well as cognitive 
performance and mood; sleep quality, manual dexterity, frontal functions and 
physiological parameters have been examined (Adan & Serra-Grabulosa, 2010; Alford, 
Cox, & Wescott, 2001; Barthel, Mechau, Wehr, Schnittker, Liesen & Weib, 2001; Jay, 
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Petrilli, Ferguson, Dawson, & Lamond, 2006). The research has often focused on their 
effects together in the form of ‘energy drinks’. This section will examine the effects of 
these substances in combination on cognition, mood and physiological outcomes; 




Individually both glucose and caffeine have been shown to improve memory function 
(Foster, et al., 1998; Kelemen & Creeley, 2001; Meikle, Riby, & Stollery, 2005; Smith et 
al., 1999; Sünram-Lea et al., 2001). Beneficial effects have also been found on memory 
when the are consumed in combination (Adan & Serra-Grabulosa, 2010; Alford et al., 
2001; Sünram-Lea, Owen-Lynch, Robinson, Jones and Hu, 2012). Alford et al., (2001) 
looked at the effects of ‘Red Bull’ energy drink, which contains 80mg caffeine and 5.25g 
glucose and found that it significantly improved immediate recall memory. Other 
researchers have found beneficial effects on both immediate and delayed memory (Adan & 
Serra-Grabulosa, 2010; Sünram-Lea, et al., 2012). Adan and Serra-Grabulosa (2010) 
compared the effects of a combination of 75mg caffeine and 75g glucose consumed in a 
water vehicle, to each of the treatments in isolation consumed in a water vehicle and a 
plain water placebo. As part of their battery of tasks they assessed memory using the 
Auditory Verbal Learning Memory Test (immediate and consolidation memory). 
Immediate recall was improved following the caffeine and glucose combination compared 
to either treatment in isolation or placebo, with more words remembered in the last two 
immediate recall trials of the RAVLT. Delayed word recall was also improved following 
the caffeine and glucose combination compared to the placebo or glucose in isolation. 
However other research has only found effects on delayed memory performance (Scholey 
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& Kennedy, 2004; Sünram-Lea et al., 2012). Sünram-Lea et al., (2012) examined the 
effects of an energy drink in a stressful, fire-fighting training situation. They looked at two 
types of energy drinks, the first contained 50g glucose and 40mg caffeine and the second 
contained 10.25g fructose/glucose and 80mg caffeine and these were both compared to a 
matched placebo. Participants were all taking part in a fire-training course. The first energy 
drink (50g glucose/40mg caffeine) ameliorated the decline in performance due to stress 
(and physical exercise) in delayed recall. Scholey and Kennedy (2004) investigated the 
individual components of an energy drink, including flavouring levels of herbs. They used 
the Cognitive Drug Research (CDR) Battery to assess cognitive performance. Participants 
received either a placebo (which was just the vehicle containing mainly water with 
artificial sweeteners and flavourings to make it matched to the active treatment); or the 
vehicle plus 75mg caffeine; or the vehicle plus 37.5g glucose; or the vehicle plus 
flavouring level of herbs (Ginseng 12.5mg, Ginkgo biloba extract 2.004mg); or the 
complete energy drink which contained 75mg caffeine, 37.5g glucose and the flavouring 
levels of herbs. Participants received all of the drinks at separate visits administered in a 
randomised balanced order. The complete energy drink led to significant improvements on 
what they termed ‘secondary memory’ (which combines the percentage accuracy scores of 
the delayed word recognition, delayed picture recognition, immediate word recall and 
delayed word recall tasks) (Scholey & Kennedy, 2004). When the constituents of the 
energy drink were administered alone, only caffeine showed a trend for improved 
performance on ‘secondary memory’. In contrast Smit & Rogers,(2002) found no effect on 
memory performance. They compared the effects of two energy drinks to equivalent 
volume of bottled spring water placebos and ‘nothing’ which was a short break. Energy 
drink A was 150ml and Energy drink B was 250ml. Both had an equivalent caffeine 
content of 75mg, and they both contained glucose and were iso-caloric, but no further 
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details were given as to the exact amount of glucose. They also contained different 
variations of vitamins and drink A also contained ferrous gluconate. They found no effects 
on either immediate or delayed memory recall by any of the treatments.  
With regards to working memory, there is little evidence to support any benefits of 
caffeine and glucose when consumed together. Whilst Scholey and Kennedy (2004) found 
some evidence to suggest a beneficial effect on working memory as there was a trend 
towards an increase in total responses on serial subtraction tasks, other researchers have 
found no effects. Adan and Serra-Grabulosa (2010) assessed working memory using the 
backward Digit Span of WAIS and found no treatment effects. Urquiza and Vieyra (2015) 
examined the effects of caffeine and sugar (glucose and fructose) on working memory 
using the N-Back task (1 back/2 back/3 back). They compared three treatments: 
Decaffeinated coffee with sugar (15g), caffeinated coffee with no sugar (~125mg 
caffeine), and caffeinated coffee with sugar. They found no effects from sugar alone and 
no evidence of a synergistic effect between caffeine and sugar. They did find significant 
improvements following the caffeine treatment and the combination treatment on the 2-
back task and following caffeine on the 3-back task. In addition, there was some evidence 
to suggest that the benefits were increased in non-habitual caffeine consumers when they 
consumed caffeine and sugar.  
Overall whilst there is some evidence to suggest that glucose and caffeine in combination 
are beneficial for verbal episodic memory it is not unequivocal. One of the reasons for this 
may be due to the dosages investigated. Whilst in the single dose literature 25g glucose has 
been found to be most effective in enhancing verbal episodic memory (Sünram-Lea et al., 
2012), this dose has not been investigated in the combined literature. It may be that as with 





Attention is another factor which has been investigated as the consumption of caffeine 
alone has been found to improve attention (Brice & Smith 2001a; Hindmarch, et al., 2000; 
Kennedy, et al., 2008; Smith, et al.,, 1999). There is some evidence of beneficial effects of 
caffeine and glucose when consumed together (Adan & Serra-Grabulosa, 2010; Gershon, 
Shiner and Ronen, 2009; Howard & Marczinski, 2010; Kennedy & Scholey, 2004; Mets, 
Ketzer, Blom, van Gerven, van Willigenberg, Olivier and Verster, 2010; Mucignat-
Caretta, 1998; Scholey & Kennedy 2004; Smit & Rogers, 2002).  
Howard & Marczinski (2010) found that ‘Red Bull’ decreased reaction times on a cued go-
no-go task. They used three different doses, 1.8ml/kg, 3.6ml/kg and 5.4ml/kg and found 
that although all the doses elicited improvements, compared to the placebo and a no drink 
condition; it was actually the lowest dose which had the greatest effect. This dose was 
approximately equivalent to half of a 250ml can for an average 70kg individual and was 
equivalent to approximately 45.6mg caffeine and approximately 2.5g glucose. Kennedy & 
Scholey (2004) carried out two studies looking at different energy drinks. In the first study 
there were two active energy drinks, one contained 68g glucose and 38mg caffeine and the 
other contained 68g glucose and 46mg caffeine. In the second study the energy drink 
contained 60g glucose and 33mg caffeine. Both studies used a matched placebo for 
comparison. They examined the effects on the Cognitive Demand Battery (CDB) which 
comprised of two minutes of Serial 3 subtractions, two minutes of Serial 7 subtractions 
and five minutes of the Rapid Visual Information Processing (RVIP) task, and a mental 
fatigue visual analogue scale. Completion of these tasks took approximately 10 minutes 
and they were repeated 6 times in total post-dose. All three active treatments improved 
accuracy on the RVIP task. In study one this was evident from 35-39 minutes after 
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treatment and in the second study from 45-49 minutes after treatment. Smit & Rogers 
(2002), investigated attention using the Simple Reaction Time (SRT) and Rapid Visual 
Information Processing (RVIP) tasks and found that both energy drinks improved 
performance on SRT, whereas only drink A showed a significant improvement on the 
RVIP task compared to ‘nothing’. Both drinks contained 75mg caffeine, the amount of 
glucose was unspecified, but they were iso-caloric, however drink A was a smaller 
quantity. Adan & Serra-Grabulosa (2010) assessed attention using the California 
Computerised Assessment Package (reaction time, sustained attention, and visual scanning 
speed). They found that reaction time was faster in the simple reaction time task following 
75mg caffeine, 75g glucose and, both the caffeine and glucose in combination compared to 
placebo. Scholey and Kennedy (2004) in their examination of the effects of a whole energy 
drink compared to its components found that the complete energy drink (containing 75mg 
caffeine and 37.5g glucose) led to significant improvements on what they described as the 
‘speed of attention’ factor (which combines the reaction time results for simple reaction 
time, choice reaction time and digit vigilance) compared to placebo. This effect was not 
found following either caffeine or glucose alone, however there was a trend towards 
improved ‘accuracy of attention’ (which combines the percentage accuracy scores for 
choice reaction time and digit vigilance), following caffeine on its own.  
The effects of these substances have also been investigated on driving performance which 
requires the maintenance of attention over a prolonged period (Gershon et al., 2009; Mets 
et al., 2010). Gershon et al., (2009) compared the use of what they termed a ‘Functional 
Energy Drink’ (FED) to a manual-dexterity/mastication activity (MD/MT task) (which 
was shelling and eating sunflower seeds) as strategies for preventing fatigue whilst driving. 
The FED used, whilst not explicitly stated as ‘Red Bull’, was described as a commercially 
available Energy Drink containing the exact same ingredients as ‘Red Bull’. The dose used 
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in this study was 2 x 250ml cans which contained 160mg caffeine and 10g glucose in total, 
consumed 20 minutes before the 2 hour morning driving task commenced. This was 
followed by a second 2 hour evening driving task on the same day for each condition. 
Driving performance, as measured by speed, steering and lane deviations, and performance 
on a peripheral target detection task was significantly better following the FED compared 
to the MD/MT task and control condition. Although it should be noted that the authors 
point to the problem that the MD/MT task participants had to use their right hand to pick 
up the sunflower seeds and this might have impacted on their ability to perform the other 
tasks (Gershon et al., 2009). Mets et al., (2010) were interested in studying the effects of a 
FED on fatigue during a prolonged driving task. They had participants drive for 2 hours, 
stop for a 15 minute break, and then drive for another 2 hours. During the 15 minute break 
participants consumed either a ‘Red Bull’ FED or a placebo, which was Red Bull without 
the active ingredients (caffeine (75mg), taurine, glucuronolactone, B vitamins (niacin, 
pantothenic acid, B6, B12 and inositol), but still containing the glucose (5.25g) and 
saccharose. They also compared this to a condition whereby the participants drove for 4 
hours without taking a break. They found no significant differences after the first 2 hours 
of driving between conditions. After ingestion of the ‘Red Bull’ FED there was a 




 hours in the Standard Deviation of Lateral 
Position (SDLP) i.e. the weaving of the car. During the 3
rd
 hour the ‘Red Bull’ FED also 
reduced the standard deviation of speed and improved the subjective driving quality (Mets 
et al., 2010). This research shows that when consumed together caffeine and glucose can 
improve attention. 
However other research has not found beneficial effects of caffeine and glucose on 
attention (Anderson & Horne, 2006; Jay et al., 2006; Mucignat-Caretta, 1998; Sünram-Lea 
et al., 2012). Mucignat-Caretta (1998) examined the effects of ‘Red Bull’ compared to a 
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matched placebo on 12 participants’ (6 male and 6 female) performance on a simple 
reaction time and a Go-no-go reaction time task. They found that ‘Red Bull’ had no effect 
on simple reaction time and only significantly improved performance in females on a Go-
no-go reaction time task. The author suggests that this may be related to caffeine acting 
differently on different cognitive strategies adopted by the males and females to complete 
the task. Specifically, that as the data showed males to be responding consistently faster 
than females, caffeine was able to modulate the performance of the females compared to 
the males as the males had already reached their maximum performance and so no further 
improvement was possible (Mucignat-Caretta, 1998).  Jay et al., (2006) investigated a 
‘Functional Energy Drink (FED) that although not stated to be ‘Red Bull’, had almost 
identical ingredients. They looked at the impact of the FED on subsequent quality of sleep. 
Participants were administered either two FED’s, one at each of two separate time points, 
or they did not consume anything. The FED’s were 250ml each and contained 1000mg 
taurine, 600mg glucoronolactone, 80mg caffeine, 5.25g glucose, 21.5g sucrose, B vitamins 
and flavours. Participants had an extended period of wakefulness (24.5hrs) during which 
the two FED’s were administered or not, followed by a recovery sleep which was followed 
in turn by post sleep assessments. Sleepiness was assessed using a 10 minute Psychomotor 
Vigilance Task (PVT) during the post sleep assessment. The important measure is ‘lapses’ 
where the response is longer that 500ms after the stimulus has appeared. The PVT consists 
of watching a computer screen and pressing a response button when a digital millisecond 
clock appears on the screen. They found no effects of the FED on performance on the 
PVT. Anderson and Horne (2006) investigated the effects of an energy drink containing 
42g glucose and 30 mg caffeine on reaction time and subjective sleepiness ratings. 
Participants were sleep restricted to 5 hours the night before, and completed the 
Psychomotor Vigilance Test (PVT) for 90 minutes. They found that participants had 
40 
 
slower reaction times and more ‘lapses’ in concentration during the final 30 minutes of the 
PVT following the energy drink. Sünram-Lea et al., (2012) used a Letter Cancellation 
Task and a Letter-digit Substitution Task to measure attention. However they found no 
effects of either energy drink (50g glucose & 40mg Caffeine / 10.25g fructose/glucose and 
80mg caffeine) on attention.  
The effects of caffeine and glucose in combination on attention are therefore not 
conclusive. However as such wide ranging doses have been examined, and often 
administered in conjunction with other potentially active ingredients, it could be that as has 
been found in the single dose literature there is an optimal dose or dose range for the 
effects and this would go some way towards explaining the equivocal results. 
 
1.6.3 Executive Function 
 
A small amount of research has examined the effects of glucose and caffeine on executive 
function; however the majority have found no effects (Adan & Serra-Grabulosa, 2010; 
Sünram-Lea et al., 2012). Adan & Serra-Grabulosa (2010) assessed executive function 
using the Wisconsin Card Sort task, but they found no effects of 75mg of caffeine or 75g 
glucose or their combination on the task. Sünram-Lea et al., (2012) included a 
Grammatical Reasoning Task in their study which is an executive function task, but they 
did not find any effects of either of the two energy drinks (50g glucose and 40mg caffeine; 
10.25g fructose/glucose and 80mg caffeine). 
However, Scholey, Savage, O’Neill, Owen, Stough, Priestley and Wetherell (2014) 
assessed the effects of 25g glucose, 60g glucose and a combination of 60g glucose and 
40mg caffeine on participants’ multi-tasking performance compared to placebo. 
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Participants completed a multi-tasking framework, consisting of the simultaneous 
completion of mathematical processing, Stroop, memory search and tracker tasks, at 
baseline and then 30 minutes post dose. Overall they found that the group who had 
received the 60g glucose and 40mg caffeine combination scored significantly higher total 
scores on the multi-tasking framework when compared to placebo or the 60g glucose 
group. There was also a trend for a treatment effect on the speed of response on the Stroop 
task, they found that the 60g glucose/40mg caffeine combination group performed 
significantly faster than the placebo and 60g glucose groups. The Stroop task measures 
selective attention and response inhibition, and therefore assesses executive function as 
participants have to inhibit their response to the meaning of the word and respond instead 
to its physical properties (Scholey et al., 2014). The authors suggest that the improvement 
in executive functioning following the combination dose is due to the ability to allocate 
more attentional resources to the demands of the multi-tasking framework. However the 
authors also acknowledge that due to the design of the study i.e. caffeine was only 
administered in combination with glucose and not alone, that these effects may solely be 
attributable to caffeine and not due to its combined effects with glucose (Scholey et al., 
2014).  
The findings here suggest that there may be some beneficial effects of caffeine and glucose 
in combination on executive functioning, but that these may be mediated by cognitive 
load. The multi-tasking nature of the tasks in the Scholey et al., (2014) study can arguably 
be said to increase the cognitive load of the task, compared to tasks used in the other 
studies and therefore this additional cognitive load may be necessary to see the beneficial 





In terms of mood, the effects of consuming glucose and caffeine in combination have been 
found to be mainly positive (Gershon, et al., 2009; Howard & Marczinski, 2010; Kennedy 
& Scholey, 2004; Mets et al., 2010; Smit & Rogers, 2002; Sünram-Lea et al., 2012). 
Howard & Marczinski (2010) found that following three doses of ‘Red Bull’ participants’ 
rating of stimulation were increased (as measured by the Biphasic Alcohol Effects Scale 
(BAES) where participants rate their feelings of stimulation and sedation after drink 
consumption), and their ratings of mental fatigue decreased. As with the cognitive effects 
they found that the mood effects were greatest following the lowest dose (1.8ml/kg) 
compared to a placebo and a no drink condition. This equated to approximately 45.6mg 
caffeine and 2.5g glucose for an average 70kg individual. Kennedy & Scholey (2004) 
found that during the completion of an extended cognitively demanding task, participants’ 
ratings of mental fatigue were improved following two of the three energy drinks 
examined, containing 68g glucose/46mg caffeine and 60g glucose/33mg caffeine, but not 
following the 68g glucose/38mg caffeine combination. Smit & Rogers (2002) assessed 12 
visual analogue scales; revitalised, energetic, awake, alert, clearheaded, overall mood, 
relaxed, thirsty, tense, fatigued, bored and tired, in their study. They conducted a Principle 
Components Analysis on the mood data and identified three main dimensions; ‘Energetic 
arousal’; ‘Tense arousal’, and ‘Thirst’. Following both of the energy drinks (Drink A 
150ml, Drink B 250ml; both 75mg caffeine and iso-caloric), ‘Energetic Arousal’ was 
increased and ratings of boredom were reduced. After drink B participants rated 
themselves as significantly less ‘Tense’ compared to after ‘nothing’. ‘Overall mood’ was 
also better after drink B. Mets et al., (2010) found in their driving study that ingestion of 





 hour and during the 3
rd
 hour it also reduced the mental effort required to 
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perform the task compared to placebo. Sünram-Lea et al., (2012) used the Bond-Lader, the 
State-Trait Anxiety Inventory (STAI) and Stress Arousal Checklist to measure mood 
changes in participants across the day during a stressful fire-fighting training situation. The 
first energy drink, which contained 50g glucose and 40mg caffeine, led to a reduction in 
anxiety and significantly reduced self-reported levels of stress following the search and 
rescue, but the second energy drink containing 10.25g fructose/glucose and 80mg caffeine 
had no effect. Arousal, alertness, contentedness and calmness were not affected by any of 
the drinks.  
Some studies however have found evidence of negative effects on mood (Anderson & 
Horne, 2006; Gershon et al., 2009). Gershon et al., (2009) found the participants rated 
themselves as significantly less fatigued in the morning driving session following the FED, 
which contained 160mg caffeine and 10g glucose, and the manual-dexterity/mastication 
activity (MD/MT task). However in the afternoon session there was a slight ‘rebound’ 
effect of the FED and the participants reported themselves as more fatigued than compared 
to the control condition. Anderson & Horne (2006) found that an energy drink containing 
42g glucose and 30mg caffeine did not counteract sleepiness as measured by the 
Karolinska Sleepiness Scale (KSS) in participants who had restricted sleep (5hrs) the night 
before compared to a taste-matched placebo. 
Whilst the evidence for mood effects is not conclusive, the evidence to date suggests 
largely beneficial effects of caffeine and glucose when consumed together. Overall the 
pattern of results is similar to that found when either substance is consumed alone. Many 
of the studies described above have found that participants report feeling less sleepy, less 
mentally fatigued, increased energy, less anxious and less tense after consumption of 
caffeine and glucose (Gershon et al., 2009; Howard & Marczinski, 2010; Kennedy & 
Scholey, 2004; Mets et al., 2010; Smit & Rogers, 2002; Sünram-Lea et al., 2012). 
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Caffeine alone has been found to increase alertness and reduce fatigue (Glade, 2010; 
Smith, 2002); while glucose has been associated with feeling less tense (Benton & Owens, 





The effects of caffeine and glucose in combination have also been examined across a wide 
range of neurocognitive and other physiological outcome measures (Barthel et al., 2001; 
Gershon et al., 2009; Jay et al., 2006; Rao, Henglong & Nobre, 2005; Reyner & Horne, 
2002; Serra-Grabulosa, Adan, Falcón & Bargallo, 2010; Specterman et al., 2005). Rao et 
al., (2005) examined Event-related potentials (ERP’s) during a sustained visual selection 
attention task, following administration of an energy drink containing 60g glucose and 
40mg caffeine, compared to a colour and taste matched placebo. They found that as well as 
improving performance in terms of speed and accuracy on the sustained visual selection 
attention task, the ERP readings following the energy drink showed earlier visual cortical 
processing and later components related to decision-making and responses were also 
enhanced. Serra-Grabulosa et al., (2010) investigated the effects of caffeine and glucose 
alone and in combination on sustained attention using functional magnetic resonance 
imaging (fMRI). Participants consumed either a placebo of 150ml of water, the water plus 
75g glucose, the water plus 75mg caffeine or the water plus 75g glucose and 75mg 
caffeine. They used a continuous performance test (CPT-IP) to measure sustained 
attention. Although there were no differences between the groups on the performance of 
the task, the participants who received the glucose-caffeine combination treatment had 
significantly lower activation in the bilateral parietal and the left prefrontal cortex. As 
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these areas are both thought to be related to attention and memory processes the authors 
interpreted it as showing that the efficiency of the attentional resources was increased 
following the glucose-caffeine combination, leading to lower activation (Serra-Grabulosa 
et al., 2010). Specterman et al., (2005) examined the effects of an energy drink containing 
68g glucose and 46mg caffeine; 68g glucose in carbonated water; 46mg caffeine in 
carbonated water, compared to a carbonated water placebo, on Motor-evoked potentials 
(MEPs). These are an index of corticospinal excitability and therefore can be used to 
investigate the effect of the energy drink and its’ components on voluntary control 
pathways and this may have implications on performance (Specterman et al., 2005). They 
used Electromyographic (EMG) recordings to monitor the response elicited by 
Transcranial Magnetic Stimulation (TMS) and Maximal Electrical Stimulation. They 
found that the MEPs rose after consumption of the energy drink, and the larger MEPs 
occurred when blood glucose concentrations were at their highest. However the individual 
effects of caffeine and glucose added together were much greater than the effects seen 
when they were administered together in the energy drink (Specterman et al., 2005). The 
authors suggest that the maximal threshold of excitability of the synapses might be reached 
by either of the active ingredients alone and therefore there can be no additional effect 
when they are consumed in combination. Sünram-Lea et al., (2012) found no effects of 
either of their treatment drinks (50g glucose and 40mg caffeine; 10.25g fructose/glucose 
and 80mg caffeine) compared to a matched placebo on cortisol measures taken during a 
stressful, fire-fighting training situation. Gershon et al., (2009) as described above, also 
measured heart rate variability was used as an objective, physiological measure of fatigue 
and found variability did increase across the drives in both morning and evening, showing 
that participants were fatiguing during the task. However the variability was significantly 
reduced following the FED and MD/MT task. 
46 
 
Barthel et al., (2001) used ‘Red Bull’ to examine the effects of taurine, caffeine and 
physical stress on the readiness potential or Bereitschaftpotentiale (BP’s), preceding 
voluntary self-paced pedalling movements. They compared a ‘Verum’ test drink which 
was original ‘Red Bull’ (80mg caffeine and 5.25g glucose per 250ml); a ‘Control’ test 
drink which was ‘Red Bull’ without taurine or glucuronolactone; and a ‘Placebo’ test drink 
which was ‘Red Bull’ without taurine, glucuronolactone, or caffeine, but with glucose and 
saccharose. The drinks were all 500ml and therefore contained twice the amount of 
ingredients found in the standard 250ml ‘Red Bull’ serving, both the ‘Verum’ and the 
‘Control’ test drinks contained 160mg caffeine. Participants cycled with increasing 
intensity during the testing sessions. They found that whilst BP’s increased at a lower 
workload following the ‘Control’ caffeine condition, the ‘Verum’ condition which 
included taurine and caffeine prevented this ‘over-shoot’. Participants also felt better at 
rest and after exercise following the ‘Verum’ condition. 
Jay et al., (2006) looked at what they termed a ‘Functional Energy Drink’ (FED) that 
although not stated to be ‘Red Bull’, had almost identical ingredients. They examined the 
impact of the FED on subsequent quality of sleep. Participants were administered either 
two FED’s, one at each of two separate time points, or they did not consume anything. The 
FED’s were 250ml each and contained 1000mg taurine, 600mg glucoronolactone, 80mg 
caffeine, 5.25g glucose, 21.5g sucrose, B vitamins and flavours. Participants had an 
extended period of wakefulness (24.5hrs) during which the two FED’s were administered 
or not, followed by a recovery sleep which was followed in turn by post sleep assessments. 
EEG was used to measure quality of sleep during the recovery sleep and sleepiness was 
assessed using a 10 minute Psychomotor Vigilance Task (PVT) during the post sleep 
assessment. Following the administration of the FED’s sleep onset latency was unaffected 
and participants still achieved the same amount of slow wave sleep. There were no effects 
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on the PVT task. Horne and Reyner (2001) found that 2 x 250ml cans Red Bull (10.5g 
glucose and 80mg caffeine) improved performance on a driving simulator task where ‘lane 
drifting’ was used as a measure of sleepiness impairing performance and the participants 
were sleep restricted to 5 hours sleep (by delaying their bedtime) prior to participating.  In 
a further study Reyner and Horne (2002) also used EEG to measure objective sleepiness 
parameters. They found that following a single serving of Red Bull (containing 5.25g 
glucose and 80mg caffeine) that there was a reduction in ‘lane drifting’ and subjective 
sleepiness in the first 90 minutes of a 2 hour drive There was a trend for the alpha (α) and 
theta (θ) power to be reduced during the middle hour of the drive, indicating that the 
participants were less sleepy, following the energy drink. 
These studies suggest that caffeine and glucose consumed together can modulate various 
physiological parameters and improve behavioural performance. However, effects on 
physiological parameters can also occur in the absence of any behavioural improvements, 
and therefore suggests that they can improve physiological processes so that the same 










Table 1.1 Summary of previous findings for combined glucose and caffeine 
administration on cognitive domains 
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1.6.6 Methodological Limitations 
 
Overall there are no clear patterns to the results found after the consumption of glucose 
and caffeine, and this, at least in part can be attributed to methodological limitations. The 
focus of much of the ‘Red Bull’ research is the effects of glucuronolactone, rather than 
glucose. Glucuronolactone is produced in the liver by the metabolism of glucose, and is 
used to build connective tissue. For example, Seidl, Peyrl, Nicham, & Hauser (2000) 
examined the effects of capsules that contained 80mg caffeine, 1g taurine and 600mg 
glucoronolatone (CTG capsules) compared to placebo capsules (containing wheat-bran). In 
both conditions participants also consumed 250ml of water with the capsules. They 
recorded event-related potentials whilst participants were performing the d2 test which 
measures attention capacity (in a stressful situation); the P300 event-related potential can 
be used as a marker for attention (Seidl, Hauser, Bernert, Marx, Freilinger & Lubec, 1997). 
They also used the Basler Befindlichkeits Skala to measure changes in the actual status of 
mood or subjective feelings of well-being. They found that CTG capsules improved 
reaction time and also preserved the P300 latencies which showed significant delay 
following placebo. Indicating that attention was improved following the CTG capsules 
(Seidl et al., 2000). The results of the d2-test confirmed the ERP-results, with the CTG 
capsules improving psychomotor speed and improving overall concentration (Seidl et al., 
2000). They also found that mood declined following the placebo treatment whereas the 
active treatment prevented this decline (Seidl et al., 2000). Whilst glucoronolatone was not 
the only potential ingredient in this study treatment, the results here suggest that it can 
have both physiological and behavioural effects or modulate the effects of other active 
ingredients.   
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This focus on glucoronolatone also has implications on the findings in terms of the effect 
of caffeine and glucose as in some studies the placebo drink contains glucose.. In Barthel 
et al.,’s study (2001) the placebo they used contained 10.5g of glucose as they only took 
out the taurine, glucuronolactone and caffeine. This was also the case in Howard and 
Marczinski’ s study (2010) where the placebo still contained glucose. For their average 
78kg individual this was 29.3g of glucose. This means that it is difficult to know exactly 
what effects glucose may be having in combination with these other substances. Although 
it must be noted that, Warburton et al., (2001) carried out two studies investigating the 
effects of ‘Red Bull’ on cognition and mood using a sugar free placebo drink (study 1) and 
a placebo drink which contained a relatively small amount of glucose (6.5 g; study 2). In 
both studies they used ‘Red Bull’ [taurine (1g), glucuronolactone (600mg), caffeine 
(80mg), glucose (5.25mg), sucrose (21.5mg), inositol (50mg), niacin (20mg), vitamin B6 
(5mg), vitamin B5 (5mg), vitamin B2 (1.5mg), vitamin B12 (0.005mg)] . They assessed 
RVIP, verbal reasoning, verbal memory, spatial memory and mood and both studies 
showed an almost identical pattern of results. On the RVIP task the active treatment 
increased accuracy and decreased reaction time. On the verbal reasoning task the active 
treatment improved reaction time, but did not improve accuracy. On the verbal memory 
task there was no improvement in words remembered or errors made for either immediate 
or delayed recall.  There were no improvements of accuracy or reaction time on the spatial 
memory task. The active treatment improved self-reported ratings of alertness, clear-
headed, attentive and quick-witted (study 2 only). This would suggest that glucose at the 
levels found in ‘Red Bull’ (approximately 5.25g per 250ml), is not exerting any significant 
effect in these studies. This could be because the levels are much lower than those 
typically found to enhance cognitive performance e.g. 25-50g (Foster, et al., 1998; 
Kennedy & Scholey, 2000; Meikle, Riby, & Stollery, 2005; Sünram-Lea et al., 2001; 
54 
 
Sünram-Lea, et al., 2002). Also (although it is not always detailed clearly in the studies), 
‘Red Bull’ contains other ingredients such as B vitamins that may remain in the placebo 
(as only glucuronolactone, taurine and caffeine are removed). These ingredients may have 
effects on cognition and mood that are not taken into account as previous research has 
shown they also have their own effects on cognition and mood (Bryan, Calvaresi, & 
Hughes, 2002). Therefore it is possible that these additional ingredients are affecting the 
results of the studies, and therefore this warrants further investigation. 
Another factor which could influence the results of the studies is the properties of the 
treatment drinks. For example, Smit, Cotton, Hughes, and Rogers, (2004) conducted three 
studies to examine the effects of carbonation in energy drinks. For all three studies they 
looked at the effects on SRT, RVIP, immediate and delayed word recall, letter search and 
mood questionnaires. In the first study they compared the effects of a full energy drink 
containing 1000mg taurine, 75mg caffeine and 37.5g carbohydrate to an energy drink 
placebo and still water. The energy drink had immediate effects on the reaction time of the 
SRT and these were sustained for at least half an hour. The accuracy performance on the 
RVIP task was also improved immediately and this was sustained following the full 
energy drink. The full energy drink also had a positive impact with participants reporting 
increases in Energetic Arousal and its components. Smit et al., (2004) suggest that the 
effect can be seen as preventing a decline in Energetic Arousal that occurs after the 
placebo treatment. This was noticeable from 30-60 minutes and sustained until 90 minutes 
post treatment. Participants also scored significantly higher on Hedonic Tone. Following 
the full energy drink participants also reported themselves as significantly more ‘jittery’ 
and ‘tense’, however the scores for all the treatments were relatively low on these 
dimensions. In the second study the researchers compared a full energy drink, this time 
containing 75mg caffeine and 37.5g carbohydrate, with a no caffeine energy drink (37.5g 
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CHO), and a no carbohydrate energy drink (75mg caffeine), an energy drink placebo and a 
none carbonated energy drink (75mg caffeine, 37.5g CHO). They found improvements in 
reaction time after the no carbohydrate (caffeine containing) treatment and mood was also 
modulated by caffeine with increases in Energetic Arousal in comparison to the other 
treatments. There was a lack of any effects due to carbohydrate content. The caffeine 
appears to have ameliorated the decline in performance and mood which was evident 
following the non-caffeine placebos. In the third study they compared a full energy drink 
containing 62.5mg caffeine and 37.5g carbohydrate, to an energy drink without 
carbohydrate (62.5mg caffeine) and an non-carbonated energy drink (62.5mg caffeine and 
37.5g carbohydrate). They found there was a significant effect of the full energy drink on 
the Letter Search task. This was due to impairment in participants’ reaction time on the 
final and most difficult block in the last session. They also found however that the full 
energy drink reduced ‘jitteriness’ at 50 minutes and ‘tension’ at 73 minutes post treatment. 
There was also a trend for the carbonised energy drink to decrease scores on the RVIP task 
45 minutes post treatment. However carbonation led to a significant immediate increase in 
assertive ratings and this tailed off by 50 minutes. There was also a trend for participants to 
feel more ‘cheerful’, ‘clearheaded’ and less ‘fatigued’ after the full energy drink towards 
the end of the session compared to the non-carbonated equivalent. Feeling ‘tense’ 
decreased over time following the carbonated energy drink compared to non-carbonated. 
Feeling ‘sluggish’ also decreased significantly immediately following the carbonated drink 
compared to the non-carbonated. Although ‘stomach bloated’ was increased immediately 
following the carbonated treatment, this only lasted until 50 minutes post treatment. This 
series of studies demonstrates that the properties of the treatment drink can lead to 
differing performance even when the active ingredients are the same. Therefore 
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differences in the treatment vehicles could add to the equivocal results that have been 
found in the research to date. 
When examining the doses of glucose and caffeine used in this research, it is difficult to 
get a clear picture as to which are the most effective doses. This is due to such varying 
doses being used in the research. Much of the research has used caffeine doses of around 
75mg, which is approximately the same as one cup of coffee (Smith, 2002). This dose has 
been shown to be effective in modulating cognitive performance and mood in the caffeine 
literature as discussed previously. Many of the effects on cognition seen after an energy 
drink treatment are related to effects that caffeine has, for example, improvements in 
attention and increases in alertness (Smith, 2002). There are few effects on aspects of 
cognition that are generally found to be enhanced by glucose (Smith et al., 2011), as 
discussed previously. This may be related to the levels of glucose administered in the 
energy drinks, 25g glucose has been suggested to be the optimal (Messier, 2004), however 
the doses administered can be more than twice this much (Adan & Serra-Grabulosa, 2010; 
Anderson & Horne, 2006; Kennedy & Scholey, 2004; Smit et al., 2006). One explanation 
for the lack of effects could be that the levels of glucose being administered are too high 
and they are taking participants beyond the optimum level for glucose facilitation, as 
would be expected from the inverted U-shaped dose response (Parsons & Gold, 1992). 
Another possibility is the tasks used in these studies. Previous glucose research has found 
that the enhancement in verbal episodic memory is only reliably found when dual-tasks 
procedures are employed (Foster, et al., 1998; Kennedy & Scholey, 2000; Sünram-Lea, et 
al., 2002). The energy drink research has so far failed to use this method when 
administering memory tasks. The dual-tasking procedure is necessary to increase cognitive 
demand for participants who otherwise would be performing at their optimum and 
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therefore not be as susceptible to the beneficial effects of glucose (Sünram-Lea, et al., 
2002).  
There are several other methodological issues which make it harder to draw any firm 
conclusions from the research. For example the choice of placebo used could have an 
effect (Smit et al., 2006). Several studies have used water or a non-matched drink as their 
placebo (Adan & Serra-Grabulosa, 2010; Alford et al., 2001; Serra-Grabulosa et al., 2010; 
Smit & Rogers, 2002). Smit et al., (2006) explored the role of familiarity/expectation 
effects of energy drinks. They looked at a well-known brand, Lucozade Energy (54g 
glucose, 30mg caffeine) and compared it to a placebo which was matched to this original 
drink, a Novel Full Energy Drink (54g glucose, 30mg caffeine) and a placebo that was 
matched to the novel drink. Participants attended an initial study day where they 
completed the baseline tasks and then received a small taste of each drink and ranked them 
according to their preference. After which they consumed their randomised treatment and 
completed the tasks. Over the next three weeks they attended the laboratory a further 7 
times and at each of these visits they took a sip of their allocated treatment. At a final visit 
participants again completed the baseline tasks and ranked all of the drinks according to 
their preference, from their most favourite to their least. They then consumed their 
treatment drink and completed the tasks. The tasks they used were the SRT, RVIP, Letter 
Search, Serial 7’s, Mood Questionnaires (Profile of Mood States (POMS); Activation-
Deactivation Checklist (AD ACL)) and VAS’s. On the first study day the two full energy 
drinks and the original placebo maintained performance on SRT and RVIP compared to 
deterioration in performance following the novel placebo. The strongest effects were found 
during the most demanding parts of the tasks for the SRT and RVIP. In contrast significant 
effects were found on the easiest, least memory taxing part of the Letter Search task. 
Ratings of ‘cheerful’ were increased immediately post-treatment for all drinks, especially 
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the full original drink. These findings on the first study day show that both the full energy 
drinks and the original matched placebo can lead to improvements in performance 
associated with energy drinks and so suggests that some of these may be due to expectancy 
effects. By the second study day participants had become familiar with their treatment 
drinks. It was found that compared to the placebo drinks both the full drinks led to an 
improvement and maintenance of alerting and energising moods. The full drinks also 
improved and maintained performance on the RVIP task. This suggests that after repeated 
exposure participants learn the effects of the drinks, i.e. that they do not experience any 
enhancement following the placebo drinks. This study highlights how important it is to 
have sensory matched drinks in order to avoid expectancy effects on the data (Smit et al., 
2006).  
 
Another aspect which has not been systematically explored is the optimal delay between 
drink administration and cognitive testing. Both plasma caffeine levels and blood glucose 
levels reach their peak at around 30 minutes after ingestion (Donohoe & Benton, 2000; 
Lorist & Tops, 2003). Whilst much of the research has begun the cognitive testing at 30 
minutes post-dose (e.g. Adan & Serra-Grabulosa, 2010; Alford, et al., 2001; Horne & 
Reyner, 2001; Howard & Marczinski, 2010; Mucignat-Caretta, 1998; Rao, et al., 2005; 
Scholey & Kennedy, 2004; Serra-Grabulosa, et al., 2010), other research has used different 
post-dose time points; for example 5 minutes (Smit, et al., 2006), 10 minutes (Anderson & 
Horne, 2006; Kennedy & Scholey, 2006), up to 60 mins (Seidl, et al., 2000) and 75 
minutes (Sünram-Lea, et al., 2011). Gershon, et al., (2009) assessed driving performance 
for 2 hours in the morning following an energy drink and then again for 2 hours in the 
evening. As discussed previously, they found a ‘rebound’ effect in the evening driving 
session with participants rating themselves as significantly more fatigued in the evening 
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session following consumption of the energy drink in the morning. These results illustrate 
that the time course of the effects following the consumption of energy drinks needs 
further investigation.  
The characteristics of the participants have also not been well controlled for. For example, 
the studies have used a wide range of ages from 18 to 56 years and so age might be a 
confounding factor. For example, glucoregulation can decline during ageing and affects 
the way that glucose is processed (Convit, 2005). Consequently, age might be an 
important moderating factor (Smith et al., 2011). The same applies to Body Mass Index 
(BMI), as it can have an effect on glucose regulation (Sünram-Lea et al., 2011). In many 
of the studies BMI is simply not reported and where it is, it ranges from normal weight 
participants to one study where the range goes up to as high as 43.3 Kg/m
2
 which is 
classified as morbidly obese (Smit et al., 2004). The variations of BMI and its potential 
impact on glucoregulation has not been taken into account by the researchers and 
therefore it has unknown implications on the findings. By comparison, research into the 
effects of glucose alone has found BMI to affect glucoregulation and the dose-response 
profile (Sünram-Lea et al., 2011). For example Sünram-Lea et al., (2011) found that 
participants who had a low to medium BMI benefited from administration of higher 
glucose loads, whereas those in the high BMI group showed decrements in performance 
following high glucose loads. Habitual caffeine consumption of participants has also often 
not been taken into account. Whilst some studies have only included low to moderate 
caffeine consumers (Adan & Serra-Grabulosa, 2010; Anderson & Horne, 2006; Alford et 
al., 2001; Horne & Reyner, 2001; Jay et al., 2006; Mucignat-Caretta, 1998; Reyner & 
Horne, 2002), others included a wide range of consumers e.g. 0-533.2mg daily (Smit et 
al., 2004), 46-705mg daily (Smit et al., 2006). It has been shown that caffeine has 
differing effects in those who consume little to no caffeine compared to those that 
60 
 
consume caffeine daily (Haskell et al., 2005; Kennedy & Haskell, 2011). Therefore the 
caffeine consumption of participants should be taken into account and controlled for when 
conducting this research.  
Overall there are a number of methodological limitations and confounding factors that 
have not been controlled for and which might explain the equivocal findings in the 
literature.  
 
1.7 Potential Mechanisms of Action for Combined Glucose and Caffeine 
Administration  
 
Apart from the mechanisms of action that glucose and caffeine exert in isolation, there are 
a number of potential mechanisms that might explain the effects of combined caffeine and 
glucose administration on cognitive performance. For example, caffeine has been found to 
increase glucose uptake and/or release (Graham, Sathasivam, Rowland, Marko, Greer, & 
Battram, 2001; Greer, Hudson, Ross, & Graham, 2001; Keijzers, De Galan, Tack, & 
Smits, 2002; Lee, Hudson, Kilpatrick, Graham, & Ross, 2005; Petrie et al., 2004; Pizziol 
et al., 1998; Thong et al., 2002). Pizziol et al., (1998) administered 200 mg of caffeine or 
a placebo prior to an Oral Glucose Tolerance Test (OGTT) and found that following 
caffeine participants had a greater blood glucose response and this was independent of 
insulin. The authors suggest that this may be because of caffeine-induced catecholamine 
release. However other research has found that following ingestion of caffeine, the insulin 
response is increased without a corresponding decrease in the glucose tolerance response, 
suggesting that caffeine’s effect of blood glucose is mediated by its effects on insulin 
response, whereby it reduces the glucose tolerance (Graham et al., 2001; Lee et al., 2005; 
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Petrie et al., 2004). For example, Graham et al., (2001) administered either 5mg/kg 
caffeine or placebo prior to an OGTT on different days. The participants then consumed 
75g of dextrose 1 hour later. Following the caffeine treatment insulin levels were 
increased for a prolonged period in comparison to the placebo condition, with an 
increased Area Under the Curve (AUC) for the caffeine condition. The authors suggest 
that caffeine affects insulin’s ability to clear the glucose load, i.e. that it induces 
temporary insulin insensitivity (Graham, et al., 2001). Similar results were found in obese 
men before and after a weight loss intervention (Petrie et al., 2004). Caffeine (5mg/kg) or 
a placebo was consumed 1 hour prior to an OGTT, and insulin response during the OGTT 
was greater following the treatment both before and after weight loss, however glycaemic 
response remained the same both before and after weight loss and following caffeine or 
placebo (Petrie, et al., 2004). 
Moreover, intestinal glucose absorption is affected by caffeine (Van Nieuwenhoven, 
Brummer, & Brouns, 2000). Van Nieuwenhoven et al., (2000) found that when a 
carbohydrate electrolyte solution was co-administered with caffeine (~120mg), glucose 
absorption was significantly increased (compared to after administration of the 
carbohydrate electrolyte solution alone). The authors suggest that because the glucose 
uptake is an energy requiring process, the energy for this could be provided by caffeine. 
Caffeine might enhance sodium-glucose-linked transporter protein activity which in turn 
leads to increased jejunal (intestinal) glucose uptake (Van Nieuwenhoven et al., 2000). 
This effect on glucose absorption might explain why some research has found the increase 
in glucose uptake caused by caffeine to be independent of insulin (Graham et al., 2001; 
Pizziol et al., 1998; Van Nieuwenhoven et al., 2000).  
Another mechanism proposed for caffeine’s effects on glucose uptake is via increase in 
adrenaline release. Adrenaline has antagonistic effects on insulin’s actions, including 
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those of glucose disposal (Laurent, Petersen, Russell, Cline & Shulman, 1998), and 
adrenaline levels have been found to be elevated during OGTT’s following caffeine 
administration (Battram, Bugaresti, Gusba, & Graham, 2007; Greer, Hudson, Ross & 
Graham, 2001; Keijzers et al., 2002). However, Battram et al., (2005) compared caffeine 
(5mg/kg), a placebo and either a placebo plus a low-dose adrenaline infusion, or a placebo 
plus a high-dose adrenaline infusion on glucose infusion rates via a isoglycaemic-
hyperinsulinaemic clamp (which assesses glucose disposal by determining during a 
constant insulin infusion the amount of glucose needed to maintain the normal 
concentration of glucose in the blood). Caffeine and the low-dose adrenaline infusion 
resulted in the same adrenaline concentrations, but caused different decreases in glucose 
infusion rates, 13% and 5% respectively. The authors concluded that this suggests the 
involvement of other mechanisms (Battram et al., 2005). 
Caffeine and glucose in combination may have beneficial effects on cognitive function 
due to their respective effects on the cholinergic system. Several authors have suggested 
that the memory enhancing effects of glucose is because it is a substrate for acetylcholine 
synthesis (Sünram-Lea et al., 2002b; Wenck, 1989), whilst caffeine’s antagonism of the 
adenosine receptors leads to increased cholinergic activity which provides a pathway for 
psychostimulant effects of caffeine (Carter et al., 1995). This may provide a mechanism in 
which caffeine and glucose could work in synergy to enhance cognitive performance 
above that achieved from either one independently (Scholey & Kennedy, 2004).  
However, as discussed above, there are other physiological mechanisms by which caffeine 
and glucose could interact and exert their effects. It is unlikely that the complex 
physiological and cognitive effects of caffeine and glucose will be the result of a single 
mechanism of action and it is likely to be a combination of neurotransmitter, 
neurohormonal and metabolic mechanisms (Scholey & Kennedy, 2004). The complexity 
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of these interactions could go some way towards explaining the equivocal effects in the 
literature, particularly with the addition of different doses and even participant 
characteristics e.g. sleep deprivation.    
 
1.8 Current Programme of Research 
 
It is clear from the literature reviewed in this chapter that further research into the effects 
of caffeine and glucose in combination is warranted. The aim of the studies described in 
this thesis was to systematically evaluate the behavioural effects of combined 
consumption of glucose and caffeine and to compare these with the effects produced by 
consuming either substance in isolation. This includes parametric investigations into the 
dose-response effects of combined administration, investigation into the cognitive 
domains susceptible to combined consumption effects, as well as investigations into 
potential moderating factors, such as age, time of day, cognitive effort. Moreover, in some 
of the studies reported in this thesis, we used a convergent operations approach that 
combined psychological and behavioural assessment (cognitive testing and assessment of 
mood) with evaluation of neural mechanisms (for example brain imaging using event-
related potentials) and biochemical mechanisms (most notably effects on corticosteroids 
and adrenaline) mechanisms. Using this approach our objective was to inform our 
theoretical understanding of the cognitive and physiological mechanisms involved as well 











Dose response investigation into the effects of low doses of 
glucose and caffeine on cognitive performance, mood and 










Extensive research has examined the effects of caffeine and glucose independently on 
cognitive performance and mood and found both substances to have beneficial effects on 
various aspects of cognition (for reviews see Messier, 2004; Smith, 2002). In terms of their 
cognitive effect profile, glucose has been found to have most robust effects on verbal 
episodic memory (Foster, Lidder & Sünram, 1998; Messier, 2004; Smith, Riby, Eekelen, 
& Foster, 2011), whereas caffeine appears to have most beneficial effects on vigilance 
tasks and reaction time tasks that require a sustained response (Smith, 2002).  More 
specifically, Foster et al., (1998) found that 25g glucose significantly improved 
performance on tests of long-term verbal episodic memory; however it did not have any 
facilitation effect on short-term memory tasks or on long-term non-memory tasks. They 
concluded that glucose may specifically enhance long-term memory through either 
enhanced retention or retrieval. In comparison, caffeine appears to have most beneficial 
effects on attention and vigilance (Smith, 2002). Brice and Smith (2002) found that both a 
single large dose of 200mg and smaller doses of 65mg consumed at four time-points led to 
improvements in attention compared to a placebo. Specifically, they found improved 
performance on reaction time tasks, a vigilance task, a sustained response task and a dual 
tracking/detection task. In addition, response moderators have been identified for both 
substances.  
There is evidence to suggest that the glucose facilitation effect is enhanced when tasks 
require an element of divided attention or they require high cognitive demand, particularly 
in healthy young adults where they are already considered to be performing optimally 
(Sünram-Lea, Foster, Durlach & Perez, 2002). Sünram-Lea et al., (2002) found that 
following a dose of 25g glucose, the enhancement on memory was only seen when 
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participants performed a secondary hand-movement task whilst encoding the word list they 
would later have to recall. When the participants did not complete the secondary task, or 
when the target words were intermixed with non-target words, distinguished by the 
speaker’s gender, there was no enhancing effect of glucose on memory. Therefore, it has 
been argued that in order to demonstrate the effect of glucose on memory performance, 
episodic memory capacity and/or the availability of glucose in the brain must be depleted. 
Kennedy and Scholey (2000) found a similar effect for working memory, whereby the 
glucose facilitation effect was only seen in the more difficult Serial 7s task compared to 
the easier Serial 3s task. This was again following 25g glucose. Scholey, Harper and 
Kennedy (2001) found again that glucose preferentially enhanced performance on the 
more difficult Serial 7s task. In addition, a significant reduction in peripheral blood 
glucose levels was observed irrespective of drink condition performing the more difficult 
Serial 7s task. Both these studies suggest that glucose preferentially enhances tasks which 
have a high cognitive load, and that glucose may increase neural energy expenditure 
(Kennedy & Scholey, 2000; Scholey et al., 2001). 
For caffeine, effects appear to be most pronounced when alertness levels are low and when 
performance demands are high (Lieberman, 1992). For example, caffeine has been found 
to improve performance on a demanding driving simulation task (Horne & Reyner, 1996; 
Reyner & Horne, 1997), but not on, for example, a simpler Serial 3s subtraction task 
(Kennedy & Scholey, 2000). Horne and Reyner (1996) compared the effect of a 15-minute 
nap, 150mg caffeine and a coffee placebo administered during a 30 min break between two 
1 hr car simulator tasks. The caffeine and nap conditions both significantly reduced driving 
impairments, subjective sleepiness and drowsiness as indicated by electroencephalography 
(EEG) measurement. However, caffeine gave more consistent effects as not all participants 
were able to nap in the allocated time and therefore caffeine would be a more practical 
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measure to reduce sleepiness (Horne & Reyner, 1996). Reyner and Horne (1997) found 
similar effects in 12 sleep restricted (5hrs) individuals. They compared a nap, 200mg 
caffeine and a placebo, taken during a 30 min break prior to a 2hr drive in a simulator. 
They found that caffeine significantly reduced driving incidents and subjective and EEG 
measures of sleepiness, as measured by lane drifting in a car simulator, self-ratings on the 
Karolinska Sleepiness Scale and, alpha and theta brain waves.  
Both glucose and especially caffeine administered in isolation have also been found to 
have effects on mood (Brice & Smith, 2002; Heatherley, Haywood, Seers & Rogers, 2005; 
Quinlan, Lane, & Aspinall, 1997; Reay, Kennedy & Scholey, 2006). Reay et al., (2006) 
found that 120 mins after consuming 25g glucose participants reported decreased fatigue 
on a visual analogue scale (VAS). However, other studies found no effect of glucose on 
mood when the Profile of Mood States (POMS) was used (Scholey & Fowles, 2002; 
Winder & Borill, 1998). For caffeine, increased levels of alertness and reduction in fatigue 
have been observed at doses typically found in a cup of tea or coffee (50-75mg) (Smith, 
2002). Moreover, improved ‘energy’ has been reported following 75mg caffeine 
(Heatherley et al., 2005) and 100mg of caffeine was found to decrease anxiety 30 mins 
after consumption (Quinlan et al., 1997). In addition, Brice and Smith (2002) found that 
caffeine increased alertness and anxiety, and this was independent of whether it was 
administered as on single dose of 200mg or as four separate doses of 65mg. 
However, while the behavioural and physiological effects of glucose, and caffeine 
consumed in isolation are reasonably well documented, there has been relatively little 
research into their effects when taken in combination. The data available suggests that 
when administered in combination; glucose and caffeine can improve certain aspects of 
cognition and mood (Adan & Serra-Grabulosa, 2010; Alford, Cox & Wescott, 2001; Antei 
et al., 2011; Barthel et al., 2001; Gendal et al., 2009; Gershon et al., 2009; Mets et al., 
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2010; Rao, Henglong & Nobre, 2005; Scholey et al., 2014). For example, improvements 
have been observed on performance on sustained attention tasks including the Rapid 
Visual Information Processing (RVIP) task (Adan & Serra-Grabulosa, 2010; Kennedy & 
Scholey, 2004; Scholey & Kennedy, 2004; Smit, Cotton, Hughes & Rogers, 2004), 
memory tasks (Adan & Serra-Grabulosa, 2010; Scholey & Kennedy, 2004), as well as 
increased subjective feelings of arousal (Smit & Rogers, 2002). 
More specifically, Adan and Serra-Grabulosa (2010) compared a combination dose of 
75mg caffeine and 75g glucose to each active ingredient individually and placebo. They 
found that compared to the effects of glucose and caffeine on their own, the combination 
dose improved attention and encoding and consolidation of verbal material. They 
concluded that the combination of glucose and caffeine has synergistic effects over and 
above the individual effects of each substance. Kennedy and Scholey (2004) also reported 
such potential synergistic effects. In one study participants received an ‘energy drink’ 
containing 68g glucose and 38mg caffeine; a second ‘energy drink’ containing 68g glucose 
and 46mg caffeine; and a placebo. In the second study they received an ‘energy drink’ 
containing 60g glucose and 33mg caffeine and a placebo. The results demonstrated 
improved performance on sustained attention task following administration of the three 
active treatment compared to placebo. The tasks were performed repetitively as part of an 
extended 60 minute cognitive battery and when administered in combination, glucose and 
caffeine were able to ameliorate the performance deficits that arose during this extended 
period of cognitive demand. Scholey and Kennedy (2004) also compared the components 
of an ‘energy drink’ (37.5g glucose, 75mg caffeine, ginseng and ginkgo biloba at 
flavouring levels) to the whole drink and placebo. They found that the whole drink 
significantly improved participants’ performance on ‘secondary memory’ factor (which 
combines the percentage accuracy scores of the delayed word recognition, delayed picture 
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recognition, immediate word recall and delayed word recall tasks) and ‘speed of attention’ 
factor (which combines the reaction time results for simple reaction time, choice reaction 
time and digit vigilance) as derived from tasks on the Cognitive Drug Research assessment 
battery. In a similar vein, Smit, et al., (2006) found that on their second study day, after 
manipulating their participants’ exposure and familiarity with two energy drinks and their 
placebos, that both energy drinks containing 54g glucose and 30mg caffeine improved and 
maintained sustained attention compared to their placebos. Sünram-Lea et al., (2011) 
examined the effects of two ‘energy drinks’ containing glucose and caffeine, administered 
prior to a search and rescue fire-fighting training task on subsequent cognition, mood and 
various physiological response. One ‘energy drink’ contained 50g glucose and 40mg 
caffeine, the other one contained 10.25g fructose/glucose and 80mg caffeine and these 
were compared to placebo. They found that following the drink containing 50g of glucose 
and 40mg of caffeine prevented a stress related decrease in memory performance. 
Information processing performance was also improved by both ‘energy drinks’ compared 
to placebo. 
Combined administration of glucose and caffeine also affects mood. In the above study 
Sünram-Lea et al., (2011) found that the ‘energy drink’ containing 50g glucose and 40mg 
caffeine led to reduced anxiety and significantly reduced self-reported levels of stress. 
However, no effects of either drinks were found on arousal, alertness, contentedness and 
calmness. Kennedy and Scholey (2004), found that drinks which contained 68g 
glucose/46mg caffeine and 60g glucose/33mg caffeine both improved participants’ self-
assessed ratings of mental fatigue during a long, cognitively demanding task. Yet again no 
effects on mood were observed following an ‘energy drink’, containing 37.5g glucose and 
75mg caffeine or its constituents.  
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However, whilst the research described here has shown that glucose and caffeine when 
administered together have some effects on cognitive function and mood, the results 
overall are equivocal. For example, Anderson and Horne (2006) found that compared to 
placebo, an ‘energy drink’ containing 42g glucose and 30mg caffeine, did not counteract 
sleepiness. Participants had slower reaction times and more lapses during a sustained 
vigilance task. Much of the research so far has shown effects on attention (Adan & Serra-
Grabulosa, 2010; Kennedy & Scholey, 2004; Scholey & Kennedy, 2004; Smit et al., 
2006), which could potentially be attributed to the caffeine content, as this is one of the 
effects most commonly seen after administration of caffeine (Smith, 2002). The research 
may have failed to find robust memory effects of glucose and caffeine in combination as 
the dosages used were much higher than the 25g glucose which has been shown to have 
the most robust memory effects when glucose is administered in isolation. Research 
investigating the combined effects of glucose and caffeine has also not utilised a dual-
tasking procedure at the stage of encoding, which may be critical in being able to 
demonstrate the memory enhancing effect of glucose (Sünram-Lea, Foster, Durlach & 
Perez, 2002). Also, the dose response profile for combined administration still needs to be 
established. In particular, there is a need to investigate the efficacy of lower dosage 
combinations and delineation of effects of component parts compared to combined 
administration.  
Consequently, the aim of the study was to investigate the dose-response profile of glucose 
and caffeine alone and in combination on glycaemic response, cognitive performance, 
mood and hormonal response by implementing a parametric approach administering 0, 15, 
and 25g of glucose and 0, 20 and 40mg of caffeine (alone and in combination) in order to 
compare the effects of different dosage combinations of caffeine and glucose. Given the 
weight of previous evidence for a beneficial effect of glucose and caffeine on attention, 
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this was chosen as the primary outcome measure, as measured by the accuracy on the Digit 
Vigilance task. A broad range of cognitive tasks were also utilised to allow comprehensive 
assessment of potential effects across various other cognitive domains (i.e. episodic and 
working memory). With regards to verbal episodic memory, a dual-tasking paradigm was 
also implemented, since this has shown to be critical in demonstrating effects of glucose 
administration on memory performance (Sünram-Lea, Foster, Durlach & Perez, 2002). 
Mood was assessed using a variety of subjective measures to allow broad evaluation of 
effects and identification of test and questionnaire that are most sensitive to energy drink 
effects.  
In addition, we investigated the effects of glucose and caffeine (combined and in isolation) 
on hypothalamic-anterior pituitary-adrenocortical axis (HPA axis) and sympatho-
adrenomedullary axis (SAM axis) response. Activation of the HPA axis is associated with 
the release of glucocorticoids from the adrenal cortex (cortisol in humans) and activation 
of the SAM axis results an increase in endogenous adrenergic activity, resulting in 
increased catecholamine activity (adrenaline and noradrenaline). Both caffeine and glucose 
administration have been shown to affect cortisol and/or catecholamine release (for 
example Bergendahl , Iranmanesh, Evans & Veldhuis, 2010; Bergendahl, Vance, 
Iranmanesh, Thorner & Veldhuis, 1996; Vance and Thorner, 1989, Robinson, Sünram-
Lea, Leach & Owen-Lynch, 2004; James, 2004; Lovallo, Whitsett, al ‘Absi, Sing, Vincent 
& Wilson, 2005, Graham, Rush, van Soeren, 1994). However, to date there is a lack of 
research investigating the combined effects of glucose and caffeine on hormonal response. 
Investigation of the effects of combined glucose and caffeine administration on these 
physiological parameters is important as these might –at least in part- mediate the 
behavioural effects. The results of the hormonal responses and their discussion will be 
presented in Chapter 3. 
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Sixty-four healthy young adults aged 18-35yrs were recruited for the study. There were 
recruited via the Online Research Participation System (SONA) at Lancaster University. A 
sample size of 32 participants in each study was deemed to be sufficient as this was 
comparable to other studies utilising a similar design who had found beneficial effects of 
caffeine and glucose on attention when co-administered (Kennedy & Scholey, 2004; 
Scholey & Kennedy, 2004; Smit & Rogers, 2002). All were frequent caffeine consumers, 
consuming a minimum of 120mg caffeine per day. Participants were excluded if they; had 
a diagnosis of Diabetes Mellitus; had any intolerance or allergic reaction to substances that 
contain phenylalanine and/or caffeine; were non-native English speakers; had a history of 
neurological or psychiatric illness (excluding depression or anxiety); had a current 
diagnosis of neurological or psychiatric illness (including depression or anxiety); were 
currently taking medication or nutritional supplements (excluding contraceptive pill); were 
pregnant, seeking to become pregnant or breastfeeding; had a history of or currently 
abused drugs or alcohol; smoked. Eligibility was confirmed via a Clinical Records Form 




A double-blind placebo controlled, balanced mixed design was used. With participants 
randomly allocated to two different dosing regimens (‘moderate’ versus ‘low’), each 
comprised of three different treatment combinations (glucose, caffeine and a glucose 
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caffeine combination) and a matching inert placebo. There was a 7 day (+/-2) washout 
period between treatments. Assessments of cognition, mood, fatigue and hormonal 




Drinks were supplied by GlaxoSmithKline Laboratories in 380ml lightly carbonated taste 
matched solutions. The ‘low’ dose regime consisted of a glucose drink (containing 15g 
glucose, 0mg caffeine); a caffeine drink (containing 0g glucose, 20mg caffeine); and a 
combined drink (containing 15g glucose and 20mg caffeine). The ‘moderate’ dose regime 
consisted of glucose (25g glucose, 0mg caffeine); caffeine (0g glucose, 40mg caffeine); 
caffeine and glucose (25g glucose, 40mg caffeine). Both regimes also utilised a taste 
matched placebo (0g glucose, 0mg caffeine). 
Participants were instructed to consume one drink per test session within 5 minutes. Post-
dose cognitive testing started 20 minutes after the drink administration. A 20-minute delay 
was chosen as peak plasma caffeine concentration is reached between 15 to 120 min after 
oral ingestion and brain levels remain stable for at least one hour following peak plasma 
levels (Nehlig, 1999; Nehlig & Boyet, 2000). Also this time frame was similar to the 
procedure of previous glucose studies (Foster, Lidder & Sünram, 1998) in order to ensure 






Initial screening was done during sign-up using the Lancaster recruitment on-line system 
(SONA). At the first visit for screening and training, all participants completed the 
voluntary written informed consent prior to any study procedures being performed. The 
participant was screened by the researcher and the outcome of the screening activities was 
recorded in the CRF. Personal demographic information (such as age, education height and 
weight) was also collected at this visit. They also completed a caffeine consumption 
questionnaire. Training on the cognitive tasks was then completed. No drinks were 
administered during the practice sessions and performance data from these sessions was 
not included in the analysis.  
Participants then attended the laboratory on a further 4 occasions to complete the testing 
sessions. Testing was carried out between 8.30am and 12 noon and participants were asked 
to fast for 12hrs prior to the session (i.e. no food or drink except water) and to abstain from 
alcohol for 24 hours prior to testing. Due to the cortisol awakening response participants 
were also asked to wake up no earlier than 6.30am and no later than 8am. There was a 
7(+/-2) day washout period between active days of the study. Consequently, participants 
were required to attend a weekly morning session over a period of approximately five to 
six weeks. Participants were randomised on arrival at the lab for their first study day. All 
active study days followed the same procedure. 
At the beginning of the study day, a small baseline sample of blood was taken, and further 
blood glucose measurements were taken 15 and 50 minutes after drink consumption. 
Immediately after the baseline blood sample two saliva samples were also taken using a 
Salivette (Sarstedt Ltd.). The first for the measurement of alpha amylase, and the second 
for cortisol. Further saliva samples were taken 45 minutes post-drink for alpha-amylase 
and 55 minutes post-drink for cortisol. The first blood and saliva samples were followed 
by pre-drink baseline evaluation of mood and cognition, using the cognitive test battery. 
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This was followed by administration of the day’s treatment (following a double-blind 
procedure). The post-drink cognitive test session commenced 20 minutes after drink 
consumption. Each test session comprised of completion of the cognitive test battery 
(cognitive performance), the Bond-Lader visual analogue scales, the Mood, Alertness and 
Physical Symptoms (MAPS) Questionnaire, the Stress Arousal Checklist, and the 
Activation-Deactivation adjective checklist (mood measures) and all participants received 



















































Computerized assessment was used to evaluate cognitive performance. All tasks were 
delivered within the Computerized Mental Performance Assessment System (COMPASS), 
a purpose designed software application for the flexible delivery of randomly generated 
parallel versions of standard and novel cognitive assessment tasks. With the exception of 
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the paper and pencil tasks (word recall); all responses were made using the computer 
keyboard and mouse. In this case the assessment comprised a selection of standard 
psychometric tasks with stimuli chosen to possess good face validity in an ‘everyday’ 
context. The elements of the cognitive assessment are described below. 
Word presentation 
A list of 20 words matched for frequency, concreteness and imagery was presented on the 
monitor at the rate of 1 every 2 seconds for participants to remember. During encoding, 
participants were required to perform two complex hand-movement sequences (Sünram-
Lea et al., 2001). Each sequence was performed using both hands and contains three 
movements: fist – chop – slap and back-slap – chop – fist. Participants were told to 
alternate the sequence every fifth word and they were not informed when to change, only 
that they had to keep track of this themselves. Hand-movements were performed 
continually during word presentation. 
Immediate word recall 
Immediately after the words were presented participants were given 60-seconds to write 
down as many words as they could from the list they have just seen. Participants’ 
responses were marked according to total number of errors and number of words recalled 
correctly. 
Picture presentation 
20 pictures were individually displayed in the centre of the screen at a rate of 1 every 3 
seconds. Each picture was displayed for 1 second. Participants were required to remember 
the pictures.  
Simple reaction time 
77 
 
The word ‘yes’ was presented repeatedly in the centre of the screen with inter-trial 
intervals varying randomly between 1 and 3.5 seconds. Participants were required to 
respond by pressing the space bar on their keyboard as quickly as possible, whenever the 
word appeared. Reaction times were recorded in milliseconds. 
Digit vigilance 
A single target digit was randomly selected and continuously displayed on the right side of 
the screen. In the centre a series of rapidly changing digits was displayed. Participants 
were required to press the space bar as quickly as possible, whenever the digit in the centre 
matches the target digit. Reaction times (milliseconds), percentage accuracy and number of 
false alarms were recorded. 
Choice reaction time 
The target words ‘yes’ and ‘no’ were repeatedly, randomly displayed individually in the 
centre of the screen. The inter-trial intervals varied randomly between 1-second and 3.5 
seconds.  Participants were instructed to respond by pressing the ‘m’ key for ‘yes’ and the 
‘z’ key for ‘no’ on the keyboard as quickly and accurately as possible. Reaction times 
(milliseconds) and percentage accuracy were recorded. 
Computerised Serial Sevens Task  
This task evaluates working-memory performance (Hayman, 1942). Participants were 
required to compute a running subtraction of 7, starting from a randomly generated 
number. Participants were given 2 minutes to complete this task. Number of responses, 
number of correct responses and number of incorrect responses were recorded. 
Computerized Corsi Block-Tapping Task 
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This task assessed the visual memory span (Milner, 1971). Illuminated squares appeared 
on the screen. The Squares flashed after each other in a tempo of one per second. Then the 
participant had to use the mouse to click on the buttons in the same order as they appeared 
on the screen. Outcome measures for this task were span and reaction time (milliseconds). 
Computerized Serial Threes Task  
This task evaluates working-memory performance (Hayman, 1942). Participants were 
required to compute a running subtraction of 3, starting from a randomly generated 
number. Participants were given 2 minutes to complete this task. Number of correct 
responses and number of incorrect responses were analysed. 
Delayed word recall  
Participants were given 60-seconds to write as many words as they could remember from 
the list they have seen at the beginning of the battery. Participant’s responses were 
analysed according to total number of errors and number of words recalled correctly. 
Delayed word recognition  
The 20 original words and 20 distractor words were presented individually in a randomised 
order. Participants were asked to indicate whether each word had been in the original list 
or not by using the ‘m’ key for ‘yes’ or the ‘z’ key for ‘no’ on their keyboard. Outcome 
measures included in the analysis were percentage accuracy and reaction times for both 
distractors and targets.  were recorded in addition to overall reaction times. 
Picture recognition 
The 20 original pictures and 20 distractor pictures were presented, individually in a 
randomised order. Participants were asked to indicate whether each word had been in the 
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original list or not by responding with the ‘m’ key for ‘yes’ or the ‘z’ key for ‘no’ on their 




The Bond-Lader visual analogue scales (VAS; Bond & Lader, 1974) 
Visual Analogue Scales were presented on the screen immediately after the cognitive tests. 
Participants used the mouse to position an arrow at the point on the scale that represented 
their feelings at that moment. The 16 scales were combined as recommended by Bond and 
Lader (1974) to form three mood factors: ‘alertness’, ‘calmness’ and ‘contentment’. 
Mood, alertness and physical symptoms questionnaire (MAPS) (Rogers et al., 2008)  
This computerised questionnaire consisted of seven unipolar and four bipolar visual 
analogue scales adapted from a similar questionnaire used in previous research on caffeine 
(e.g. Rogers et al., 2005). ‘Headache’, ‘heart pound’, jittery/shaky’, ‘light-headed/feeling 
faint/dizzy’, ‘hands trembling’, ‘scared’ and ‘feeling hot/sweating (not due to heat)’ were 
rated on unipolar scales labelled ‘I don’t have this feeling at all’ (left-hand end=0) and ‘I 
have this feeling strongly (right-hand end=100). The bipolar scales were Relaxed (labelled 
‘anxious/tense/nervous/on edge’=0 and ‘relaxed/calm’=100), Clearheaded (labelled 
‘muzzy/dazed’=0, and ‘clearheaded’=100), Happy (labelled ‘sad/gloomy/miserable’=0 and 
‘happy/cheerful/light-hearted’=100), and Alert (labelled 
‘drowsy/sluggish/tired/fatigued’=0 and ‘alert/energetic/lively’=100). Instructions asked 
participants to rate ‘how you feel RIGHT NOW’. Scores for each item were obtained. 
The Stress Arousal Checklist (SACL; Mackay et al., 1978) 
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The SACL was used to measure stress and arousal levels. It consists of twenty-five 
adjectives which describe feelings and moods and participants were instructed to indicate 
on a four point scale how accurately each adjective matches their current state. The choices 
for the four-point scale were: ‘Definitely Feel’, ‘Slightly Feel’, ‘Cannot Decide’ and 
‘Definitely Do Not Feel’. The adjectives belong to distinct categories: stressors or arousers 
both of which could be either positive (e.g. nervous, stimulated) or negative (e.g. peaceful, 
sluggish) respectively. The classification was used to calculate the overall Stress and 
Arousal scores. The responses for each adjective are first scored as follows. If ‘Definitely 
feel’ or ‘Slightly feel’ are chosen for an adjective classified as positive, then the score is 1; 
if ‘Cannot decide’ or ‘Definitely not’ are chosen for an adjective classified as negative 
then the score is 1; in all other situations the score is 0. The overall STRESS score is 
obtained by summing over the scores for the adjectives classified under ‘STRESS’. The 
overall Arousal score is obtained by summing over the scores for the adjectives classified 
under ‘AROUSAL’.  
The Activation-Deactivation adjective checklist (short form; AD ACL; Thayer 1989) 
The AD ACL is a paper-pencil multidimensional self-rating test constructed and 
extensively validated for rapid assessments of activation or arousal states. The two core 
dimensions, energetic arousal (including tiredness) and tense arousal (including calmness) 
have been replicated repeatedly. Participants were instructed to use the four-point rating 
scale next to each word to describe their feelings at that moment. The choices for the four-
point scale are: ‘Definitely Feel’, ‘Slightly Feel’, Cannot Decide’ and ‘Definitely Do Not 
Feel’. The 20 scales were then combined as recommended to form subscale adjectives: 
‘energetic’, ‘tired’, ‘tension’ and ‘calmness’. The scoring for the AD ACL was done by 
assigning 4, 3, 2, and 1 respectively to the ‘Definitely Feel’, ‘Slightly Feel’, Cannot 
Decide’ and ‘Definitely Do Not Feel’ scale points, and summing or averaging the five 
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scores for each subscale. In order of appearance, the subscale adjectives are as follows: 
Energy (active, energetic, vigorous, lively, full-of-pep); Tired (sleepy, tired, drowsy, wide-
awake, wakeful); Tension (jittery, intense, fearful, clutched-up, tense); Calmness (placid, 
calm, at-rest, still, quiet). Scoring for “wakeful” and “wide-awake” was reversed for the 
‘Tired’ subscale. Furthermore, the two bipolar activation dimensions were evaluated: 
Energetic Arousal (EA); combining the two opposite poles, Energetic and Tired. The 
tiredness scores were reversed (but not wakeful and wide-awake) before adding the 10 
scores. Tense Arousal (TA); combining the two opposite poles, Tension and Calmness. 
Calmness scores were reversed before summing the ten scores.   
 
Blood glucose measurement 
Blood glucose readings were obtained using the ExacTech® blood glucose monitoring 
equipment (supplied by MediSense Britain Ltd, 16/17 The Courtyard, Gorsey Lane, 
Coleshill, Birmingham B46 1JA), following the recommended procedure: The researcher 
swabbed the finger of the volunteer with a Sterets Isopropyl Alcohol BP Pre-injection swab 
(Seton Healthcare Group, Oldham, UK) and allowed the skin to air dry. The skin was 
punctured using an automatic lancing devise and a drop of blood was collected onto the 
analytical test strip. The volunteer applying a tissue blotted any excess blood. Ambidex-HG 
powder free polymer bonded latex examination gloves were worn by the experimenter at all 
times during the procedure. Each lancet and cap was only used once and then disposed of 
into a sharps container. Swabs, test strips, tissues and gloves were placed in a clinical waste 
sack.   
Performance characteristics of ExacTech® blood glucose monitoring equipment:  
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Performance has been evaluated in clinical, laboratory and patient studies.  
1) Precision:  
Experienced operators performed testing in the laboratory. At each glucose level, readings 
were carried out using electrodes selected from a single box of G2 Sensor Electrodes. 
 
Within Run   N  Mean  SD  CV (%) 
      mmol/l  mmol/l 
 
Blood (Low)   20  2.94  0.19  6.5 
Blood (Med Low)  20  5.28  0.23  4.3 
Blood (Med High)  20  11.50  0.51  4.4 
Blood (High)   20  21.17  1.17  5.5 
 
2) Accuracy: 
Accuracy was assessed by comparison with the YSI model 23AM Glucose Analyzer as used 
in clinical laboratories. The following data were obtained using fresh capillary blood: 
n = 144 
y =1.059(x) – 0.42 mmol/l 




Cortisol and Alpha Amylase Measurement 
Assessment of salivary cortisol levels is the classic measurement of response to stress, 
associated with activation of the HPA axis. Salivary alpha-amylase is a measure of 
adrenergic activity (SAM axis).  Collection of saliva, in preference to blood sampling, 
provided a non-invasive mechanism to collect physiological samples from subjects.  
Saliva samples were collected using the salivette saliva sampling device (Sarstedt LTD, 
Leicester, UK). These consist of a small test tube fitted with an inner receptacle containing a 
sterile cotton wool bud. For the measurement of alpha-amylase, participants were instructed 
to give un-stimulated saliva samples by placing a Salivette in the top right hand corner of 
their mouth for a timed two-minute period. For the measurement of cortisol, participants 
were asked to lightly chew on the Salivette for one-minute. Ambidex-HG powder free 
polymer bonded latex examination gloves were worn by the experimenter at all times during 
saliva sampling. Excess saliva was removed using Sterets Isopropyl Alcohol BP Pre-
injection swabs (Seton Healthcare Group, Oldham, UK). All saliva contaminated waste was 
placed in a yellow bio hazard bag and disposed of via Lancaster University’s Biology 
Autoclave system. Samples were stored at -40oC until analysis. Saliva was recovered by 
centrifugation and salivary volume determined by weighing. This allows for the calculation 
of the saliva flow rate. Cortisol concentration (nmol/l), alpha amylase (μ/mL) concentration 
in saliva was determined by commercially available kits (Salimetrics, USA).   
The results of these analyses will be reported in Chapter 3. 
 




The Intent To Treat (ITT) population was used for the efficacy analysis. The primary 
efficacy variable was Digit Vigilance accuracy. The secondary outcome variables were 
other measures of attention (Digit Vigilance speed and false alarms; Simple Reaction 
Time; Choice Reaction Time accuracy and speed), memory (Immediate Word Recall 
correct and errors; Delayed Word Recall correct and errors; Word Recognition accuracy, 
speed, target and distractor reaction time; Picture Recognition accuracy, speed, target and 
distractor reaction time), working memory (Serial 3s correct and errors; Serial 7s correct 
and errors; Corsi Block span and reaction time), mood measures (Bond-Lader; MAPS; 
SACL; ADACL). All cognitive and mood outcome measures were transformed into 
change from baseline scores. Using IBM SPSS Statistics Version 22 each dosing regimen 
(low and moderate) treatments were performed on the change from baseline scores using a 
linear mixed model. Treatment and period were added as fixed effects and subject as 
random effect to the model. Baseline average for each individual task was added as a 
covariate to the model. The Estimates of Fixed Effects were used to compare each active 
treatment with placebo. 
For glycaemic treatment, comparisons were performed on the blood glucose levels using a 
linear mixed model. The model included a random effect for subject and fixed effects for 
period, treatment and time. The Estimates of Fixed Effects were used to compare each active 
treatment with placebo. 
For the exploratory outcome measure, hormonal responses (cortisol and alpha amylase), 
measures were transformed into change from baseline scores and analysed using a linear 
mixed model. Treatment and period were added as fixed effects and subject as random 





Table 2.1. Participant Demographics (Means and Standard Deviations) 
 
2.3.1 Glycaemic Response  
 
There was a significant main effect of the low dose treatments on blood glucose, F (2.01, 
60.19) = 29.81, p < .001. There was a significant effect of time, F (2, 113.94) = 26.44, p < 
.001 and treatment x time interaction F (6, 68.07) = 24.98, p < .001 were observed. 
Comparisons showed that baseline blood glucose levels did not differ, however after 
administration of glucose containing drinks, higher blood glucose levels were observed at 
both post dose measures compared to placebo and the caffeine only drink (all p < .001) 





































Figure 2.2 Glycaemic response to low dose treatments as a function of drink and time 
 











Baseline 4.69 (0.14) 4.55 (0.12) 4.62 (0.11) 4.72 (0.13) 
1
st
 Post Dose 4.43 (0.12) 6.21 (0.20) 4.21 (0.12) 6.02 (0.20) 
2
nd
 Post Dose 4.23 (0.14) 5.12 (0.22) 4.32 (0.13) 5.21 (0.18) 
 
The same picture emerged for the moderate treatment group, with significant effects of 
treatment, F (3, 92.45) = 99.76, p < .001), time (2, 115.53) = 37.76, p < .001, and a 
significant interaction between both factors, F (6, 80.98) = 40.10, p < .001. Again no 


































drinks resulted in significantly higher glycaemic response at both post dose measures 
compared to placebo and the caffeine only drink (all p < .001) (see Figure 2.3 for 
glycaemic response as a function of treatment and time). 
 
Figure 2.3 Glycaemic response to moderate dose treatment as a function of drink and 
time  
 












Baseline 4.52 (0.10) 4.39 (0.11) 4.48 (0.10) 4.46 (0.07) 
1
st
 Post Dose 4.12 (0.08) 6.10 (0.22) 4.06 (0.07) 6.15 (0.20) 
2
nd


































2.3.2 Cognitive Performance 
 
Performance data from tasks that were completed incorrectly were removed. For the low 
dose treatments, the data for one participant on the Serial 3s task on the day they consumed 
the low glucose/caffeine combination treatment drink was excluded as they completed the 
task incorrectly at baseline (all their responses were scored as errors). For the moderate 
dose treatments one participant’s scores on the Serial 3s task on the day they consumed the 
low glucose/caffeine combination treatment drink were also excluded as they completed 
the task incorrectly at the post dose testing session. Two participant’s scores on the Serial 
7s task on the day they received the low glucose/caffeine combination treatment drink 
were excluded as one completed the task incorrectly at baseline and one incorrectly at post 
dose. 
 
2.3.2.1 Primary Outcome: 
 
Digit Vigilance % Correct 
There was no significant main effect of the ‘low dose’ treatments on the percentage 
accuracy of the Digit Vigilance task, F (3, 39.34) = 0.04, p = .99, no main effect of period, 
F (3, 34.85) = 0.50, p = .69; or the interaction, F (9, 30.73) = 1.13, p = .37. There were no 
significant differences observed following administration of treatment drinks compared to 
placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the percentage 
accuracy of the Digit Vigilance task, F (3, 33.96) = 1.51, p = .23, or period, F (3, 37.62) = 
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1.83, p = .16; or their interaction, F (9, 23.73) = 0.57, p = .81. There were no significant 
differences observed following administration of treatment drinks compared to placebo. 
 
2.3.2.2 Secondary Outcomes: Attention  
 
Simple Reaction Time 
There was no significant main effect of the ‘low dose’ treatments on the Simple Reaction 
Time task, F (3, 17.10) = 0.42, p = .74. There was no main effect of period, F (3, 12.56) = 
0.60, p = .63; or the interaction, F (9, 20.52) = 1.27, p = .31. There were no significant 
differences observed following any of the active treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on simple reaction 
time, F (3, 23.28) = .73, p = .54; or period, F (3, 30.67) = 0.03, p = .99; or treatment x 
period interaction, F (9, 22.46) = 1.41, p = .24. No significant benefits from any of the 
active drinks were observed compared to placebo.  
 
Choice Reaction Time % Correct 
There was no significant main effect of the ‘low dose’ treatments on the percentage 
accuracy of the Choice Reaction Time task, F (3, 30.57) = 0.63, p = .60. There was no 
main effect of period, F (3, 29.47) = 0.97, p = .42; or the interaction effect between 
treatment and period, F (9, 24.27) = 1.43, p = .23. There were no significant differences 
observed following administration of treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the percentage 
accuracy of the Choice Reaction Time task, F (3, 24.28) = 1.99, p = .14. There was no 
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main effect of visit, F (3, 26.10) = 2.67, p = .07; or interaction, F (9, 22.64) = .65, p = 74. 
Again, no significant benefits from any of the active drinks were observed compared to 
placebo.  
 
Choice Reaction Time Reaction Time 
There was no significant main effect of the ‘low dose’ treatments on the reaction time of 
the Choice Reaction Time task, F (3, 14.18) = 0.49, p = .69. There was no main effect of 
period, F (3, 12.86) = 1.52, p = .26; or the interaction, F (9, 17.80) = 0.61, p = .78. There 
were no significant differences observed following administration of treatment drinks 
compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the reaction 
time of the Choice Reaction Time task, F (3, 22.00) = 1.09, p = .37; or main effect of 
period F (3, 22.03) = 0.14, p = .94; or the interaction, F (9, 22.06) = 1.32, p = .28. Again, 
there were no significant differences observed following administration of treatment drinks 
compare to placebo. 
 
Digit Vigilance Reaction Time 
The main effect of the ‘low dose’ treatments on the reaction time responses of the Digit 
Vigilance task failed to reach significance, F (3, 34.88) = 2.45, p = .08. There was no main 
effect of period, F (3, 31.99) = 0.66, p = .58; or interaction, F (9, 28.17) = 0.76, p = 
.66.Comparison with placebo showed there were no significant differences compared to 
following the administration of treatment drinks. 
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There was no significant main effect of the ‘moderate dose’ treatments on the reaction 
time responses of the Digit Vigilance task, F (3, 41.54) = 0.87, p = .47; or of period, F (3, 
39.60) = 0.62, p = .61; or the interaction, F (9, 26.99) = 0.29, p = .97.  There were no 
significant differences observed following administration of treatment drinks compared to 
placebo. 
 
Digit Vigilance False Alarms 
There was no significant main effect of the ‘low dose’ treatments on the false alarm 
responses on the Digit Vigilance task, F (3, 37.10) = 1.39, p = .26. There was no main 
effect of period, F (3, 46.52) = 1.01, p = .40; or the interaction effect between treatment 
and period, F (9, 27.47) = 0.53, p = .84. There were no significant differences observed 
following administration of treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the false alarm 
responses on the Digit Vigilance task, F (3, 22.97) = 1.17, p = .34; period, F (3, 25.15) = 
0.81, p = .50; or treatment x period, F (9, 17.50) = 2.04, p = .10. There were no significant 
differences observed following administration of treatment drinks compared to placebo.  
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Table 2.4 Measures of attention and vigilance, means and standard errors  







































































































































1 Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: Simple Reaction Time = 314.7; CRT % Correct = 95.16; CRT RT = 413.9; Digit Vigilance % Correct = 
93.0; Digit Vigilance RT = 455.9; Digit Vigilance False Alarms = 0.29. 
2 Change from baseline; covariates appearing in the model for moderate dose treatments are evaluated at the following 
average baseline values: Simple Reaction Time = 296.4; CRT % Correct = 94.43; CRT RT = 389.7; Digit Vigilance % 
Correct = 94.50; Digit Vigilance RT = 457.0; Digit Vigilance False Alarms = 0.30. 
 
2.3.2.3 Secondary Outcomes: Memory 
 
Immediate Word Recall Correct 
No significant main effect of the ‘low dose’ treatments, F (3, 43.02) = 0.03, p = .99 was 
observed. There was no main effect of period, F (3, 39.24) = 0.69, p = .56; or interaction 
effect between treatment and period, F (9, 24.42) = 0.58, p = .80.  
For ‘moderate dose’ regimen, no significant effect of treatment was observed, F (3, 47.65) 
= 1.59, p = .21. There was no main effect of period, F (3, 101.29) = 2.49, p = .07; or 
significant interaction between treatment and period, F (9, 53.87) = 1.11, p = .37. 
In addition, no significant differences were observed following administration of any of 
the active treatment drinks compared to placebo. 
 
Immediate Word Recall Errors 
There was no significant main effect of the ‘low dose’ treatments on number of errors in 
the Immediate Word Recall task, F (3, 38.33) = 1.43, p = .25. There was no main effect of 
period, F (3, 43.30) = 0.58, p = .63 and no treatment x period interaction, F (9, 26.23) = 
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0.44, p = .91. There were no significant differences observed following administration of 
treatment drinks compared to placebo. 
For the ‘moderate dose’ treatments again no treatment effect was observed on number of 
errors, F (3, 34.60) = 0.44, p = .73. There was no significant main effect of period, F (3, 
26.03) = 2.03, p = .14; or interaction between treatment and period, F (9, 30.16) = 0.24, p 
= .99. There were no significant differences observed following administration of 
treatment drinks compared to placebo.  
 
Delayed Word Recall Correct 
No significant main effect of the ‘low dose’ treatments, F (3, 39.72) = 0.32, p = .81, and 
no effect of period, F (3, 37.50) = 0.81, p = .50; or interaction between both factors, F (9, 
22.76) = 1.45, p = .23.  
A similar picture emerged for the ‘moderate dose’ regimen with no effect of treatment, F 
(3, 46.61) = 0.58, p = .63, period, F (3, 32.11) = 2.58, p = .07; or interaction, F (9, 49.00) = 
1.21, p = .31.  
Moreover, no differences were observed following administration of active drinks 
compared to placebo under both treatment regimens.  
 
Delayed Word Recall Errors 
There was no significant main effect of the ‘low dose’ treatments, F (327.22) = 1.71, p = 
.19, period, F (3, 30.17) = 0.56, p = .64 or treatment x period interaction, F (9, 26.32) = 
1.56, p = .18.  
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For ‘moderate dose’ regimen, no effects of treatment, F (3, 34.60) = 0.44, p = .73, period, 
F (3, 26.03) = 2.03, p = .14; or interaction effect between treatment and period, F (9, 
30.16) = 0.24, p = .99 was observed.  
For both treatment regimens (‘low’ and ‘moderate’) no significant performance differences 
were observed following administration of treatment drinks compared to placebo (for 
performance on free recall task see table 2.4). 
 
Table 2.5 Free Recall Performance, means and standard errors 




































































































1 Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: IFR correct = 28.45; IFR Incorrect = 0.80.; DFR correct = 5.50; DFR error= 0 .80. 
2Change from baseline; covariates appearing in the model are evaluated at the following values: IFR correct = 26.45, IFR 
Incorrect = 0.69; DFR correct= 4.72; DRF error = 1.08. 
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*Significant compared to placebo at p<0.05 
 
Word Recognition Accuracy 
There was no significant main effect of the ‘low dose’ treatments, F (3, 33.48) = 0.36, p = 
.79, and no main effect of period, F (3, 39.48) = 0.79, p = .51; or interaction, F (9, 25.22) = 
0.79, p = .63. Compared to placebo none of the active drinks resulted in superior 
performance.  
The same picture emerged for the ‘moderate’ treatment regime, with no effect of 
treatment, F (3, 18.36) = 0.66, p = .59, period, F (3, 27.29) = 1.48, p = .24; or interaction, 
F (9, 27.29) = 1.69, p = .14. Comparison of active drinks with placebo showed an 
advantage of the combined glucose and caffeine drink compared to placebo (p = .03). 
 
Word Recognition Speed 
There was no significant main effect of the ‘low dose’ treatments on the reaction time for 
the correct responses on the Word Recognition task, F (3, 39.68) = 0.17, p = .92. There 
was no main effect of period, F (3, 40.65) = 1.74, p = .18; or interaction between treatment 
and period, F (9, 33.95) = 0.91, p = .53. There were no significant differences observed 
following administration of treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the reaction 
time for correct responses on the Word Recognition task, F (3, 18.36) = 0.66, p = .59, 
period, F (3, 27.29) = 1.48, p = .24; or interaction, F (9, 27.29) = 1.69, p = .14. 
Comparison of active drinks with placebo showed an advantage of the combined drink 




Word Recognition Target Reaction Time 
The effect of the ‘low dose’ treatments on the reaction time for targets failed to reach 
significance, F (3, 35.03) = 1.81, p =.16. There was no main effect of period, F (3, 39.88) 
= .65, p = .59; or interaction between treatment and period, F (9, 28.48) = .65, p = .75. 
However, comparison with placebo showed that after consumption of the glucose drink, 
participants reacted significantly faster to target words compared to placebo (p = .04).  
There was no significant main effect of the ‘moderate dose’ treatments on the reaction 
time for targets on the Word Recognition task, F (3, 26.59) = 1.43, p = .26. There was no 
main effect of period, F (3, 25.17) = 3.32, p = .14; or the interaction effect between 
treatment and period, F (9, 29.22) = 1.02, p = .45. Moreover, no significant differences 
were observed following administration of treatment drinks compared to placebo. 
 
Word Recognition Distractor Reaction Time 
There was no effect of the ‘low dose’ treatments on the reaction time for distractors, F (3, 
39.84) = 0.69, p = .56. There was no main effect of period, F (3, 41.70) = 0.89, p = .45; or 
interaction between treatment and period, F (9, 27.10) = 1.35, p = .26. No significant 
differences following administration of active treatment drinks compared to placebo were 
observed. 
There was no significant main effect of the ‘moderate dose’ treatments on the reaction 
time for distractors on the Word Recognition task, F (3, 40.74) = 1.66, p = .19. There was 
no main effect of period, F (3, 39.12) = 0.30, p = .82; or treatment x period interaction, F 
(9, 26.26) = 1.06, p = .43.  There were no significant differences observed following 
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administration of treatment drinks compared to placebo. (See Table 2.5. for the Word 
Recognition Performance, means and standard errors). 
 
Table 2.6 Word Recognition Performance, means and standard errors 













































































































1 Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: Word Recognition Accuracy = 73.86; Word Recognition Speed = 837.4; Word Recognition Target 
Reaction Time = 850.0; Word Recognition Distractor Reaction Time = 870.2. 
2Change from baseline; covariates appearing in the model for moderate dose treatments are evaluated at the following 
values: Word Recognition Accuracy = 67.67; Word Recognition Speed = 814.5; Word Recognition Target Reaction 
Time = 831.5; Word Recognition Distractor Reaction Time = 842.7. 
*Significant compared to placebo at p < .05 
 
Picture Recognition Accuracy 
There was no significant main effect of the ‘low dose’ treatments on the correct responses 
for the Picture Recognition task, F (3, 38.41) = 1.91, p = .15. There was a significant main 
effect of period, F (3, 35.49) = 3.37, p = .04, participants performed worse on study day 4 
(period 4). There was no significant interaction between treatment and period, F (9, 26.42) 
= 0.80, p = .620. Compared to placebo, performance decrements were significantly 
reduced after the caffeine drink compared to placebo (p = .04).  
There was no significant main effect of the ‘moderate dose’ treatments on the correct 
responses for the Picture Recognition task, F (3, 26.20) = 1.42, p = .26. There was no main 
effect of period, F (3, 34.14) = 0.98, p = .41, and no interaction effect between treatment 
and period, F (9, 26.77) = 0.94, p = .51. As observed for the ‘low dose’ group, decrements 
in performance on the task were significantly less following the caffeine treatment drink 
compared to placebo drink, (p = .02). 
 
Picture Recognition Speed 
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There was no significant main effect of the ‘low dose’ treatments on the correct response 
reaction time for the Picture Recognition task, F (3, 25.46) = .91, p = .45. There was no 
main effect of period, F (3, 30.29) = .14, p = .94, and no interaction effect between 
treatment and period, F (9, 24.17) = 0.94, p = .51. There were no significant differences 
observed following administration of treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the correct 
response reaction time for the Picture Recognition task, F (3, 32.55) = 0.55, p = .65. There 
was no main effect of period, F (3, 32.45) = 0.15, p = .93; or their interaction, F (9, 29.64) 
= 0.83, p = .60. There were no significant differences compared to placebo were observed 
following administration of active treatment drinks.  
 
Picture Recognition Target Reaction Time 
There was no significant main effect of the ‘low dose’ treatments on the target response 
reaction time for the Picture Recognition task, F (3, 20.02) = 0.82, p = .50. There was no 
main effect of period, F (3, 18.87) = .72, p = .55; or treatment x period interaction, F (9, 
20.23) = 1.94, p = .10. Significant differences following administration of active treatment 
drinks compared to placebo were not identified. 
There was no significant main effect of the ‘moderate dose’ treatments on the target 
response reaction time for the Picture Recognition task, F (3, 23.01) = 0.51, p = .68. There 
was no main effect of period, F (3, 33.41) = 0.08, p = .97; or interaction between treatment 
and period, F (9, 29.62) = 0.84, p = .59. There were no significant differences compared to 




Picture Recognition Distractor Reaction Time 
There was no significant main effect of the ‘low dose’ treatments on the distractor 
response reaction time for the Picture Recognition task, F (3, 28.01) = 0.82, p = .50. There 
was no main effect of period, F (3, 32.30) = 0.58, p = .64; or interaction between treatment 
and period, F (9, 21.27) = 0.59, p = .80. 
There was no significant main effect of the ‘moderate dose’ treatments on the distractor 
response reaction time for the Picture Recognition task, F (3, 37.25) = 0.74 p = .54. There 
was no main effect of period, F (3, 31.58) = 0.54, p = .66; or the interaction effect between 
treatment and period, F (9, 42.98) = 1.01, p = .45. There were no significant differences 
observed following administration of treatment drinks compared to placebo. (See Table 2.6 






Table 2.7 Picture Recognition Performance, means and standard errors  
 






















































































































1 Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: Picture Recognition Accuracy = 93.31; Picture Recognition Speed = 772.6; Picture Recognition Target 
Reaction Time = 768.0; Picture Recognition Distractor Reaction Time = 792.6. 
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2 Change from baseline; covariates appearing in the model for moderate dose treatments are evaluated at the following 
average baseline values: Picture Recognition Accuracy = 91.54; Picture Recognition Speed = 780.9, Picture Recognition 
Target Reaction Time = 778.3; Picture Recognition Distractor Reaction Time = 802.0. 




Serial 3’s Correct 
There was no significant main effect of the ‘low dose’ treatments on the correct responses 
on the Serial 3 task, F (3, 32.19) = 0.70, p = .56. There was no main effect of period, F (3, 
37.41) = 0.07, p = .98; or interaction between treatment and period, F (9, 35.06) = 1.19, p 
= .33. There were no significant differences observed following administration of 
treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the correct 
responses on the Serial 3 task, F (3, 35.99) = 1.06, p = .38. There was no main effect of 
period, F (3, 33.59) = 1.40, p = .26; or treatment x period interaction, F (9, 29.08) = 0.20, p 
=. 99. There were no significant differences observed following administration of 
treatment drinks compared to placebo,  
 
Serial 3’s Errors 
There was no significant main effect of the ‘low dose’ treatments on the erroneous 
responses on the Serial 3 task, F (3, 37.06) = 0.85, p = .48. There was no main effect of 
period, F (3, 43.41) = 0.51, p = .68; or interaction between treatment and period, F (9, 
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30.69) = 1.22, p = .32. There were no significant differences observed following 
administration of treatment drinks compared to placebo. 
For the ‘moderate dose’ treatments no significant effect of treatment, F (3, 37.53) = 0.59, p 
= .62, period, F (3, 35.69) = 0.70, p = .56; or interaction between treatment and period, F 
(9, 34.47) = 1.03, p = .44 were observed for number of errors. In addition, there were no 
significant differences following administration of treatment drinks compared to placebo. 
 
Serial 7’s Correct 
There was no significant main effect of the ‘low dose’ treatments on the correct responses 
on the Serial 7 task, F (3, 48.03) = 0.74, p = .54. There was no main effect of period, F (3, 
43.52) = 0.85, p = .48; or interaction, F (9, 26.50) = 1.49, p = .20.  There were no 
significant differences observed following administration of treatment drinks compared to 
placebo.  
For the ‘moderate dose’ group, no significant effect of treatment, F (3, 26.05) = 0.184, p = 
.91, period, F (3, 31.90) = 0.85, p = .48; or treatment x period interaction, F (9, 21.12) = 
0.91, p = .53 were observed on the correct responses on the Serial 7 task. Moreover, no 
significant differences following administration of treatment drinks compared to placebo 
were evident. 
 
Serial 7’s Errors 
There was no significant main effect of the ‘low dose’ treatments on the error responses on 
the Serial 7 task, F (3, 28.13) = 0.85, p = .48. There was no main effect of period, F (3, 
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40.46) = 0.48, p = .70; or interaction between treatment and period, F (9, 44.83) = 0.28, p 
= .98.  There were no significant differences observed following administration of active 
treatment drinks compared to placebo. 
The main effect of the ‘moderate dose’ treatments on the error responses on the Serial 7 
task failed to reach significance, F (3, 29.85) = 2.54, p = .09. There was no main effect of 
period, F (3, 28.23) = 0.92, p = .45; or treatment x period interaction, F (9, 22.02) = 0.66, p 
= .74. There were no significant differences following administration of active treatment 
drinks compared to placebo. 
 
Corsi Block Span Score 
There was no significant main effect of the ‘low dose’ treatments on the span score on the 
Corsi Block task, F (3, 34.38) = 0.31, p = .82. There was no main effect of period, F (3, 
32.27) = 0.01, p = .99; or interaction between treatment and period, F (9, 29.15) = 1.65, p 
= .15. 
For ‘moderate dose’ no effect of treatment, F (3, 35.52) = 0.08, p = .97, period, F (3, 
32.10) = 0.85, p = .48, or interaction between those factors, F (9, 28.50) =0. 95, p =.50 was 
observed.  
Moreover, there were no significant performance differences following administration of 
any of the active treatment drinks in either of the dosing regimens compared to placebo. 
 
Corsi Block Reaction Time 
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There was no significant main effect of the ‘low dose’ treatments on the reaction time 
score on the Corsi Block task, F (3, 32.55) = 1.30, p = .29. There was no main effect of 
period, F (3, 37.44) = 0.61, p = .62; but a significant period x treatment interaction, F (9, 
24.84) = 2.59, p = .03, with performance following the combined drink on visit 4 better 
than combined drink on visit 3, p = .04. There were no significant differences observed 
following administration of active treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the reaction 
time score on the Corsi Block task, F (3, 32.788) = 0.09, p = .97. The main effect of period 
did not reach significance, F (3, 31.64) = 2.26, p = .10, and the interaction between 
treatment and period was not significant, F (9, 25.76) = 0.72, p = .70. There were no 
significant differences observed following administration of treatment drinks compared to 
placebo. (See Table 2.7 for the Working Memory Performance, means and standard 
errors).  
Table 2.8 Working Memory Performance, means and standard errors  
Treatment Combined Glucose Caffeine Placebo 
Low
1







































































































































1 Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: Serial 3s Correct = 44.18; Serial 3s Errors = 2.90.; Serial 7s Correct = 27.32; Serial 7s Errors = 2.97; 
Corsi Span Score = 6.21; Corsi Block RT = 5524.5. 
2 Change from baseline; covariates appearing in the model for moderate dose treatments are evaluated at the following 
average baseline values: Serial 3s Correct = 44.71; Serial 3s Errors = 3.04; Serial 7s Correct = 27.06; Serial 7s Errors = 
3.21; Corsi Span Score = 6.18; Corsi Block RT = 5333.2. 
*Significant compared to placebo at p < .05 
 
2.3.2.4 Secondary Outcomes: Mood Results 
 
Bond-Lader Visual Analogue Scales 
Alert 
There was no significant main effect of the ‘low dose’ treatments on self-ratings on the 
Alert scale of the Bond-Lader Visual Analogue Scales, F (3, 36.87) = 1.93, p = .14. There 
was a significant main effect of period, F (3, 77.09) = 2.92, p = .04, with participants 
reporting to be less alert at period 1 compared to their other visits (p = .06). However, 
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there was no significant interaction between treatment and period, F (9, 61.08) = 1.06, p = 
.40. Moreover, no significant differences were observed following administration of active 
treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on self-rated 
alertness, F (3, 59.57) = 1.95, p = .13; or period, F (3, 84.56) = 1.05, p = .37. There was a 
significant treatment x period interaction, F (9, 64.11) = 2.53, p = .02. Participants rated 
themselves as significantly more alert on study day 4 (period 4) following the combined 
drink, compared to on study day 1 (period 1) (p = .004) and study day 3 (period 3) (p = 
.002). Participants also rated themselves as significantly more alert on study day 4 (period 
4) following the caffeine drink compared to on study day 1 (period 1), p = .007. 
Comparisons of the active drinks to placebo revealed that participants rated themselves as 
significantly more alert following the caffeine treatment drink (M = 4.11) and the 




There was no significant main effect of the ‘low dose’ treatments on the self-ratings on the 
Content scale of the Bond-Lader Visual Analogue Scales, F (3, 48.76) = 0.14, p = .94; or 
of period, F (3, 105.26) = 1.04, p = .38; or treatment by period interaction, F (9, 52.15) = 
0.88, p = .55.  
For the ‘moderate dose’ group, no significant effect of treatment, F (3, 57.05) = 0.27, p = 
.84; period, F (3, 92.55) = 0.67, p = .58; or treatment by period interaction, F (9, 59.15) = 
1.09, p = .39 was observed for level of contentedness  
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In addition, no significant differences were observed following administration of active 
treatment drinks compared to placebo for either of the dosing regimens. 
 
Calm 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings on the 
Calm scale of the Bond-Lader Visual Analogue Scales, F (3, 46.27) = 0.58, p = .63; 
period, F (3, 70.67) = 0.96, p = .42; or their interaction, F (9, 58.61) = 0.94, p = .50.  
There was no significant main effect of the ‘moderate dose’ treatments , F (3, 49.94) = 
0.62, p = .60; period, F (3, 101.48) = 1.97, p = .12; or treatment by period interaction, F (9, 
62.10) = 1.43, p = .20 on this measure. No significant differences in level of self-reported 
calmness were observed following administration of active treatment drinks compared to 
placebo for either dosing regimens (see table 2.9 for Bond-Lader Mood ratings, means and 
standard errors). 
Table 2.9 Bond-Lader Mood ratings, means and standard errors 














































Calm -11.4 -9.6 -8.0 -6.7 
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(2.7) (2.7) (2.5) (2.4) 
1 Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: Bond Lader Alert = 46.2; Bond Lader Content = 55.9; Bond Lader Calm = 60.7. 
2Change from baseline; covariates appearing in the model are evaluated at the following values: Bond Lader Alert = 47.3; 
Bond Lader Content = 55.7; Bond Lader Calm = 63.0. 
*Significant compared to placebo at p < .05 
 
Mood, Alertness and Physical Symptoms Questionnaire (MAPS) 
 
Headache 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
headache on the MAPS, F (3, 47.33) = 0.58, p = .63; or period, F (3, 87.34) = 1.27, p = 
.29; or their interaction, F (9, 47.67) = 1.17, p = .33. There were no significant differences 
observed following administration of treatment drinks compared to placebo. 
The main effect of the ‘moderate dose’ treatments on the self-ratings of headache on the 
MAPS did not reach significance, F (3, 47.18) = 2.27, p = .09. There was no main effect of 
period, F (3, 98.03) = 0.99, p = .40; or interaction between treatment and period, F (9, 
48.98) = 0.85, p = .57. There were no significant differences observed following 





There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
heart pounding on the MAPS, F (3, 52.80) = 0.31, p = .82; or period, F (3, 104.79) = 2.42, 
p = .07; or their interaction, F (9, 53.78) = 0.98, p = .47.  
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of heart pounding on the MAPS, F (3, 50.24) = 0.05, p = .99; or period, F (3, 101.34) = 
0.87, p = .46; or their interaction, F (9, 58.65) = 1.14, p = .35. 
There were no significant differences observed following administration of active 
treatment drinks compared to placebo for either of the dosing regimens. 
 
Jittery/Shaky 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
jitter/shaky on the MAPS, F (3, 57.68) = 0.36, p = .78; period, F (3, 94.43) = 1.24, p = .30; 
or interaction, F (9, 58.34) = 0.75, p = .66. 
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of jitter/shaky on the MAPS, F (3, 50.61) = 0.45, p = .72; or period, F (3, 99.58) = 0.99, p 
= .40; or their interaction, F (9, 53.40) = 0.80, p = .62. 
There were no significant differences observed following administration of active 
treatment drinks compared to placebo for either of the dosing regimens. 
 
Light-headed/feeling faint/dizzy 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
light-headed/feeling faint/dizzy on the MAPS, F (3, 46.75) = 0.60, p = .62; or period, F (3, 
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93.98) = 0.25, p = .86; or their interaction, F (9, 48.33) = 0.76, p = .66. There were no 
significant differences observed following administration of treatment drinks compared to 
placebo. 
There was a significant main effect of the ‘moderate dose’ treatments on the self-ratings of 
light-headed/feeling faint/dizzy on the MAPS, F (3, 48.14) = 4.20, p = .01. There was no 
main effect of period, F (3, 100.64) = 0.08, p = .97; or their interaction, F (9, 53.45) = 
1.47, p = .18. There were no significant comparisons with placebo.  
 
Hands-trembling 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
hands-trembling on the MAPS, F (3, 98.88) = 0.38, p = .47; or period, F (3, 98.88) = 0.38, 
p = .77; or their interaction, F (9, 52.92) = 1.15, p = .35. There were no significant 
differences observed following administration of treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of hands-trembling on the MAPS, F (3, 50.05) = 0.85, p = .48; or period, F (3, 97.91) = 
0.25, p = .86; or their interaction, F (9, 54.14) = 0.72, p = .69. There were also no 






There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
scared on the MAPS, F (3, 59.88) = 0.35, p = .79; or period, F (3, 93.73) = 0.68, p = .57; 
or their interaction, F (9, 62.24) = 0.86, p = .56.  
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of scared on the MAPS, F (3, 44.80) = 0.42, p = .74; or period, F (3, 85.67) = 0.16, p = 
.92; or their interaction, F (9, 45.87) = 1.14, p = .36. 
There were no significant differences observed following administration of treatment 
drinks compared to placebo for either of the dosing regimens. 
 
Feeling hot/sweating (not due to heat) 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
feeling hot/sweating on the MAPS, F (3, 54.61) = 1.30, p = .29; or period, F (3, 97.25) = 
0.54, p = .66; or their interaction, F (9, 55.29) = 0.83, p = .59. 
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of feeling hot/sweating on the MAPS, F (3, 38.81) = 0.30, p = .82; or period, F (3, 72.03) 
= 0.09, p = .97; or their interaction, F (9, 55.24) = 0.79, p = .68.  
There were no significant differences observed following administration of treatment 
drinks compared to placebo for either of the dosing regimens. 
 
Relaxed 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
relaxed on the MAPS, F (3, 54.51) = 0.54, p = .66. There was a significant main effect of 
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period, F (3, 96.58) = 3.26, p = .03, participants rated themselves as least relaxed at their 
first visit (period 1), p = .02. There was no significant interaction between treatment and 
period, F (9, 61.82) = 0.33, p = .96.  
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of relaxed on the MAPS, F (3, 53.04) = 0.62, p = .61; or period, F (3, 96.97) = 2.59, p = 
.06. There was no significant interaction between treatment and period, F (9, 55.93) = 
0.28, p = .98. 
There were no significant differences observed following administration of treatment 
drinks compared to placebo for either of the dosing regimens. 
 
Clearheaded 
There was no significant main effect of low dose’ treatments on the self-ratings of 
clearheaded on the MAPS, F (3, 53.75) = 1.24, p = .31. There was a significant main effect 
of period, F (3, 101.35) = 3.63, p = .02, participants rated themselves as least clearheaded 
at their first and last visit (period 1 and 4) although these differences were not significant, 
p = .06 and p = .09 respectively. There was no significant interaction effect between 
treatment and period, F (9, 55.22) = 1.02, p = .43.  
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of clearheaded on the MAPS, F (3, 52.66) = 0.73, p = .54; or period, F (3, 98.79) = 0.72, p 
= .54; or treatment x period, F (9, 56.19) = 1.84, p = .08.  
There were no significant differences observed following administration of treatment 




There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
feeling happy on the MAPS, F (3, 50.98) = 0.87, p = .46; or period, F (3, 106.48) = 1.58, p 
= .20; or their interaction, F (9, 58.84) = 1.03, p = .43.  
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of happy on the MAPS, F (3, 58.12) = 0.14, p = .93; or period, F (3, 90.28) = 0.53, p = .60; 
or their interaction, F (9, 59.94) = 0.84, p = .58.  
There were no significant differences observed following administration of treatment 
drinks compared to placebo for either of the dosing regimens. 
Alert 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
alert on the MAPS, F (3, 52.99) = 0.60, p = .62; or period, F (3, 103.97) = 2.58, p = .06; or 
their interaction, F (9, 56.82) = 1.17, p = .33.  
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of alert on the MAPS, F (3, 53.68) = 1.20, p = .32; or period, F (3, 96.65) = 1.15, p = .33; 
or their interaction, F (9, 56.93) = 1.85, p = .08.  
There were no significant differences observed following administration of treatment 
drinks compared to placebo for either of the dosing regimens. (See Table 2.10 for Mood, 





Table 2.10 Mood, Alertness and Physical Symptoms Questionnaire, means and 
standard errors 
Treatment Combined Glucose Caffeine Placebo 
Low
1


































































































































































































1 Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: Headache = 19.7; Heart pound = 15.8; Jittery/shaky = 18.0; Light-headed/feeling faint/dizzy = 23.2; 
Hands trembling = 16.3; Scared = 14.5; Feeling hot/sweating (not due to heat) = 13.8; Relaxed = 57.9; Clearheaded = 
42.3; Happy = 51.2; Alert = 39.0. 
2Change from baseline; covariates appearing in the model are evaluated at the following values: Headache = 21.6; Heart 
pound = 17.7; Jittery/shaky = 18.7; Baseline Light-headed/feeling faint/dizzy = 25.9; Hands trembling = 18.2; Scared = 
12.1; Feeling hot/sweating (not due to heat) = 10.7; Relaxed = 60.1; Clearheaded = 44.6; Happy = 52.3; Alert = 41.8. 
*Significant compared to placebo at p < .05 
 





There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
stress on the SACL, F (3, 59.25) = 0.53, p = .67; or period, F (3, 96.18) = 0.35, p = .79; or 
their interaction, F (9, 62.65) = 0.290, p = .98. 
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of stress on the SACL, F (3, 53.30) = 0.15, p = .93; or period, F (3, 95.50) = 0.46, p = .71; 
or their interaction, F (9, 56.45) = 0.36, p = .95. 
There were no significant differences observed following administration of active 
treatment drinks compared to placebo for either of the dosing regimens. 
 
Arousal 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
arousal on the SACL, F (3, 41.08) = 1.08, p = .37; or period, F (3, 74.20) = 1.94, p = .13; 
or their interaction, F (9, 56.25) = 1.16, p = .34. There were no significant differences 
observed following administration of treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of arousal on the SACL, F (3, 38.26) = 0.63, p = .60; or period, F (3, 75.70) = 1.74, p = 
.17. However, there was a significant interaction effect between treatment and period, F (9, 
49.29) = 3.29, p = .003. Participants rated themselves as significantly less aroused on study 
day 3 (period 3) following the combined drink compared to on study day 4 (period 4), p = 
.02. Participants also rated themselves as less aroused following the caffeine drink on their 
first study day (period 1) compared to after the caffeine drink on study day 4, p = 
.023.There were no significant differences observed following administration of treatment 
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drinks compared to placebo.. (See Table 2.11 for the Stress Arousal Checklist (SACL), 
means and standard deviations). 
 
2.11 The Stress Arousal Checklist (SACL), means and standard errors 
Treatment Combined Glucose Caffeine Placebo 
Low
1


































1 Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: SACL Stress = 14.23; SACL Arousal = 4.53. 
2Change from baseline; covariates appearing in the model are evaluated at the following values: SACL Stress = 14.43; 
SACL Arousal = 4.27. 
*Significant compared to placebo at p < .05 
 
The Activation-Deactivation Adjective Checklist (AD ACL) 
 
Energy 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
energy on the AD ACL, F (3, 37.29) = 1.16, p = .34; or period, F (3, 76.92) = 0.64, p = 
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.59; or their interaction, F (9, 59.09) = 0.90, p = .53. There were no significant differences 
observed following administration of treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of energy on the AD ACL, F (3, 54.78) = 0.42, p = .74; or period, F (3, 95.37) = 0.10, p = 
.96; or their interaction, F (9, 56.92) = 1.09, p = .39. There were no significant differences 
observed following administration of treatment drinks compared to placebo. 
 
Tired 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
tiredness on the AD ACL, F (3, 53.23) = 0.13, p = .94; or period, F (3, 103.76) = 0.87, p = 
.46. There was a significant interaction effect between treatment and period, F (9, 54.64) = 
2.19, p = .04. Participants rated themselves as significantly more tired following the 
glucose treatment on study day 3 (period 3) compared to after the glucose on study day 4 
(period 4), p = .031. There were no significant differences observed following 
administration of active treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of tired on the AD ACL, F (3, 53.40) = 0.61, p = .61; or period, F (3, 98.16) = 0.30, p = 
.83; or their interaction, F (9, 57.27) = 0.73, p = .677. There were no significant 






There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
tension on the AD ACL, F (3, 55.20) = 1.27, p = .29; or period, F (3, 100.67) = 0.60, p = 
.62; or their interaction, F (9, 60.61) = 0.36, p = .95. There were no significant differences 
observed following administration of active treatment drinks compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of tension on the AD ACL, F (3, 50.78) = 0.43, p = .73; or period, F (3, 96.45) = 1.45, p = 
.23. There was a significant interaction effect between treatment and period, F (9, 53.27) = 
4.74, p < .001. Following the combination treatment participants rated themselves as 
significantly more tense on study day 4 (period 4), compared to on study day 1 (period 1), 
2 (period 2) and 3 (period 3); p = .004, p = .012 and p = .001 respectively. Participants also 
rated themselves as significantly more tense following the caffeine drink on study day 2 
(period 2), compared to on study day 4 (period 4), p = .038. Comparisons of the active 
drinks compared to placebo showed participants rated themselves as significantly more 
tense following the combination drink (M = 1.71) compared to after the placebo drink (M 
= 1.38), p = .002. 
 
Calmness 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
calmness on the AD ACL, F (3, 53.85) = 1.35, p = .27; or period, F (3, 103.83) = 0.15, p = 
.931; or their interaction, F (9, 57.56) = 0.50, p = .87. There were no significant 




There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of calmness on the AD ACL, F (3, 52.93) = 0.93, p = .43; or period, F (3, 93.01) = 0.78, p 
= .52. There was a significant interaction effect between treatment and visit, F (9, 56.19) = 
3.12, p = .004. Following the combination treatment participants rated themselves as 
significantly calmer at study day 1 (p = .022); study day 2 (p = .035) and study day 3 (p = 
.006) compared to on study day 4. After consumption of the glucose drink on study day 3 
participants rated themselves as calmer compared to after the glucose drink on study day 4, 
although this did not reach significance, p = .059. On study day 2 participants rated 
themselves as significantly less calm following consumption of the caffeine drink 
compared to on study day 4, p = .046. Comparison with placebo showed that participants 
rated themselves as significantly calmer following the combination drink (M = -1.13) 
compared to after the placebo treatment drink (M = -1.91), p = .04. 
 
Energetic Arousal 
There was no significant main effect of the ‘low dose’ treatments on the self-ratings of 
energetic arousal on the AD ACL, F (3, 53.92) = 0.30, p = .83; or period, F (3, 102.62) = 
0.91, p = .44. The interaction effect between treatment and period did not reach 
significance, F (9, 55.45) = 1.85, p = .08.  
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
of energetic arousal on the AD ACL, F (3, 54.56) = 0.58, p = .63; or period, F (3, 96.52) = 
0.19, p = .91; or their interaction, F (9, 58.80) = 0.87, p = .56.  
There were no significant differences observed following administration of active 




There was no significant main effect of the ‘low dose’ treatments on the self-ratings that 
make up the tense arousal subscale on the AD ACL, F (3, 57.08) = 1.43, p = .24; or period, 
F (3, 97.89) = 0.31, p = .82; or their interaction, F (9, 59.64) = 0.25, p = .99. There were 
no significant differences observed following administration of active treatment drinks 
compared to placebo. 
There was no significant main effect of the ‘moderate dose’ treatments on the self-ratings 
that make up the tense arousal subscale on the AD ACL, F (3, 47.76) = 0.62, p = .61; or 
period, F (3, 96.76) = 1.12, p = .35. There was a significant treatment by period 
interaction, F (9, 50.73) = 4.82, p < .001. Participants’ tense arousal scores were 
significantly lower after the combination drink on study days 1, 2, and 3, compared to on 
study day 4 (p = .006; p = .01; p = .001 respectively). After the glucose drink on study day 
3 participants’ scores were significantly compared to on study day 4. Participants’ tense 
arousal scores were significantly higher following the caffeine drink on study day 2 
compared to on study day 4, p = .02. Comparisons of the means found participants’ tense 
arousal scores were significantly lower following the combination drink (M = 2.83) 
compared to after the placebo drink (M = 3.278), p = .005. (See Table 2.12 for the 
Activation-Deactivation Adjective Checklist (AD ACL), means and standard errors). 
 
Table 2.12. The Activation-Deactivation Adjective Checklist (AD ACL), means and 
standard errors 
 
Treatment Combined Glucose Caffeine Placebo 
Low
1
 Energy 0.89 2.52 1.56 1.61 
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Tense Arousal 2.83 * 







1 Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: AD ACL Energy = 8.10; AD ACL Tired = 14.98; AD ACL Tension = 6.94; AD ACL Calmness = 13.31; 
AD ACL Energetic Arousal = 18.08; AD ACL Tense Arousal = 18.63. 
2Change from baseline; covariates appearing in the model are evaluated at the following values: AD ACL Energy = 8.01; 
AD ACL Tired = 14.88; AD ACL Tension = 6.64; AD ACL Calmness = 13.73; AD ACL Energetic Arousal = 18.13; AD 
ACL Tense Arousal = 17.92. 





Although glucose and caffeine are both widely consumed, few studies have looked at the 
effects on cognitive performance and mood when they are administered in combination. 
Moreover, one of the major limitations of previous research is the lack of dose-response 
investigations and in particular assessment of the lowest efficacy range. Consequently, the 
aim of this study was to investigate the effects of a ‘low’ dose (15g glucose and 20mg 
caffeine), and a ‘moderate’ dose of glucose and caffeine (25g glucose and 40mg caffeine), 
in isolation and in combination compared to placebo on cognitive performance, mood and 
hormonal response in healthy young adults. In terms of the glycaemic response, the 
findings were as expected and showed that blood glucose levels were significantly higher 
following the glucose and glucose and caffeine combination drinks compared to the 
placebo and caffeine drinks, for both the low and moderate dosing regimens.  
Evidence for improved performance following any of the active drinks in either dosing 
regimen (‘low’ and ‘moderate’) was limited across all cognitive domains. The primary 
outcome variable of interest was the effects on attention as measured by the accuracy on 
the Digit Vigilance task. This was because of the weight of previous evidence that 
suggested that caffeine and glucose have a beneficial effect on attention. However no 
effects were found on accuracy on the Digit Vigilance task following any of the treatment 
drinks. There were no improvements on any measures of attention following any of the 
active drinks..  
There was some evidence for improvement of performance in tasks assessing declarative 
long-term memory performance. More specifically, participants’ accuracy in recognising 
previously presented words was greater after ingestion of the moderate combination drink 
compared to placebo. When looking at speed of recognition, both the ‘moderate’ 
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combination drink led to participants recognising words faster, whereas for the low dose 
group, faster performance was seen after administration of 15g of glucose in isolation. A 
different effect profile was observed for picture recognition, where both 20mg and 40mg 
of caffeine led to reduced performance decrements compared to placebo. Beneficial effects 
on working memory were not observed. None of the comparisons between active 
treatments and placebo were significant. 
In terms of mood, the effects were exclusively limited to the moderate dose regimen. The 
40mg caffeine drink led to participants rating themselves as more alert. Following the 
moderate combination drink participants rated themselves as significantly more alert, 
calmer and had lower overall tense arousal scores. In addition, after consumption of the 
moderate combination drink, participants rated themselves as feeling less light-
headed/dizzy/faint, reported higher levels of tension compared to the placebo drink.  There 
were no effects of the low dose active drinks on any of the mood measures.  
 There were no effects of the active drinks on any of the measures of attention, and 
therefore offers no support for previous research findings (Adan & Serra-Grabulosa, 2010; 
Brice & Smith, 2001a; Chubley, et al., 1979; Gershon, et al., 2009; Howard & Marczinski, 
2010; Kennedy & Scholey, 2004; Mets, et al., 2010; Mucignat-Caretta, 1998; Scholey & 
Kennedy 2004; Smit & Rogers, 2002; Smith, et al., 1992; Smith, et al., 1994; Smith, et al., 
1997). Previously for example,Howard and Marczinski (2010) found that reaction time 
was decreased on a cued go-no-go task after consumption of the ‘Red Bull’ energy drink. 
The lowest dose had the greatest effect; this was the equivalent to 45.6mg caffeine and 5g 
glucose, which in caffeine content is closest to the moderate dose treatments in this study. 
However as a) both caffeine in isolation and in combination with glucose improved 
performance and b) the glucose dose was rather small, it is likely that the benefits were 
driven by caffeine rather than a synergistic effect between glucose and caffeine. The 
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failure to observe clearer effects on measures of attention in our study, might be due to the 
nature of the attention tasks employed as they were possibly not ‘sustained’ enough, most 
only lasted a few minutes. A longer duration may be necessary in order to see the effects 
of caffeine in otherwise healthy and well-rested participants. For example Kennedy & 
Scholey (2004), found that three active combination drinks (68g glucose and 38mg 
caffeine; 68g glucose and 46mg caffeine; 60g glucose and 33mg caffeine) all improved 
performance on a rapid visual information processing (RVIP) task. However, this was only 
evident later in the task after over 30 mins of a demanding cognitive battery. Indeed, the 
mere act of switching to a different task could be enough to raise attention levels 
regardless of the treatment consumed (Einother & Giesbrecht, 2013). 
The limited beneficial effects found following 15g of glucose could be explained as a 
result of sub-optimal dosing given that 25g has previously been identified as the most 
effective in improving verbal declarative memory (Messier, Pierre, Desrochers & Gravel, 
1998; Sünram-Lea, Owen, Finnegan and Hu, 2011). However, the failure to observe any 
beneficial effects of 25g of glucose is unexpected and more difficult to explain. As 
mentioned earlier, previous studies have shown that in order to demonstrate glucose 
facilitation of memory performance tasks need to be sufficiently difficult and/or cognitive 
resources need to be stretched through administration of a dual task design (Foster, et al., 
1998; Sünram-Lea, et al., 2002).  Although a dual task paradigm was employed in the 
current study, since task performance on the secondary hand movement task was not 
monitored, it might have been the case that participants were not equally dividing their 
attention between the two tasks, which is important for the effectiveness of the dual-
tasking paradigm. However, when administered in combination with 40g of caffeine, an 
improvement in speed of recognition was observed for verbal material. Although, is in line 
with previous research that has also found combinations of caffeine and glucose to 
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positively affect performance on this domain (Alford et al., 2001; Horne & Reyner, 2000), 
support for any synergistic effect is limited as yet again a different effect profile was 
observed for picture recognition, where none of the combined drinks enhanced 
performance. Beneficial effects were only observed following 20mg of caffeine and 40mg 
of caffeine administered in isolation.  
The finding that caffeine improved some aspects of long term memory performance 
supports previous research that caffeine consumption can lead to memory improvements 
(Kelemen & Creeley, 2001; Smith, Sturgess & Gallagher, 1999). Smith et al., (1999) 
found that whilst there was no beneficial effect of caffeine (40mg) on a free recall memory 
task, it did significantly speed up the response times in a delayed recognition task. Kelman 
& Creeley (2001) found that caffeine did benefit performance on a free recall task. 
However, it is important to note that they found that when caffeine was administered on 
both recall and encoding days, recall was significantly better than when it was just 
administered on one of the days. This is suggestive of state dependent learning (Overton, 
1978) rather than caffeine facilitation per se. Moreover, they administered a much higher 
dose of 4mg/kg; which for their average participant weight of approximately 76kg was 
304mg of caffeine. With regards to working memory, previous research has found 
evidence of improvements in working memory following administration of an energy 
drink containing 75mg caffeine, 37.5mg glucose, 12.5mg ginseng and 2.004mg ginkgo 
biloba extract (Scholey & Kennedy, 2004). No significant effect of glucose and caffeine 
administrated in isolation or in combination were observed in the current study on working 
memory. However, it may be that the tasks used were not sufficiently difficult or 
demanding enough to tease out the effects of treatment on working memory performance 
where participants are otherwise performing at an optimum level, particularly given the 
short (2min) duration of the task.  
129 
 
Whilst evidence for beneficial effect on cognition was limited across all active treatment 
drinks, the moderate dosing regimen was relatively effective at augmenting participants’ 
mood. Participants rated themselves as significantly more alert following both 40mg of 
caffeine in isolation or in combination with 25g of glucose. Moreover, this combination 
drink increased ratings of tension, which is in line with previous research (Gershon, et al., 
2009; Glade, 2010; Haskell, Kennedy, Wesnes & Scholey, 2005; Howard & Marczinski, 
2010; Kennedy & Scholey, 2004; Mets et al., 2010; Smith, 2002). Interestingly, 
participants also rated themselves as significantly calmer and had lower tense arousal 
scores following the combination drink, suggesting that increased feeling of arousal are 
seen as positive and not accompanied by negative mood states such as increased agitation. 
The effects of caffeine are likely to be responsible for the combined drinks’ alerting effects 
(Glade, 2010; Smith, 2002), however glucose has been associated with feeling less tense 
(Benton & Owens, 1993). Other research has found that an energy drink containing 54g 
glucose and 30mg caffeine reduced anxiety ratings and increased ratings of ‘Cheerfulness’ 
(Smit et al., 2006). The amounts of caffeine and glucose in the moderate dosing regimen 
are similar to the amounts studied in Smit et al., (2006) research.  
In conclusion, whilst some of the findings in this study are supportive of previous research 
they do not demonstrate clear benefits of glucose and caffeine containing drinks on 
different aspects of cognition and do not allow a clear picture as to the possible synergistic 
effects of caffeine and glucose when administered in combination. Not all of the previous 
literature supports the idea for a synergistic effect of caffeine and glucose above those 
effects of these ingredients in isolation (Jay et al., 2006; Urquiza & Vieyra, 2015). 
However, for those studies that have found effects one important common denominator is 
that these are often carried out on a sample of participants who are performing below their 
optimal potential, for example after sleep restriction, physical exertion or over long periods 
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of cognitive demand (Alford et al., 2001; Horne & Reyner, 2001; Kennedy & Scholey, 
2004). Horne and Reyner (2001) restricted participants to 5 hours sleep the night before 
testing them on a driving simulator the following afternoon. They found that after 
consuming an energy drink containing 42g glucose and 30mg caffeine, there were reduced 
incidents of lane drifting, a proxy measure for attention, and their reaction time to an 
auditory beep were significantly improved, compared to the placebo drink. This could also 
be why no mood effects were found in terms of energy and alertness ratings. Smit et al., 
(2004) found effects of an energy drink (75mg caffeine, 37.5g glucose), maintained self-
rated levels of arousal compared to a decline in these following the placebo treatment. 
However this was following a fatiguing and cognitively demanding task, where the 
duration and repetition of the tasks were sustained over an extended period (Smit et al., 
2004). 
As previously mentioned, the vigilance/attention tasks used in this study were all relatively 
short. It may be that the constant switching between tasks was enough to increase attention 
and alertness regardless of the treatment consumed. In a similar vein, previous research 
suggests that the beneficial effects of glucose are enhanced when the tasks require an 
element of divided attention or they require a high cognitive demand (Foster, et al., 1998; 
Kennedy & Scholey, 2000; Sünram-Lea, et al., 2002). In particular this effect is found 
when looking at the performance of healthy young adults where it is generally considered 
they are performing at an optimum level to begin with (Messier, 2004; Smith et al., 2011). 
Although a dual-task paradigm was used in this study for the memory task in the hope that 
this would help to tease out the effects of glucose administration on its’ own and in 
combination with caffeine, performance on the secondary task was not monitored and 
therefore it might be the case that participants failed to equally divide their attention. 
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The data suggest that further research should employ more prolonged and difficult tasks 
which will hopefully tease out the effects of glucose and caffeine. It may be that the state 
of the participant is also an important mediator for the effectiveness of caffeine and 
glucose. The psychoactive properties of these substances might be most effective when 
participants are already fatigued and their performance and mood is below optimal levels. 
It may be that rather than improving performance, these substances are most useful in 
ameliorating the decline in performance under sub-optimal conditions. For example, in this 
study both caffeine drinks reduced the decrements seen on a memory task rather than 
enhancing performance per se. Further research should seek to manipulate the state of 
participants to fully elucidate this effect. It would also be interesting to look at the 
physiological effects these substances are having, as it may be a case that the participant 
are performing at a higher level with less effort, i.e. underlying neuro-physiological 
processes are more cost effective in order to produce the same behavioural response. For 
example it has been found that although consumption of a glucose and caffeine 
combination (75g glucose and 75mg caffeine) led to the same performance on a sustained 
attention task as the components in isolation, there was a decrease in the bilateral parietal 
and left prefrontal cortex only after the complete drink (Serra-Grabulosa, Adan, Falcon & 
Bargallo, 2010). As these areas are related to sustained attention and working memory, this 
suggests that the combination may be increasing the efficiency of the attentional system 
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The popularity of caffeine as a mild stimulant is in part attributable to its effects in the 
nervous system (Nehlig, Daval & Debry, 1992), including its ability to increase rates of 
dopamine release in the anterior cingulate gyrus (Daly & Fredholm, 1998). Caffeine 
activates the two major stress axes, resulting in elevated glucocorticoid and catecholamine 
output along with increases in blood pressure (al'Absi & Lovallo, 2004). More specifically, 
activation of the hypothalamic-anterior pituitary-adrenocortical axis (HPA axis) is 
associated with the release of glucocorticoids from the adrenal cortex (cortisol in humans) 
and activation of the sympatho-adrenomedullary axis (SAM axis) results an increase in 
endogenous adrenergic activity, resulting in increased catecholamine activity (adrenaline 
and noradrenaline). A major physiological role of activation of both endocrine systems is 
considered to be a temporary increase in energy production and more specifically 
provision of additional metabolic fuel through increase in glucose availability (Evans et 
al., 1986). The release of glucocorticoids leads to an increase in blood glucose levels 
through gluconeogenesis in the liver and decreasing glucose absorption from peripheral 
tissue. Moreover, the release of adrenaline also produces an increase in circulating blood 
glucose levels via the liver (Gold, 1992). Consequently, energy mobilization through 
increases in glucose levels can be seen as a major factor in order to prepare the body for 
the 'fight or flight' response.  
Both caffeine and glucose administration have been shown to affect cortisol and/or 
catecholamine release (for example Bergendahl et al., 1996; 2000; Gonzalez-Bono, 
Rohleder, Hellhammer, Salvador, & Kirschbaum, 2002; Graham, Rush, van Soeren, 1994; 
Kirschbaum, Bono, Rohleder, Gessner, Pirke, Salvador, & Hellhammer, 1997; Vance & 
Thorner, 1989; James, 2004; Lovallo, Farag, Vincent, Thomas, & Wilson, 2006; Lovallo, 
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Whitsett, al’Absi, Sung, Vincent, & Wilson 2005; Robinson, Sünram-Lea, Leach, & 
Owen-Lynch, 2004). For example, Lovello et al., (2006) administered caffeine throughout 
the day (3x250mg) and found that caffeine increased cortisol levels across the day. 
Moreover, when cortisol levels were already raised due to a mental stress task, caffeine 
had an additive effect in raising these further. Some studies suggest that glucose 
administration may increase the cortisol response to a psychosocial stressor (Gonzales-
Bono et al., 2002; Kirschbaum et al., 1997). Kirschbaum et al., (1997) found that 
administration of 100g glucose one hour before exposure to a psychosocial stressor led to 
an exacerbated cortisol response that was not seen in participants who consumed water. 
However, other research observed that administration of a glucose drink (25g) can blunt 
the cortisol response to a brief naturalistic stressor which has both a psychological and a 
physical component (fire-fighting training, Robinson et al., 2004). 
Whilst cortisol provides a measure of the HPA axis reactivity, more recently salivary 
alpha-amylase (sAA) has been identified as a measure of SAM axis reactivity (Nater, La 
Marca, Florin, Moses, Langhans, Koller, & Ehlert, 2006; Nater, Rohleder, Gaab, Berger, 
Jud, Kirschbaum, & Ehlert, 2005). Salivary alpha amylase (sAA) - a critical protein 
produced with saliva (Rohleder & Nater, 2009) - has the main function of digesting 
carbohydrates (Baum, 1993); however, evidence (Chatterton, Vogelsong,  Lu, Ellman, & 
Hudgens, 1996) suggests that it can also be used as an indicator of sympathetic nervous 
systems (SNS) activity (see Nater & Rohleder, 2009 for a review of the literature). Thus, 
stressful or demanding situations are argued to activate the SNS with sAA being a useful 
measure of such activation (Rohleder, Nater, Wolf, Ehlert & Kirschbaum, 2004; 
Maruyama et al., 2012). There are very few studies that fail to observe a significant 
increase in the release of sAA in response to stressful situations; higher during both 
physical and psychological stress (Chatterton et al., 1996). More specifically, sAA has 
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been suggested as a biomarker of the noradrenergic component of SNS activation (Ditzen 
et al., 2014; Kuebler et al., 2014; Rohleder and Nater, 2009; Wiemers et al., 2013).  
However, the effects of caffeine on sAA activity are not widely known. There are two 
studies which suggest that caffeine can stimulate sAA activity (Bishop, Walker, Scanlon, 
Richards, & Rogers, 2006; Morrison, Haas, Shaffner, Garrett, & Fackler, 2003), whereas 
others found no such effect (Nater, Rohleder, Schlotz, Ehlert, & Kirschbaum, 2007; Klein, 
Bennett, Whetzel, Granger, Ritter, 2010; Klein, Whetzel, Bennett, Ritter, Nater, & 
Schoelles, 2014). Bishop et al., (2006) reported an increase in sAA after caffeine 
administration in male endurance athletes under prolonged exercise condition. Morrison et 
al., (2003) found that caffeine intake, but not self-reported stress levels, predicted sAA 
levels among nurses on a paediatric intensive care unit. However, Nater et al., (2007) did 
not find an effect of self-reported caffeine intake on diurnal sAA activity. Klein, Bennett, 
Whetzel, Granger, Ritter, (2010) observed no relationship between basal caffeine levels 
and basal sAA activity levels in habitual caffeine consumers and recent evidence suggests 
that sAA activity is not affected by administration of 200mg or 400mg of caffeine in 
regular caffeine consumers (Klein, Whetzel, Bennett, Ritter, Nater,  & Schoelles, 2014).  
Thus, the limited literature is inconclusive regarding the effects of caffeine on sAA 
activity. Moreover, there has been limited investigation into the effects of combined 
glucose and caffeine administration on hormonal responses and activation. Sünram-Lea et 
al., (2012) found an increase in cortisol following a stressful fire-fighting training exercise, 
however there were no effects of glucose and caffeine when administered in combination 
on cortisol response following either a 40mg caffeine: 50g glucose drink or a 80mg 
caffeine:12.5g glucose drink. To the best of the author’s knowledge there is currently no 
study reported in the literature that examined the effects of combined administration on 
sAA activity. However, investigation into the effects of combined administration of 
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caffeine and glucose on these physiological parameters is important as it may help to 
further elucidate the underlying mechanisms of the behavioural effects. Consequently, the 
aim of the study was to investigate the effect of caffeine and glucose administration on 
neuroendocrine activity in order to further elucidate the mechanisms through which these 





3.2 Method and Materials 
 
3.2.1 Participants 
As described in Chapter 2, sixty-four healthy young adults aged 18-35yrs were recruited 
for the study. There were recruited via the Online Research Participation System (SONA) 
at Lancaster University. A sample size of 32 participants in each study was deemed to be 
sufficient as this was comparable to other studies utilising a similar design who had found 
beneficial effects of caffeine and glucose on attention when co-administered (Kennedy & 
Scholey, 2004; Scholey & Kennedy, 2004; Smit & Rogers, 2002). All were frequent 
caffeine consumers, consuming a minimum of 120mg caffeine per day. Participants were 
excluded if they; had a diagnosis of Diabetes Mellitus; had any intolerance or allergic 
reaction to substances that contain phenylalanine and/or caffeine; were non-native English 
speakers; had a history of neurological or psychiatric illness (excluding depression or 
anxiety); had a current diagnosis of neurological or psychiatric illness (including 
depression or anxiety); were currently taking medication or nutritional supplements 
(excluding contraceptive pill); were pregnant, seeking to become pregnant or 
breastfeeding; had a history of or currently abused drugs or alcohol; smoked. Eligibility 
was confirmed via a Clinical Records Form (CRF) after the participants had given their 
signed informed consent to take part. 
 
3.2.2 Design 
A double-blind placebo controlled, balanced mixed design was used. With participants 
randomly allocated to two different dosing regimens (‘moderate’ versus ‘low’), each 
comprised of three different treatment combinations (glucose, caffeine and a glucose 
caffeine combination) and a matching inert placebo. There was a 7 day (+/-2) washout 
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period between treatments. Assessments of cognition, mood, fatigue and hormonal 
response were completed pre-treatment (baseline) and 20 minutes after (post-dose). 
 
3.2.3 Treatments 
Drinks were supplied by GlaxoSmithKline Laboratories in 380ml lightly carbonated taste 
matched solutions. The ‘low’ dose regime consisted of a glucose drink (containing 15g 
glucose, 0mg caffeine); a caffeine drink (containing 0g glucose, 20mg caffeine); and a 
combined drink (containing 15g glucose and 20mg caffeine). The ‘moderate’ dose regime 
consisted of glucose (25g glucose, 0mg caffeine); caffeine (0g glucose, 40mg caffeine); 
caffeine and glucose (25g glucose, 40mg caffeine). Both regimes also utilised a taste 
matched placebo (0g glucose, 0mg caffeine). 
Participants were instructed to consume one drink per test session within 5 minutes. Post-
dose cognitive testing started 20 minutes after the drink administration. A 20-minute delay 
was chosen as peak plasma caffeine concentration is reached between 15 to 120 min after 
oral ingestion and brain levels remain stable for at least one hour following peak plasma 
levels (Nehlig, 1999; Nehlig & Boyet, 2000). Also this time frame was similar to the 
procedure of previous glucose studies (Foster, Lidder & Sünram, 1998) in order to ensure 
successful transfer of plasma glucose to the brain. 
 
3.2.4 Procedure 
Initial screening was done during sign-up using the Lancaster recruitment on-line system 
(SONA). At the first visit for screening and training, all participants completed the 
voluntary written informed consent prior to any study procedures being performed. The 
participant was screened by the researcher and the outcome of the screening activities was 
recorded in the CRF. Personal demographic information (such as age, education height and 
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weight) was also collected at this visit. They also completed a caffeine consumption 
questionnaire. Training on the cognitive tasks was then completed. No drinks were 
administered during the practice sessions and performance data from these sessions was 
not included in the analysis.  
Participants then attended the laboratory on a further 4 occasions to complete the testing 
sessions. Testing was carried out between 8.30am and 12 noon and participants were asked 
to fast for 12hrs prior to the session (i.e. no food or drink except water) and to abstain from 
alcohol for 24 hours prior to testing. Due to the cortisol awakening response participants 
were also asked to wake up no earlier than 6.30am and no later than 8am. There was a 
7(+/-2) day washout period between active days of the study. Consequently, participants 
were required to attend a weekly morning session over a period of approximately five to 
six weeks. Participants were randomised on arrival at the lab for their first study day. All 
active study days followed the same procedure. 
At the beginning of the study day, a small baseline sample of blood was taken, and further 
blood glucose measurement was taken 15 and 50 minutes after drink consumption. 
Immediately after the baseline blood sample two saliva samples were also taken using a 
Salivette (Sarstedt Ltd.). The first for the measurement of alpha amylase, and the second 
for cortisol. Further saliva samples were taken 45 minutes post-drink for alpha-amylase 
and 55 minutes post-drink for cortisol. The first blood and saliva samples were followed 
by pre-drink baseline evaluation of mood and cognition, using the cognitive test battery. 
This was followed by administration of the day’s treatment (following a double-blind 
procedure). The post-drink cognitive test session commenced 20 minutes after drink 
consumption. Each test session comprised of completion of the cognitive test battery 
(cognitive performance), the Bond-Lader visual analogue scales, the Mood, Alertness and 
Physical Symptoms (MAPS) Questionnaire, the Stress Arousal Checklist, and the 
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Activation-Deactivation adjective checklist (mood measures) and all participants received 















































Figure 3.1 Schematic of the study day procedure 
3.2.5 Alpha Amylase and Cortisol Measurement 
Assessment of salivary cortisol levels is the classic measurement of response to stress, 
associated with activation of the HPA axis. Salivary alpha-amylase is a measure of 
adrenergic activity (SAM axis).  Collection of saliva, in preference to blood sampling, 
provided a non-invasive mechanism to collect physiological samples from subjects.  
Saliva samples were collected using the salivette saliva sampling device (Sarstedt LTD, 
Leicester, UK). For the measurement of alpha-amylase, participants were instructed to give 
un-stimulated saliva samples by placing a Salivette in the top right hand corner of their 
mouth for a timed two-minute period. For the measurement of cortisol, participants were 
asked to lightly chew on the Salivette for one-minute. Samples were stored at -40oC until 
analysis. Saliva was recovered by centrifugation and salivary volume determined by 
weighing. This allows for the calculation of the saliva flow rate. Cortisol concentration 
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(nmol/l), alpha amylase (μ/mL) concentration in saliva was determined by commercially 
available kits (Salimetrics, USA).  
 
3.2.6 Statistical Analyses 
For hormonal responses (cortisol and alpha amylase), measures were transformed into 
change from baseline scores and analysed using a linear mixed model. Treatment and period 
were added as fixed effects and subject as random effect to the model. The model also 






3.3.1 Alpha amylase 
There was no significant main effect of the ‘low dose’ treatments on alpha amylase, F (3, 
11.55) = 1.59, p =.24, or period, F (3, 18.16) = 2.69, p = .07; or interaction, F (9,7.05) = 
1.33, p = .36. Comparison with placebo showed no significant differences between any of 
the active treatments.  
There was no significant main effect of the ‘moderate dose’ treatments on alpha amylase, 
F (3, 46.05) = 0.12, p = .95. There was no main effect of period, F (3, 77) = 2.49, p = .07; 
or the interaction, F (9, 27.64) = 0.95, p = .50.  There were no significant differences 
observed following administration of treatment drinks compared to placebo. 
 
3.3.2 Cortisol 
There was no significant main effect of the ‘low dose’ treatment, F (3, 14.76) = 0.34, p = 
.80; period, F (3, 16.85) = 0.35, p = .79, or interaction, F (9, 16.73) = 1.13, p = .40. 
For the ‘moderate dose’ treatment group, there were no significant effects of treatment, F 
(3, 30.27) = 0.32, p = .81; period, F (3, 24.81) = 0.07, p= .97, or interaction between both 
factors observed, F (9, 22.05) = 0.61, p = .78.  
There were no significant differences observed following administration of treatment 







Table 3.1 Alpha Amylase and Cortisol, means and standard errors 
Treatment Combined Glucose Caffeine Placebo 
Low
1










































1 Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: Alpha Amylase = 63.53; Cortisol = 0.53. 
2Change from baseline; covariates appearing in the model are evaluated at the following values: Alpha Amylase = 80.52; 
Cortisol = 0.58. 






The effects of glucose and caffeine alone and in combination on hormonal response were 
examined. No significant treatment effects were found for any of the active drinks in either 
dosing regimen (‘low’ or ‘moderate’) on either cortisol or alpha amylase were found. 
These findings do not support previous research which has found caffeine and glucose can 
have a modulating effect on hormonal response (Bergendahl et al., 1996; 2000; Gonzalez-
Bono et al., 2002; Graham et al., 1994; Kirschbaum et al., 1997; Vance & Thorner, 1989; 
James, 2004; Lovallo et al., 2006; Lovallo et al., 2005; Robinson et al., 2004). However 
other research has also found no effects of these substances on either the HPA or SAM 
axes (Klein et al., 2014; Sünram-Lea et al., 2012).   
The lack of effects seen in this study could be due to the relatively low doses of caffeine 
and glucose administered, i.e. 20/40mg and 15/25g respectively. Previous research found 
that higher doses of glucose of 100g (Kirschbaum et al., 1997) and three doses of 250mg 
caffeine across the course of the day (Lovello et al., 2006) increased cortisol reactivity. 
However, Robinson et al., (2004) found just 25g glucose attenuated the cortisol response 
to a naturalistic stressor, however in their study glucose was administered after stress 
exposure. Timing of administration might be an important factor. Another potential 
moderating factor might be the nature of the task or more specifically whether or not a task 
is stressful. . Whilst the prolonged cognitive testing battery employed in the current study 
could be considered a stressor, it probably does not have the stress inducing effects of 
other stressors that have been employed to elicit a stress response. For example, 
Kirschbaum et al., (1997) only found the increased cortisol response following glucose 
consumption when participants completed a psychosocial stressor (Trier Social Stress 
Test). Similarly, Lovello et al., (2006) found caffeine increased the cortisol response to a 
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mental stressor which consisted of 15mins demanding attention task and 15mins of a 
working memory, mental arithmetic task. However, Sünram-Lea et al., (2012) failed to 
find any effects on cortisol response when two glucose and caffeine combination drinks 
were administered prior to a naturalistic stressor.  
It is also possible that individual participants’ characteristics impacted on the results. al’ 
Absi, Lovallo, McKey, Sung, Whitsett, and Wilson (1998) found that caffeine (3.3mg/kg-
equivalent to 2/3 cups of coffee) increased cortisol reactivity to a greater extent in 
individuals with increased central nervous system activation, for example those with a high 
risk of hypertension. As the participants utilised in this study were young, healthy adults, it 
is unlikely that they would be presenting with an increased hypertension risk. Similarly, 
Klein et al., (2014) found that caffeine, at doses of 200mg or 400mg did not affect alpha 
amylase activity in participants who were regular caffeine consumers. Again, the 
participants in the current study were regular caffeine consumers. Therefore, the 
mechanisms of action for any effects via these hormonal pathways may be sensitive to 
specific individual’s characteristics. 
Although the effects of these active drinks on cognitive performance and mood (as 
reported in chapter 2) were limited, the fact that beneficial effects were seen in the absence 
of hormonal responses suggest that these are not, or at least not solely responsible for the 
observed behavioural effects. Indeed, it may be that the hormonal mechanisms are only of 













The effects of pre-retrieval administration of glucose, caffeine 






So far, when assessing effects on memory performance the studies reported in this thesis 
have employed a pre-learning administration approach, in which the treatment drink is 
administered shortly before the material to be remembered is presented. However, the 
administration of glucose and/or caffeine just before the learning period does not allow one 
to distinguish between the effects of glucose on learning (i.e. encoding) or on memory (i.e. 
storage), as it might be the case that improved memory performance is simply a carry-over 
effect of improved drink-related encoding of the to-be-remembered target material. If, 
however, delayed recall performance is also facilitated when glucose and/or caffeine are 
administered after encoding, depending on the time frame when administration occurs, this 
would enable one to conclude that these substances improve consolidation or retrieval of 
the memory material. 
To date, research into the facilitative properties of combined caffeine and glucose 
administration on memory performance has exclusively employed a pre-learning 
administration approach. However, in terms of the effects of glucose and caffeine 
administration in isolation, both have been found to improve memory when administered 
at different stages of the memory process. More specifically glucose has been shown to 
improve memory when it is administered immediately after encoding and also when 
administered immediately prior to recall (Kopf & Baratti, 1996; Flint & Riccio, 1998; 
Manning, et al., 1992; Manning, Stone, Korol & Gold, 1998; Sünram-Lea, et al., 2002a). 
For example, Kopf and Baratti (1996) obtained evidence for a significant facilitating effect 
of retrograde peripheral administration of glucose on retention of a habituation response in 
mice. In this study, male mice were permitted to explore a novel environment (open-field 
activity chamber) for 10 minutes. This procedure was conducted twice with a 24-h 
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interval, and the difference in the exploratory activity between the first (training) and the 
second (testing) exposures to the chamber was taken as an index of retention. The results 
showed that post-training administration of glucose enhanced retention. The effect of 
glucose on retention was time-dependent, insofar as glucose administration 180 minutes 
after training did not result in better memory performance; only glucose injection 
immediately after the training period resulted in significantly better retention compared to 
the control group (which received saline injection). Similarly, Flint and Riccio (1998) 
examined the effects of glucose on infantile amnesia in 17-day old preweanling rats using 
a retrograde administration approach. Rats were trained to criterion on a passive avoidance 
conditioning task. They were tested 24hrs later, immediately prior to which they were 
injected with either a saline or glucose. Following glucose injection the poor performance 
in retention, suggestive of infantile amnesia which was seen following saline, was 
attenuated. Stone, Rudd and Gold (1990) also found that performance was enhanced when 
glucose was administered prior to testing in mice. Manning et al., (1992) examined 
anterograde and retrograde glucose administration on memory performance in elderly 
human participants. Participants were asked to listen to a narrative prose passage and their 
recall was tested immediately afterwards and 24hrs later. The treatment, either 50g glucose 
or placebo (23.7mg saccharin) was administered either immediately before or directly after 
hearing the material to be recalled . Both pre- and post-acquisition administration of 
glucose improved recall 24hrs later compared to placebo. They concluded that, as scores 
on the immediate recall task following both glucose and placebo were similar, glucose 
specifically improved memory storage processes, i.e. retention rather than encoding. The 
results also showed that memory recall at 24hr following pre-acquisition glucose was 
significantly better compared to placebo. The authors suggest that the enhancing effects of 
glucose may be due to preventing memory degradation (Manning et al., 1992). Further 
149 
 
evidence that the glucose memory facilitation effect outlasts the rise in blood glucose 
levels after treatment was provided in a further study by Manning et al., (1998). In this 
study healthy elderly participants received 50g glucose or 35mg saccharin across four 
study days, either immediately before acquisition, or immediately before recall 24 hrs 
later. They found that both anterograde and retrograde administration led to significantly 
better recall. However participants showed significantly better recall following the pre-
acquisition administration compared to after pre-retrieval administration of glucose. The 
results suggest that whilst glucose can be beneficial for encoding, storage and retrieval, its 
effects may be less pronounced on retrieval (Manning et al., 1998). Sünram-Lea, Foster, 
Durlach and Perez (2002a) investigated the effect of post-acquisition glucose 
administration on memory performance in healthy young adults. Participants consumed 
25g glucose or a placebo either immediately before, 15 minutes before, or immediately 
after the presentation of a word list. The word list was then recalled 30mins and 24hrs 
later. Both immediate pre-acquisition and immediate post-acquisition administration of 
glucose improved memory performance compared to placebo at 30min and 24hrs. 
However, their findings also showed that effect of anterograde glucose administration on 
memory performance is time-dependent, as the enhancement of retention was decreased 
when the administration-learning interval was increased.  
While there is extensive literature suggesting beneficial effect of caffeine on memory in 
both humans (Keleman & Creeley, 2001; Smith et al., 1999; Smith, Clark & Gallagher, 
1999) and animals (Costa, Botton, Mioranzza, Ardais, Moreira, Souza & Porciúncula, 
2008; Prodiger, Batista & Takahasi, 2005) in terms of an anterograde administration mode, 
some studies have actually reported inhibitory effects on retention after anterograde 
administration (Childs & de Wit, 2006). Indeed, it has been argued that caffeine is most 
effective at improving retrieval and storage rather than acquisition. For example, 
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retrograde administration of caffeine, in particular at lower doses (1 – 30 mg/kg) has been 
shown to improve memory consolidation (Angelucci, Cesário, Hiroi, Rosalen & Cunha, 
2002; Angelucci, Vital, Cesário, Zadusky, Rosalen & Cunha, 1999). In their first study, 
Angelucci et al., (1999) administered 1, 3, 10, 30 or 100mg/kg of caffeine or saline and 
measured inhibitory avoidance and habituation to a new environment in rodents. The 
results demonstrated that for the 10-30mg/kg doses, when caffeine was administered 
30mins before the training session, retention scores were impaired. However, caffeine 
improved the inhibitory avoidance (but not habituation) retention scores when 
administered immediately after the training or 30 min before the test session at the doses of 
1–30 mg/kg or 3–10 mg/kg. The authors conclude that depending on anterograde or 
retrograde administration caffeine can impair or improve memory, respectively. In a 
second study, the group investigated the effects of caffeine on spatial memory in rats using 
the Morris Water Maze (Angelucci, Cesário, Hiroi, Rosalen & Cunha, 2002). Caffeine was 
administered either at 30mins before training, immediately after training or 30mins before 
testing, at doses of 0.3, 3, 10 or 30mg/kg. Again, post-training administration of caffeine 
improved memory consolidation, although this was only observed for the lower doses (0.3-
10mg/kg dose). Pre-test administration of caffeine also resulted in a slight memory 
advantage (shortened escape latencies). Interestingly, whilst pre-training caffeine 
administration did not significantly improve memory performance, it also did not result in 
memory impairments as previously reported. The inhibitory effect of caffeine on memory 
acquisition could be related to a direct impairment effect on learning or to state-dependent 
learning mechanisms. Angelucci et al., (1999) suggested that the amnestic effects induced 
by pre-training caffeine administration in rodents submitted to both an inhibitory 
avoidance task could not be attributed to state- dependent learning as they were not 
abolished by a subsequent pre-test caffeine administration. A relatively recent study by 
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Sanday et al., (2013) however suggested that caffeine-induced memory deficits might be 
due to state dependent learning mechanisms as pre-test caffeine administration abolished 
the memory impairments effect produced by pre-training injection of caffeine. Despite, the 
controversy surrounding the potential underlying mechanisms, the data suggest that 
caffeine is most effective at improving retrieval and storage rather than acquisition 
(Angelucci et al., 2002).  
Since both substances in isolation have been shown to enhance consolidation and retrieval, 
the aim of the current study was to investigate their combined effects when administration 
occurs pre-retrieval. Previous research carried out with human participants has found that 
glucose has beneficial effects on free recall following anterograde and retrograde 
administration, therefore the primary outcome will be the number correct on the delayed 
word recall task. The findings of the proposed research will have ecological relevance as 
glucose and caffeine containing beverages (such as energy drinks) are often consumed 
when consumers want to boost their performance. In the case of pre-retrieval 
administration, this could be prior to an exam or prior to an important presentation where 
the to-be-remembered material has been learned previously. In addition, memory 
performance will be tested in the afternoon, following a two hour fast. Given that all 
previously reported studies in the literature examining the effects of combined glucose and 
caffeine administration were conducted in the morning, it was decided not only to 
manipulate the administration mode (pre-versus post acquisition) but also to carry out 
testing in the afternoon. Given that people may consume energy drinks as an afternoon 
‘pick-me-up’ after a period of post- lunch fasting, the aim of this study was to increase the 
generalisability of the previously observed facilitation effect and to establish its ecological 
validity. Moreover, there is evidence to suggest that both glucose (Sünram-Lea, Foster, 
Durlach& Perez, 2001) and caffeine (Smith, Hatfield & Hostetter, 2002; Ryan, Hatfield & 
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Hoffstetter, 2002; Nehling, 2010) administration in isolation can facilitate performance 
irrespective of time of day. The memory enhancing effect of glucose was essentially 
equivalent whether administration and testing occurred in the morning or in the afternoon 
(2-h after lunch; it was given after an over- night fast or a 2-h fast following breakfast or 
lunch. For caffeine, there is an indication that effects might be even stronger in the 
afternoon. This suggestion is in line with the observation that beneficial caffeine effects on 
mood and performance are more prominent under low arousal conditions. For example, 
caffeine has been shown to ameliorate the decline in in sustained attention after lunch, and 
is more effective during night work and prolonged work (Smith, Hatfield & Hostetter, 
2002; Nehling, 2010). In older adults caffeine has been shown to ameliorate a decline in 
cognitive performance in the afternoon, which is commonly observed in most adults over 
the age of 65 (Ryan, Hatfield & Hoffstetter, 2002). It has been suggested that these effects 
might be moderated by physiological arousal. In general, caffeine has been shown to 
mainly improve performance by reducing decrements in performance under suboptimal 
alertness conditions (Nehling, 2010).  
In terms of dosage, 40mg of caffeine was chosen given that previous studies reported in 
this thesis have shown this dosage to be effective in improving cognitive performance, 
including memory. For glucose, although 25g has been shown to robustly enhance 
memory performance when administrated in isolation, this has not been the case in the 
studies reported here. In the current study 40g of glucose was chosen as the dose of interest 
to investigate.  In summary, the current study aimed to provide further insight into the 
effects of caffeine and glucose containing drinks using a more realistic testing paradigm 








Thirty healthy young adults (10 males, 20 females) took part in the study, recruited via the 
Online Research Participation System (SONA) at Lancaster University. A sample size of 
30 participants was deemed to be sufficient as this was comparable to other studies 
examining the same domains, both retrograde administration on recall and effects on the 
attention networks, and where effects of caffeine and glucose had been found (Brunyé, 
Mahoney, Lieberman, Giles & Taylor, 2010a; Brunyé, Mahoney, Lieberman & Taylor 
2010b; Manning et al., 1998). The age range was 18-35 years (mean age 21.53 years). 
They all consumed at least 120mg caffeine per day, (average consumption was 225.75mg). 
Exclusion criteria included; a diagnosis of Diabetes Mellitus; any intolerance or allergic 
reaction to substances that contain phenylalamine and/or caffeine; being non-native 
English speakers; having a history of neurological or psychiatric illness (excluding 
depression or anxiety); having a current diagnosis of neurological or psychiatric illness 
(including depression or anxiety); currently taking medication or nutritional supplements 
(excluding the contraceptive pill); being pregnant, seeking to become pregnant or 
breastfeeding; having a history of or currently abusing drugs or alcohol; or smoking. The 
study was approved by the Department of Psychology Ethics Committee at Lancaster 
University. Participants gave their signed informed consent prior to taking part and a 






The study followed a placebo controlled, repeated measures design; the within factor being 
treatment (glucose (40g), caffeine (40mg), glucose/caffeine (40g/40mg), and placebo). 
There was at least a 48hr washout period between visits. Participants were randomly 
allocated to a treatment regime using a Latin square which counterbalanced the order of 




The treatments were supplied by Suntory Food and Beverage Europe in 380ml solutions. 
There were three active drinks; glucose containing 40g glucose, caffeine containing 40mg 
caffeine and a glucose and caffeine combination containing 40g glucose and 40mg 
caffeine. A taste matched placebo was also utilised.  
Participants were instructed to consume one drink per test session within 5 min. Cognitive 
testing started 20 minutes after drink administration. A twenty-minute delay was chosen as 
peak plasma caffeine concentration is reached between 15 to 120 min after oral ingestion 
and brain levels remain stable for at least one hour following peak plasma levels (Nehlig, 
1999; Nehlig & Boyet, 2000). Also this time frame is similar to the procedure of previous 
glucose studies (Foster et al., 1998) in order to ensure successful transfer of plasma 




Initial screening was done during sign-up using the Lancaster recruitment on-line system 
(SONA). At the first visit for screening and training, all participants completed the 
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voluntary written informed consent prior to any study procedures being performed. The 
participant was screened by the researcher and the outcome of the screening activities was 
recorded in the CRF. Personal demographic information (such as age, education, height 
and weight) was also collected at this visit. They also completed a caffeine consumption 
questionnaire to confirm their daily caffeine consumption. Training on the cognitive tasks 
was then completed. No drinks were administered during the practice sessions and 
performance data from these sessions was not included in the analysis.  
Participants then attended the laboratory on a further four times to complete their study 
sessions. All the study days followed the same procedure and were separated by at least a 
48hr wash out period. Upon arrival at the morning encoding session, baseline blood 
glucose measurements were taken. Participants were then presented with the material to be 
remembered (acquisition phase). Participants were then free leave the laboratory until they 
returned for their afternoon session, where memory performance was assessed. The 
afternoon session started 6hrs after encoding. Upon arrival the participant gave a finger 
prick blood sample. They then consumed their treatment drink for the day (following a 
double-blind procedure). The post-drink test session commenced 20 minutes after drink 
consumption. At around 15 mins post treatment a further blood glucose reading was taken. 
After the full 20 mins absorption period, participants’ memory performance on the various 
tasks was assessed. Following on from this they then completed the Attention Network 
task, which will be discussed in chapter 5. A final blood glucose reading was taken at the 











































Computerised assessment was used to evaluate cognitive performance. The memory tasks 
were delivered within the Computerised Mental Performance Assessment System 
(COMPASS), which is a purpose designed software application for the flexible delivery of 
randomly generated parallel versions of standard and novel cognitive assessment tasks. 
With the exception of the paper and pencil tasks (word recall); all responses were made 
using the computer keyboard and mouse. In this case the assessment comprised a selection 
of standard psychometric tasks with stimuli chosen to possess good face validity in an 





Word presentation. – A list of 20 words matched for frequency, concreteness and 
imagery were presented on the monitor at the rate of 1 every 2 seconds for participants to 
remember. During encoding, participants were required to perform two complex hand-
movement sequences (Sünram-Lea, Foster, Durlach & Perez, 2002b). Each sequence was 
performed using both hands and contained three movements: fist – chop - slap and back-
slap – chop – fist. Participants were told to alternate the sequence every fifth word and 
they were not informed when to change, they had to keep track of this themselves. Hand-
movements were performed continually during word presentation. Participants were told 
that the hand-movements were being video recorded during the task to ensure they fully 
engaged with this aspect of the task. 
Distractor Task. – After viewing the words participants engaged in an arithmetic 
task, which served to prevent the rehearsal of items in working memory. The Serial 3s task 
was used, this is where participants are presented with a starting number between 800 and 
999 on the screen and they have to serially subtract 3 from this number. The distracter task 
lasted for 30 seconds. Performance on this task was not used for analysis. 
Immediate word recall. - Participants were given 60-seconds to write down as 
many words as they could from the list they have just seen. Participants’ responses were 
marked according to total number of words recalled correctly and number of errors. 
Picture presentation. – 20 pictures were individually, displayed in the centre of the 
screen at a rate of 1 every 3 seconds. Each picture is displayed for 1 second. Participants 
were required to remember the pictures.  
Face presentation. – 20 faces were individually, displayed in the centre of the 
screen at a rate of 1 every 3 seconds. Each face is displayed for 1 second. Participants were 





Delayed word recall. - Participants were given 60-seconds to write as many words 
as they could from the list they have seen at the encoding phase. Participants’ responses 
were marked according to total number of words recalled correctly and number of errors. 
Delayed word recognition. – The 20 original words and 20 distractor words were 
presented individually in a randomised order. Participants were asked to indicate whether 
each word had been in the original list or not by responding using the ‘m’ key for ‘yes’ or 
the ‘z’ key for ‘no’ on their keyboard. Percentage accuracy and reaction times for both 
distractors and targets were recorded in addition to overall reaction times. 
Picture recognition. - The 20 original pictures and 20 distractor pictures were 
presented, individually in a randomised order. Participants were asked to indicate whether 
each word had been in the original list or not by responding with the ‘m’ key for ‘yes’ or 
the ‘z’ key for ‘no’ on their keyboard. Percentage accuracy and reaction times for both 
distractors and targets were recorded in addition to overall reaction times. 
Face recognition. - The 20 original faces and 20 distractor faces were presented, 
individually in a randomised order. Participants were asked to indicate whether each word 
had been in the original list or not by responding with the ‘m’ key for ‘yes’ or the ‘z’ key 
for ‘no’ on their keyboard. Percentage accuracy and reaction times for both distractors and 
targets were recorded in addition to overall reaction times. 
 
Blood glucose measurement 
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Blood glucose readings were obtained using the ExacTech® blood glucose monitoring 
equipment (supplied by MediSense Britain Ltd, 16/17 The Courtyard, Gorsey Lane, 
Coleshill, Birmingham B46 1JA), following the recommended procedure: The researcher 
swabbed the finger of the volunteer with a Sterets Isopropyl Alcohol BP Pre-injection swab 
(Seton Healthcare Group, Oldham, UK) and allowed the skin to air dry. The skin was 
punctured using an automatic lancing devise and a drop of blood was collected onto the 
analytical test strip. The volunteer applied a tissue to blot any excess blood. Ambidex-HG 
powder free polymer bonded latex examination gloves were worn by the experimenter at all 
times during the procedure. Each lancet and cap was only used once and then disposed of 
into a sharps container. Swabs, test strips, tissues and gloves were placed in a clinical waste 
sack.   
For performance characteristics of ExacTech® blood glucose monitoring equipment see 
Chapter 2.   
 
4.2.6 Statistical Analysis 
 
The primary efficacy variable was the number of correctly recalled words on the delayed 
word recall task. The secondary efficacy variables included; Immediate word recall correct 
and errors, delayed word recall errors, word recognition accuracy and speed, picture 
recognition accuracy and speed and face recognition accuracy and speed. The absolute 
values for all the behavioural and mood variables were used in the analysis. Using IBM 
SPSS Statistics Version 22 a linear mixed model was used to analyse the treatment drinks 
(Caffeine, Glucose, Caffeine and Glucose, and placebo). Treatment drink, period and 
treatment by period interaction were added as fixed factors and subject as a random factor. 
The Estimates of Fixed Effects were used to compare each active treatment with placebo. 
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For glycaemic measurement comparisons were performed on the blood glucose levels using 
a linear mixed model. The model included a random effect for subject and fixed effects for 
period, treatment and time. The Estimates of Fixed Effects were used to compare each active 






Table 4.1 Demographics, means and standard deviations 
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4.3.1 Blood Glucose 
There was a significant main effect of the low dose treatments on blood glucose, F (3, 
164.18) = 94.02, p < .001. There was a significant effect of time, F (3, 128.25) = 89.87; p 
< .001; and treatment x time interaction F (9, 89.82) = 36.47, p < .001 were observed. 
Comparisons showed that baseline blood glucose levels did not differ, however after 
administration of glucose containing drinks, higher blood glucose levels were observed at 
both post dose measures compared to placebo and the caffeine only drink (all p < .001) 




Figure 4.2 Glycaemic response to treatment as a function of drink and time 
 
 
Table 4.2 Blood glucose, means and standard errors 
Time Point 
Treatment 
Placebo Glucose (40g) Caffeine (40mg) Glucose (40g) / 
Caffeine (40mg)  
Baseline 4.87 (0.12) 4.82 (0.10) 4.94 (0.14) 4.93 (0.15) 
2
nd
 Baseline 5.03 (0.20) 4.65 (0.13) 5.14 (0.12) 5.24 (0.14) 
1
st
 Post Dose 5.08 (0.20) 7.61 (0.21) 4.93 (0.16) 8.41 (0.27) 
2
nd
 Post Dose 4.46 (0.15) 7.81 (0.34) 4.84 (0.13) 8.81 (0.34) 
 
 
4.3.2 Memory Results 
Data of all participants were included in the analysis. 




Delayed Word Recall Correct 
There was no significant main effect of the treatment on correctly recalled words in the 
Delayed Word Recall task, F (3, 28.74) = 1.88, p = .16. There was no main effect of 
period, F (3, 29.30) = 0.43, p = .73; or treatment x period interaction, F (9, 35.26) = 1.20, p 
= .33. No significant differences in performance were observed following administration 
of active treatment drinks compared to placebo. 
 
4.3.2.2 Secondary Outcomes - Memory 
 
Immediate Word Recall Correct 
There was no significant main effect of treatment on correctly recalled words, F (3, 33.78) 
= 1.87, p = .15. There was a significant main effect of period, F (3, 34.72) = 2.85, p = .05, 
with participants remembering fewer words at their first visit, but no significant interaction 
between treatment and period, F (9, 32.22) = 1.07, p = .41. Comparison with placebo 
showed no significant differences following administration of any of the active treatment 
drinks. 
 
Immediate Word Recall Errors 
There was no significant main effect of treatment on number of incorrectly recalled words, 
F (3, 34.77) = 0.58, p = .63. There was no main effect of period, F (3, 25.29) = 1.68, p = 
.20, and no significant interaction between treatment and period, F (9, 28.19) = 1.03, p = 
.44. There were no significant differences observed following administration of active 
treatment drinks compared to placebo. 
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Delayed Word Recall Errors 
There was no significant main effect of the treatment drinks on incorrectly recalled words, 
F (3, 19.61) = 0.19, p = .90. There was no main effect of period, F (3, 20.20) = 0.98, p = 
.42, and no interaction between treatment and period, F (9, 21.16) = 1.23, p = .33. 
However, participants performed significantly better following the placebo drink (M = 
1.67) compared to after the caffeine only drink (M = 1.71), p = .04.  
 
Word Recognition Accuracy 
There was no significant main effect of treatment on word recognition accuracy, F (3, 
33.71) = 1.08, p = .37. There was no main effect of period, F (3, 35.94) = 1.42, p = .25; or 
interaction between treatment and period, F (9, 35.86) = 1.60, p = .15. There were no 
significant differences observed following administration of active treatment drinks 
compared to placebo. 
 
Word Recognition Speed 
There was no significant main effect of treatment on reaction time for correctly recognised 
words, F (3, 29.14) = 0.23, p = .88; no main effect of period, F (3, 28.95) = 0.52, p = .67; 
and no significant treatment x period interaction, F (9, 32.12) = 0.84, p = .59. There were 
no significant differences observed following administration of active treatment drinks 
compared to placebo. 
 
Picture Recognition Accuracy 
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There was no significant main effect of treatment on the percentage correct responses on 
the picture recognition task, F (3, 48.67) = 0.29, p = .84. There was no main effect of 
period, F (3, 43.20) = 0.31, p = .82; or interaction between treatment and period, F (9, 
32.99) = 0.66, p = .74.  
 
Picture Recognition Speed 
There was no significant main effect of treatment on the reaction time of correctly 
recognised pictures, F (3, 15.36) = 1.34, p = .30. There was no main effect of period, F (3, 
23.55) = 2.61, p = .08; or interaction between treatment and period, F (9, 23.05) = 1.57, p 
= .18. There were no significant differences observed following administration of active 
treatment drinks compared to placebo. 
 
Face Recognition Accuracy 
There was no significant main effect of the treatment drinks on the correct responses on 
the face recognition task, F (3, 29.04) = 0.78, p = .51, and no main effect of period, F (3, 
31.48) = 1.57, p = .22, or treatment x period interaction, F (9, 20.36) = 1.63, p = .17. 
Comparison with placebo revealed no significant effects.  
 
Face Recognition Speed 
There was no significant main effect of treatment on the correct reaction time responses on 
the Face Recognition task, F (3, 39.04) = 0.17, p = .92. There was no main effect of 
period, F (3, 32.65) = 0.35, p = .79; or interaction between treatment and period, F (9, 
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26.65) = 1.86, p = .10. No significant differences were observed following administration 
of active treatment drinks compared to placebo. 
 
Table 4.3 Memory Results, means and standard errors 
Treatment
 












































































































The current study aimed to provide further insight into the effects of caffeine and glucose 
containing drinks using a more realistic testing paradigm with greater ecological validity. 
More specifically, we assessed the effects of drinks on memory performance when 
administered in the afternoon prior to retrieval, primarily on delayed free recall. Whereas 
previous studies have shown that in isolation, caffeine and glucose improve memory when 
administered prior to retrieval, in particular when measured by free recall (Angelucci et 
al., 1999; Angelucci et al., 2002; Kopf & Baratti, 1996; Flint & Riccio, 1998; Manning, et 
al., 1992; Manning, Stone, Korol & Gold, 1998; Sünram-Lea, Foster, Durlach & Perez, 
2002a), the results of the current study provided no evidence for such facilitation effect as 
neither the delayed free recall task, nor any of the other tasks showed glucose facilitation. 
For caffeine and for both substances in combination there was no evidence of any 
enhancement to performance when they were administered prior to retrieval. Indeed there 
was evidence to show that participants’ memory performance was impaired following 
caffeine, as participants’ performance was better following placebo compared to after the 
caffeine and combination drinks. 
Previous research has found that pre-test administration of glucose attenuated retention 
loss indicative of infantile amnesia in rats (Flint & Riccio, 1998). Manning et al., (1998) 
found that 50g glucose improved memory performance when administered immediately 
prior to testing memory of a previously heard passage. It may be that whilst 40g glucose is 
a similar dose to 50g used in Manning et al.,’s study, it is not effective for enhancement of 
recognition memory. The dose response profile for different tasks may be quite sensitive to 
changes in dose levels. The dose response profile for glucose has been previously shown to 
be different for different types of tasks (Sünram-Lea, Owen, Finnegan & Hu, 2011), and so 
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it may be that the specific stages of the memory process i.e. learning, storage and retrieval 
are also modulated by different doses.  
The caffeine drink was found to have detrimental effects on some of the performance 
measures, and so it seems that when consumed in isolation, caffeine has a negative effect. 
This finding does not support previous literature as caffeine has previously been found to 
impair memory acquisition, but have beneficial effects on memory consolidation and 
retrieval (Angelucci et al., 1999; Angelucci et al., 2002). One explanation for this finding 
may be state-dependent memory effects; whereby memory retrieval requires the state is the 
same as when encoding took place (Bruins Slot & Colpaert, 1999; Ceretta, Camera, Mello 
& Ruben, 2008). Sanday et al., (2013) found that pre-training caffeine-induced amnesia 
could be abolished by the administration of pre-test caffeine. This was further supported 
by the finding that whilst pre-training administration of caffeine impaired memory 
performance on a subsequent test, it did not alter the way mice learned to avoid the 
aversive enclosed arm compared to saline (Sanday et al., 2013). Therefore, the pre-training 
amnesia was not related to impaired learning of the task (Sanday et al., 2013). In the 
current study caffeine was only administered at recall and not at encoding, whereas in 
previous studies where caffeine was found to have beneficial effects on memory (see 
Chapter 2) caffeine was administered prior to encoding; therefore caffeine was present at 
both encoding and retrieval and this could have resulted in state-dependent memory 
effects. Another reason why no effects were observed might have been that the time scale 
between encoding and retrieval was too short to see the beneficial effects of these 
substances on memory retrieval. In this study the interval was only 6hrs from the start of 
the encoding session to the start of the retrieval session, whereas in previous research there 
has been a gap of 24hrs (Flint & Riccio, 1998; Manning et al., 1998) or 48hrs (Angelucci 
et al., 1999; Angelucci et al., 2002). The longer timeframe would increase the cognitive 
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demand of the task as participants would have to maintain the to-be-remembered material 
for longer. 
In conclusion, this study aimed to examine the effects of administration of glucose and 
caffeine and their combination prior to memory retrieval, primarily as measured by the 
performance of correctly recalled words on the delayed word recall task. No facilitation of 
memory performance after glucose administration was evident on this task or any of the 
secondary outcome measures. Consequently, the result of this study do not support 
previous research which found more robust effects following retrograde glucose 
administration (Flint & Riccio, 1998; Manning et al., 1998) and beneficial effects when 
caffeine was administered pre-retrieval (Angelucci et al., 1999; Angelucci et al., 2002). 
Moreover, there were no effects when caffeine and glucose were administered in 
combination. However, there are a number of factors that might have led to the failure to 
observe any effects. These include dose, time of day, level of fasting. For example, it 
would be useful to establish the dose-response profile of retrograde administration in order 
to see whether there is an optimal combination dose that is specific to enhancing retrieval. 












The effects of glucose, caffeine and their combination on the 















The effects of caffeine on attention have been extensively reviewed (for reviews see 
Einöther & Giesbrecht, 2013; Lieberman, 1992; Nehlig, 2010; Ruxton, 2008; Smith, 2002; 
Smith, 2005; Smith, Osborne, Mann, Jones & White, 2004; Stafford, Rusted & Yeomans, 
2006). Although not all studies found effects of caffeine on attention tasks, most studies 
found improvements in reaction time and there is evidence that caffeine can help sustain 
attention in demanding tasks (Einöther & Giesbrecht, 2013). For glucose, benefits have 
preferentially been observed on memory processes over other aspects of cognition 
including attention (Foster, et al., 1998; Meikle, Riby, & Stollery, 2005; Sünram-Lea et 
al., 2001). However, this might be due to the fact that effects on attention and vigilance 
have not been evaluated to the same extent. Studies that have assessed the impact of 
glucose on non-mnemonic processes including attention have also reported positive 
effects, especially when tasks are sufficiently difficult (Owens et al., 1994; Reay et al., 
2006).  
Yet, the studies reported in this thesis which have examined the effects of caffeine, glucose 
and their combination on measures of simple and complex attention demonstrated no clear 
effects of these substances on any of these attention measures.  
Attention is an essential aspect of cognitive functioning. The concept of attention as 
central to human performance extends back to the start of experimental psychology 
(James, 1890). Optimal attention is an important prerequisite for improving other cognitive 
processes, including memory. Consequently, assessment of effects of attention is crucial 
when trying to evaluate neurocognitive enhancement, especially when cognitive 
enhancement is defined as ‘the amplification or extension of core capacities of the mind 
through improvement or augmentation of internal or external information processing 
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systems’ (Bostrom & Sandberg, 2009). It is generally accepted that the concept of 
attention entails a number of distinct but related processes, but the exact structure of 
attention remains a matter of scientific debate (Raz and Buhle 2006). Yet, as observed with 
other psychoactive substances (for example nicotine; Hahn et al., 2009), the attention-
enhancing effect of caffeine and/or glucose might depend on the nature of the attentional 
function. There are currently two main theories of attention; the more traditional, which 
divides attention into simple and complex attentional processes, and more recently the 
Attention Network Theory (Posner & Petersen, 1990; Posner & Rothbart, 2007). The 
Attention Network Theory (ANT) postulates the existence of three distinct attentional 
networks, which differ both in functionality and anatomically (Posner & Petersen, 1990). 
These are the alerting, orienting and executive control attention networks (Fan, 
McCandliss, Sommer, Raz & Posner 2002; Posner & Petersen, 1990; Posner & Rosthbert, 
2007). The alerting network helps to achieve and maintain an alert state; the orienting 
network helps to select information from sensory input; and the executive control network 
is responsible for resolving conflict between responses (Fan et al., 2002). Fan et al., (2005) 
used event-related functional magnetic resonance imaging (fMRI) during the ANT to 
examine the brain areas involved in the three attentional systems. All three systems were 
shown to be related to separate distinct brain regions. They found the alerting network 
showed strong thalamic involvement along with the activation of the anterior and posterior 
cortical sites, whereas parietal sites and frontal eye fields were activated by the orienting 
network. The anterior cingulate, right and left frontal areas and several other sites e.g. left 
and right fusiform gyrus were activated by the executive control network (Fan et al., 
2005).  However, there is evidence for an interdependency of the different networks 
(Posner, 1994, Funes & Lupiáñez, 2003, Callejas, Lupiáñez & Tudela, 2004). 
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The ANT allows assessment of several aspects of attention (alerting, orienting, and 
central-executive function) within a single procedure (Fan et al., 2002). In order to assess 
the alerting network, participants are measured as to whether cues which alert them to trial 
onset improve their performance (Fan et al., 2002; Fan, McCandliss, Fossella, Flombaum 
& Posner, 2005). To assess the orienting network, the extent to which participants’ 
performance is improved when they see cues which orient them to the upper or lower 
section of the screen in preparation for the trial onset, compared to cues which do not 
provide spatially relevant information, is measured (Fan et al., 2002; Fan et al., 2005). For 
the assessment of the executive control network the extent to which participants can 
respond to the direction of a middle arrow, whilst inhibiting the effects of opposite facing 
flanker arrows, is compared to their performance when the flanker arrows are congruent 
and a slowed performance demonstrates the inefficiency of the network (Fan et al., 2002; 
Fan et al., 2005). 
There is evidence to suggest that different attentional networks are sensitive to glucose and 
caffeine administration. Brunyé, Mahoney, Lieberman & Taylor (2010b) examined the 
effect of caffeine (0mg, 100mg, 200mg & 400mg) on the ANT using a placebo-controlled, 
double-blind, repeated-measures design, in low caffeine consumers (M = 42.5mg/day). 
The results showed that caffeine improved the alerting and executive control networks 
following both the 200mg and 400mg doses, whereas 400mg of caffeine resulted in 
performance impairments on the orienting network components. In a further study the 
group assessed the effects on the attention networks in high caffeine consumers (M = 
592.3mg/day; Brunyé, Mahoney, Lieberman, Giles & Taylor, 2010a) using the same 
experimental design. Whereas no effects on the orienting network were observed, there 
was a dose dependant increase in improvement on the alerting networks. However, 
compared to placebo a significant improvement was only seen at the highest dose 
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(400mg). Similarly, a dose dependant improvement in performance was evident on the 
executive control network; but only significant compared to placebo at the 400mg dose. 
There is also evidence that glucose (albeit in combination with taurine) can enhance the 
orienting network (Giles, Mahoney, Brunyé, Gardony, Taylor and Kanarek, 2012). Giles et 
al., (2012) evaluated the effects of caffeine, taurine and glucose alone and in combination 
on the attention networks. Participants received various caffeine and taurine dosage 
combinations together with either glucose (50g) or placebo.  They found that 200mg 
caffeine improved the performance of the executive control network, and glucose in 
combination with taurine improved the performance of the orienting network.  
Taken together these findings suggest that caffeine and glucose can have beneficial effects 
on attention. As the ANT allows assessment of several aspects of attention (alerting, 
orienting, and central-executive function) within a single procedure, using this approach 
might help elucidate substance specific effects on attention and might help explain why 
some studies failed to find effects on attention. As previous research has found the most 
robust effects with caffeine administration on the executive control network, this will be 
primary efficacy outcome for this study. In addition, attention will be tested in the 
afternoon, following a two hour fast. Given that people may consume energy drinks as an 
afternoon ‘pick-me-up’ after a period of post-lunch fasting; this will increase the 
generalisability of the previously observed facilitation effect and to establish its ecological 
validity.  
The doses of 40mg caffeine and 40g of glucose where chosen with consideration to the 
memory tasks reported in Chapter 4 as these two studies utilised the same participants and 
testing schedule. So far the 25g glucose has not been shown to have beneficial effects on 
cognitive performance, and therefore 40g of glucose was chosen as the dose of interest to 
investigate.   
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Thirty healthy young adults (10 males, 20 females) took part in the study, recruited via the 
Online Research Participation System (SONA) at Lancaster University. A sample size of 
30 participants was deemed to be sufficient as this was comparable to other studies 
examining the same domains, both retrograde administration on recall and effects on the 
attention networks, and where effects of caffeine and glucose had been found (Brunyé, 
Mahoney, Lieberman, Giles & Taylor, 2010a; Brunyé, Mahoney, Lieberman & Taylor 
2010b; Manning et al., 1998). The age range was 18-35 years (mean age 21.53 years). 
They all consumed at least 120mg caffeine per day, (average consumption was 225.75mg). 
Exclusion criteria included; a diagnosis of Diabetes Mellitus; any intolerance or allergic 
reaction to substances that contain phenylalamine and/or caffeine; being non-native 
English speakers; having a history of neurological or psychiatric illness (excluding 
depression or anxiety); having a current diagnosis of neurological or psychiatric illness 
(including depression or anxiety); currently taking medication or nutritional supplements 
(excluding the contraceptive pill); being pregnant, seeking to become pregnant or 
breastfeeding; having a history of or currently abusing drugs or alcohol; or smoking. The 
study was approved by the Department of Psychology Ethics Committee at Lancaster 
University. Participants gave their signed informed consent prior to taking part and a 






The study followed a placebo controlled, repeated measures design; the within factor being 
treatment (glucose (40g), caffeine (40mg), glucose/caffeine (40g/40mg), and placebo). 
There was at least a 48hr washout period between visits. Participants were randomly 
allocated to a treatment regime using a Latin square which counterbalanced the order of 




The treatments were supplied by Suntory Food and Beverage Europe in 380ml solutions. 
There were three active drinks; glucose containing 40g glucose, caffeine containing 40mg 
caffeine and a glucose and caffeine combination containing 40g glucose and 40mg 
caffeine. A taste matched placebo was also utilised.  
Participants were instructed to consume one drink per test session within 5 min. Cognitive 
testing started 20 minutes after drink administration. A twenty minute delay was chosen as 
peak plasma caffeine concentration is reached between 15 to 120 min after oral ingestion 
and brain levels remain stable for at least one hour following peak plasma levels (Nehlig, 
1999; Nehlig & Boyet, 2000). Also this time frame is similar to the procedure of previous 
glucose studies (Foster, Lidder & Sünram, 1998) in order to ensure successful transfer of 




Initial screening was done during sign-up using the Lancaster recruitment on-line system 
(SONA). At the first visit for screening and training, all participants completed the 
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voluntary written informed consent prior to any study procedures being performed. The 
participant was screened by the researcher and the outcome of the screening activities was 
recorded in the CRF. Personal demographic information (such as age, education, height 
and weight) was also collected at this visit. They also completed a caffeine consumption 
questionnaire to confirm their daily caffeine consumption. Training on the cognitive task 
was then completed. No drinks were administered during the practice sessions and 
performance data from these sessions was not included in the analysis.  
Participants then attended the laboratory on a further four times to complete their study 
sessions. All the study days followed the same procedure and were separated by at least a 
48hr wash out period. Upon arrival at the morning encoding session, participants gave a 
small sample of blood for the measurement of blood glucose. They then completed the 
presentation phase of the memory tasks. The results of the memory tasks are not reported 
or discussed here; they form the experimental data for chapter 4. Participants were then 
free to go until they returned for their afternoon retrieval session. The afternoon session 
started 6hrs after the start of the encoding session. Upon arrival the participant gave a 
finger prick blood sample (the results of the blood glucose analysis are discussed in 
chapter 4). They then consumed their treatment drink for the day (following a double-blind 
procedure). The post-drink cognitive test session commenced 20 minutes after drink 
consumption. At around 15 mins post treatment they gave another finger prick blood 
sample for blood glucose measurement. After the full 20 mins absorption period, they then 
completed the retrieval phase of the memory tasks. Following on from this they then 
completed the Attention Network test. A final finger prick blood sample was taken at the 


























































Figure 5.1 Schematic of the study day procedure 
5.2.5 Assessments 
The Attention Network Test (ANT) (Fan et al., 2002) was delivered using E-Prime. 
The ANT is used to assess the performance of the three visual attention networks (alerting, 
orienting, and executive control; Posner & Petersen, 1990), which are all neuroanatomically-
defined. 
During each trial, the participant fixated on a point (400-1600ms), they then saw a cue 
(100ms), there was then a continued fixation period (400ms) and then an array of 
horizontally-aligned arrows appeared, either above or below a central fixation point 
(maximum 1700ms). The cue could alert the participant that the trial was about to be 
presented (“centre”), or it could also orient the individual to where the trial would be 
presented (above or below fixation: “spatial”; both above and below fixation: “double”). A 
central target arrow was then presented within an array of horizontally-aligned congruent 
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arrows (same facing direction), incongruent arrows (opposite facing direction), or neutral 
lines (without arrow heads). There was then a variable intertribal interval (calculated as 
3500ms minus first fixation duration minus reaction time).  
Three blocks of 96 trials were presented in a random order (total of 288 trials). In each 
block, there were two trials presented for each of the four cue conditions (none, centre, 
double and spatial), two target locations (top, bottom), two target directions (left, right), and 
the three flanker conditions (neutral, congruent, incongruent). Participants responded to the 
central arrow’s direction (left or right) and this reaction time was measured. 
In order to assess each of the attention networks, change scores were calculated for alerting, 
orienting and executive function (Fan et al., 2002). 
For the alerting score, the average double-cue RTs was subtracted from the no-cue RTs. For 
the orienting score, the average spatial RTs were subtracted from the centre cue RTs. Higher 
scores on both of these would indicate more efficient alerting and orienting functioning. For 
the executive control, a conflict change score was calculated by taking the incongruent 
flankers RTs and subtracting the average congruent flankers RTs (across all cue types). Here 
a lower score would indicate more efficient executive control functioning with conflicting 
information. 
 
Blood glucose measurement 
Blood glucose readings were obtained using the ExacTech® blood glucose monitoring 
equipment (supplied by MediSense Britain Ltd, 16/17 The Courtyard, Gorsey Lane, 
Coleshill, Birmingham B46 1JA), following the recommended procedure: The researcher 
swabbed the finger of the volunteer with a Sterets Isopropyl Alcohol BP Pre-injection swab 
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(Seton Healthcare Group, Oldham, UK) and allowed the skin to air dry. The skin was 
punctured using an automatic lancing devise and a drop of blood was collected onto the 
analytical test strip. The volunteer applying a tissue blotted any excess blood. Ambidex-HG 
powder free polymer bonded latex examination gloves were worn by the experimenter at all 
times during the procedure. Each lancet and cap was only used once and then disposed of 
into a sharps container. Swabs, test strips, tissues and gloves were placed in a clinical waste 
sack.   
For performance characteristics of ExacTech® blood glucose monitoring equipment see 
Chapter 2.   
 
5.2.6 Statistical Analysis 
 
The primary efficacy variable was the executive control network. The secondary outcome 
variables were the alerting and alerting and orienting networks. The absolute scores for all 
the behavioural variables were used in the analyses. Using IBM SPSS Statistics Version 22 
a linear mixed model was used to analyse the treatment drinks (Caffeine, Glucose, 
Caffeine and Glucose, and placebo). Treatment drink, period and treatment by period 
interaction were added as fixed factors and subject as a random factor. The Estimates of 
Fixed Effects were used to compare each active treatment with placebo. 
For glycaemic treatment comparisons were performed on the blood glucose levels using a 
linear mixed model. The model included a random effect for subject and fixed effects for 
period, treatment and time. The Estimates of Fixed Effects were used to compare each active 






Participant demographics are as described in Chapter 3. 
 
5.3.1 Blood Glucose 
 
As reported in Chapter 3. 
 
5.3.2 Attention Network Task Results 
 
5.3.2.1 Primary Outcome 
 
Executive Control 
There was no significant main effect of treatment on the executive control component of 
the ANT, F (3, 36.52) = 0.44, p = .73. There was no significant main effect of period, F (3, 
35.43) = 2.40, p = .08, or treatment x period interaction, F (9, 22.55) = 0.61, p = .78. None 
of the active treatment drinks led to superior performance compared to placebo. 
 
5.3.2.2 Secondary Outcomes - Attention 
 
Alerting 
There was no significant main effect of treatment on the alerting component of the ANT, F 
(3, 39.94) = 1.25, p = .30. The main effect of period, F (3, 38.93) = 2.83, p = .05, failed to 
182 
 
reach significance and no treatment x period interaction was observed, F (9, 25.28) = 0.46, 
p = .89. Comparison with placebo showed no significant differences following 
administration of any of the active treatment drinks. 
 
Orienting 
There was no significant main effect of treatment on the orienting component of the ANT, 
F (3, 37.95) = 0.59, p = .63. There was no main effect of period, F (3, 36.77) = 0.77, p = 
.52; and the interaction between treatment and visit was also not significant, F (9, 33.11) = 
1.79, p = .11. As before, no significant differences were observed following administration 
of treatment drinks compared to placebo. 
 
Table 5.1 Attention Network Results, means and standard errors 
Treatment
 
































The aim of the study was to investigate the effect of caffeine and glucose administered in 
isolation and combination on attention, using an approach that allows evaluation of 
different attentional networks and systems. The study found no significant effects of 
glucose, caffeine and their combination on the primary efficacy variable of the executive 
attention network, or on either of the secondary efficacy variables (alerting and orienting 
network) and therefore fails to support previous findings that caffeine has beneficial 
effects on the alerting and executive control networks (Brunyé et al., 2010a; Brunyé et al., 
2010b) and that glucose (in combination with taurine) has beneficial effects on the 
orienting network (Giles et al., 2012).  
Limited research has examined the effects of caffeine and glucose on these attention 
networks, however there are clear underlying mechanisms of action whereby consumption 
of glucose and caffeine could assert their effects. For example, the areas of the brain which 
underlie the alerting and executive control network are rich in dopamine receptors (Ferre et 
al., 1992; Ferre, 2008; Lumme, Aalto, Ilonen, Nagren & Hietal, 2007). For the alerting 
network this is the thalamus and bilateral frontal and parietal brain regions (Fan et al., 
2005); and for the executive control network this is the anterior cingulate cortex (ACC) 
and lateral prefrontal cortices (Botvinick, Braver, Barch, Carter & Cohen, 2001; Bush, Luu 
& Posner, 2000; Fan et al., 2005). Therefore these attention networks are likely to be the 
most susceptible to caffeine modulation as caffeine has a strong interaction with central 
dopaminergic systems (Einother & Giesbrecht, 2013). Conversely, the brain areas 
underlying the orienting network have limited dopaminergic activity and so caffeine is 
unlikely to modulate this area (Einother & Giesbrecht, 2013). However the parietal lobe, 
which is the brain area which underlies the orienting network, is involved in the 
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cholinergic system (Einother & Giesbrecht, 2013) and therefore could be susceptible to 
modulation by glucose (Messier, 2004). In their review of the literature on the effects of 
caffeine on attention, Einother and Giesbrecht (2013) concluded that doses ranging from 
60-400mg had beneficial effects on the executive control network.  
Consequently, dose might be an important factor when trying to explain the lack of effect 
observed in the current study. Previously quite high levels of caffeine i.e. 200mg and 
400mg have been needed to elicit beneficial effects on the attention networks (Brunyé et 
al., 2010a; Brunyé et al., 2010b). Despite the fact that previous research has found caffeine 
doses of between 12.5mg to 100mg to have a fairly flat dose response rate on cognitive 
task performance (Smit & Rogers, 2000), it might be that higher caffeine doses are needed 
to elicit the effects on the attention networks. With regards to glucose, previous research 
by Giles et al., (2012) found that 50g glucose in combination with 2000mg taurine 
improved the orienting network. This dose of glucose is very close to the one used in this 
research (40g), however it may be that the addition of the taurine has some modulating 
effect in addition to the glucose. 
Also, whilst the task was fairly long (approximately 20mins), participants who were 
otherwise performing optimally (e.g. fully rested), may not have found it sufficiently 
difficult to maintain their attention for this period of time. Therefore it may be necessary to 
deplete participants’ cognitive resources prior to the drink consumption and completion of 
the ANT in order to tease out the potential beneficial effects of these substances. Giles et 
al., (2012) also suggested that the lack of effects of glucose could be due to low task 
difficulty, as previously glucose has been shown to preferentially enhance task with a 
higher cognitive load (Kennedy & Scholey, 2000), so this may be one way to increase the 
cognitive load of the ANT. Increasing the duration of the task may also have this effect 
and increase its sensitivity to glucose and caffeine.  
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Whilst previous research has shown that caffeine and glucose can have beneficial effects 
on the attention networks (Brunyé et al., 2010a; Brunyé et al., 2010b; Giles et al., 2012), 


























Moderating effects of cognitive resource depletion on cognitive 
















Study 1 showed some improvements following both the low (15g glucose/20mg caffeine) 
and moderate dose (25g glucose/40mg caffeine) combination treatments on aspects of 
memory and attention with faster reaction times being observed on several task (e.g. 
Picture Recognition and Word Recognition). Whilst these findings are in line with 
previous research that also found combinations of caffeine and glucose to positively 
modulate performance on these tasks (Alford et al., 2001; Horne & Reyner, 2000), they 
are not clear cut in terms of which aspects of cognition are improved by combined glucose 
and caffeine consumption. In general, when administered together they have been found to 
improve attention and ameliorate fatigue (Adan & Serra-Grabulosa, 2010; Kennedy & 
Scholey, 2004; Scholey & Kennedy, 2004; Smit, Cotton, Hughes & Rogers, 2004). 
However, the overall results of the literature remain equivocal and one reason for this 
could be due to participants’ characteristics. 
Task demand and more generally the activation state of the consumer may be important 
effect moderators. The psychoactive properties of caffeine and/or glucose may be most 
effective when participants are already fatigued and their performance and mood is below 
optimal levels or when task demand is particularly high. Indeed previous research has 
demonstrated that tasks, which are more cognitively demanding, are more susceptible to 
improvement by caffeine and glucose (Brice & Smith, 2001; Donohoe & Benton, 1999; 
Kennedy & Scholey, 2000; Smith et al., 1999; Brown & Riby, 2013; Brandt, Gibson & 
Rackie, 2013). For example, Donohoe and Benton (2000) found that higher levels of blood 
glucose had more beneficial effects on the more cognitively demanding tasks. Indeed, 
falling blood glucose has also been associated with participants rating themselves as 
feeling less energetic when performing cognitively demanding tasks (Owens, Parker and 
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Benton, 1997). Kennedy and Scholey (2000) found that 25g glucose was more effective in 
enhancing performance on a cognitively demanding Serial 7s task (as rated by the 
participants). In addition, enhanced performance following glucose administration was 
observed for the for the most demanding episodic memory and attention task conditions 
(Brown and Riby, 2013; Meikle, Riby & Stollery, 2005) and the incongruent and therefore 
more difficult trials in the Stroop task paradigm (Brandt et al., 2013).  Moreover, glucose 
facilitation of memory performance has most robustly been observed under dual task 
conditions (Sünram-Lea, Foster, Durlach & Perez, 2002). Consequently, tasks that are 
more cognitively demanding may be particularly sensitive to glucose loading. For caffeine, 
there is evidence to suggest effects are most pronounced when consumers are fatigued, 
sleep-deprived (Lorist, Snel, Kok and Mulder 1994; Schweitzer, Muehlbach & Walsh, 
1992; Horne & Reyner, 1996), and/or have to sustain performance over longer periods of 
time (Scholey and Kennedy, 2004). Lorist et al., (1994) examined the effects of 200mg 
and 50mg caffeine on Event Related Potentials (ERPs) during a selective search task. 
Participants were either well-rested or fatigued. Although no difference in effectiveness 
between well-rested or fatigued individuals was observed on behavioural measures 
(reaction time), the state of the participants determined the neurocognitive effects to 
caffeine as measured by the P3b component.  The effect of caffeine on this component 
considered to reflect the maintenance in working memory was greater in participants who 
were fatigued compared to those who were well-rested. Another example is Brice and 
Smith’s (2001) study which demonstrated that when performing two consecutive 
cognitively demanding tasks (either a simulated driving task or a sustained attention task), 
performance on the second task was improved following administration of 3mg/kg of 
caffeine. Specifically it improved steering accuracy in the driving task and increased 
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accuracy on the sustained attention task. Self-reported alertness was also increased 
following the caffeine treatment prior to and on completion of both tasks.  
With regards to the combined administration literature, where more robust effects of 
glucose and caffeine have been found, these are often in participants who are performing 
below their optimal potential, for example after sleep restriction, physical exertion; over 
long periods of cognitive demand or performing under stress (Alford, Cox & Wescott, 
2001; Horne & Reyner, 2001; Kennedy & Scholey, 2004; Sünram-Lea, Owen-Lynch, 
Robinson, Jones & Hu, 2012). Horne and Reyner (2001) administered an ‘energy drink’ 
containing 42g glucose and 30mg caffeine to participants prior to a 2hr drive in driving 
simulator. To ensure the participants were tired, they were sleep restricted to 5hrs sleep the 
night before testing. They found that, particularly in the first hour, the ‘energy drink’ in 
comparison to placebo, reduced lane drifting incidents and reduced the participants’ 
reaction time to an auditory beep. Kennedy and Scholey (2004) examined the effects of 
three ‘energy drinks’ (68g glucose/38mg caffeine; 68g glucose/46mg caffeine; 60g 
glucose/33mg caffeine) compared to placebo, and they found that the active drinks 
improved performance and reduced mental fatigue during an extended period (60mins) of 
cognitively demanding tasks. An ‘energy drink’ containing 75mg caffeine and 37.5g 
glucose was found to maintain self-rated levels of arousal compared to a decline in this 
following placebo (Smit, Cotton, Hughes & Rogers, 2004). This was following tasks 
which due to their duration and repetition over an extended period of time were fatiguing 
and cognitively demanding (Smit et al., 2004). The beneficial effects of glucose and 
caffeine have also been shown when participants have been under conditions of 
physiological and psychological stress. Sünram-Lea et al., (2012) administered either one 
of two ‘energy drinks’ or a placebo to participants before they underwent a fire fighting 
search and rescue training exercise. Energy drink 1 contained 50g glucose and 40mg 
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caffeine, and energy drink 2 contained 10.25g fructose/glucose and 80mg caffeine. 
Memory performance was not impaired following energy drink 1 compared to the other 
two treatments. Both energy drinks improved information processing performance in 
comparison to a decrease in performance following the placebo. The participants also 
reported reduced self-assessed anxiety and stress following energy drink 1. These research 
findings support the idea that the beneficial effects of caffeine and glucose are most 
reliably observed when participants are operating at below optimal levels.   
However, to date it is unclear whether prior depletion of cognitive and/or energy resources 
might be important to demonstrate beneficial effects. As demonstrated by time-on-task 
research, performance on prolonged tasks declines due to depletion of limited cognitive 
resources (Grier, Warm, Dember, Matthews & Galinsky, 2003; Smit, Eling & Coenen, 
2004; Warm, Parasuramen & Matthews, 2008). The importance of the effects of state 
dependent moderating factor in drug research has been long recognised (Janke, 1983). 
However, to date no study has specifically addressed this question in the context of 
combined glucose and caffeine administration by manipulating the level of cognitive 
resource depletion prior to drink administration.  
Consequently, the aim of this study is to further assess the effects of glucose and caffeine 
administration on cognition and mood and to evaluate whether these substances might 
have their greatest effects when cognitive resources are under strain due to prior depletion. 
Given that the most robust findings in the previous combined literature show effects of 
caffeine and glucose on attentional measures, the primary efficacy analysis will be the 
accuracy performance on the RVIP task.  
The study is also designed to address issues raised around the memory task used 
previously in this research series (see chapter 2), for example it appears that tasks 
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involving more complex cognitive processes are more likely to show enhancement 
following single and combined drink administration (Kennedy and Scholey, 2000; 
Kennedy and Scholey, 2004; Smit et al., 2004; Smit, Grady, Finnegan, Hughes, Cotton & 
Rogers, 2006). Therefore a memory task which includes a dual-tasking paradigm to 
increase the workload, an extended attention/vigilance task and a demanding working 
memory task were implemented.  In addition, two different doses of glucose and caffeine 










Fifty-nine healthy young adults aged 18-35yrs took part in the study. The Online Research 
Participation System (SONA) at Lancaster University was used for recruitment. A sample 
size of 30 participants in each condition (high and moderate) was deemed to be sufficient 
as this was comparable to other studies examining the effects of caffeine and glucose on 
cognitively demanding tasks, (Kennedy & Scholey, 2004; Scholey & Kennedy, 2000). 
They all consumed at least 120mg caffeine per day. Exclusion criteria included; a 
diagnosis of Diabetes Mellitus; any intolerance or allergic reaction to substances that 
contain phenylalamine and/or caffeine; being non-native English speakers; having a 
history of neurological or psychiatric illness (excluding depression or anxiety); having a 
current diagnosis of neurological or psychiatric illness (including depression or anxiety); 
currently taking medication or nutritional supplements (excluding the contraceptive pill); 
being pregnant, seeking to become pregnant or breastfeeding; having a history of or 
currently abusing drugs or alcohol; or smoking. Participants gave their signed informed 





The study followed a placebo controlled, mixed 3x2x2 design; the within factors was 
treatment (two different doses of glucose and caffeine in combination; 60g glucose/40mg 
caffeine and 25g glucose/40mg caffeine, and placebo) and time (pre- versus post drink 
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assessment) and the between factor was the manipulation of resource depletion (depletion 
versus no depletion). Depending on the resource depletion condition they were assigned to, 
they either completed a resource depletion task at the beginning of their visits or watched a 
DVD prior to baseline testing and drink administration. There was a 7(+/-2)-day washout 
period between visits. Participants were randomly assigned to one of the two resource 




The treatments were supplied by GlaxoSmithKline Laboratories in 380ml solutions. The 
“high” dose consisted of 60g glucose and 40mg caffeine; the “moderate” dose consisted of 
25g glucose and 40mg caffeine, and a taste matched placebo was also utilised.  
Participants consumed one treatment drink per test session. They were instructed to 
consume these within 5 minutes and post-dose testing started 20 minutes later. A 20 
minute delay was chosen as peak plasma caffeine concentration is reached between 15 to 
120 min after oral ingestion and brain levels remain stable for at least one hour following 
peak plasma levels (Nehlig, 1999; Nehlig & Boyet, 2000). Moreover, a recent GSK study 
has shown that behavioural effects can be observed 14 minutes following caffeine 
consumption (Rogers; RHS00794). Also this time frame was similar to the procedure of 
previous glucose studies (Foster, Lidder & Sünram, 1998) in order to ensure successful 






Initial screening was done during sign-up using the Lancaster recruitment on-line system 
(SONA). At the first visit for screening and training, all participants completed the 
voluntary written informed consent prior to any study procedures being performed. The 
participant was screened by the researcher and the outcome of the screening activities was 
recorded in the CRF. Personal demographic information (such as age, education, height 
and weight) was also collected at this visit. They also completed a caffeine consumption 
questionnaire to confirm their daily caffeine consumption. Training on the cognitive task 
was then completed. No drinks were administered during the practice sessions and 
performance data from these sessions was not included in the analysis.  
Participants then attended the laboratory on a further 3 occasions to complete the testing 
sessions. Testing was carried out between 8am and 12 noon and participants were asked to 
fast for 12hrs prior to the session (i.e. no food or drink except water) and to abstain from 
alcohol for 24 hours prior to testing. There was a 7(+/-2) day washout period between 
active days of the study. Consequently, participants were required to attend a weekly 
morning session over a period of approximately five to six weeks. Participants were 
randomised to their Depletion/No Depletion group and treatment schedule on arrival at the 
lab for their first study day. All active study days followed the same procedure. 
Upon their arrival participants completed either the resource depletion task or watched a 
DVD for 30 minutes. All participants then had a blood glucose sample taken via a finger 
prick to measure their baseline blood glucose levels. Further samples were taken at 15 and 
40 minutes after treatment administration. The first blood samples were followed by pre-
treatment baseline evaluation of mood and cognition. This was followed by administration 
of the day’s treatment (following a double-blind procedure). The post-treatment cognitive 
test session commenced 20 minutes after drink consumption. Each test session comprised 
of the completion of the cognitive test battery (cognitive performance), the Bond-Lader 
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visual analogue scales, and the Mood, Alertness and Physical Symptoms (MAPS) 
















































Computerized assessment was used to evaluate cognitive performance. All tasks were 
delivered within the Computerized Mental Performance Assessment System (COMPASS), 
a purpose designed software application for the flexible delivery of randomly generated 
parallel versions of standard and novel cognitive assessment tasks. With the exception of 
the paper and pencil tasks (word recall); all responses were made using the computer 
keyboard and mouse. In this case the assessment comprised a selection of standard 
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psychometric tasks with stimuli chosen to possess good face validity in an ‘everyday’ 
context. The elements of the cognitive assessment are described below. 
Resource Depletion Battery  
The manipulation of cognitive-resource depletion was achieved by using two repetitions of 
two cognitively demanding tasks, each repetition lasting 15 minutes, making the total 
battery 30 minutes. The tasks were;  
Computerised Serial Sevens Task  
This task evaluates working-memory performance (Hayman, 1942). Participants were 
required to compute a running subtraction of 7, starting from a randomly generated 
number. Participants were given 5 minutes to complete this task. The number of responses, 
number of correct responses and number of incorrect responses were recorded. 
Digit Vigilance 
This task measures sustained attention (Lewis, 1995). A single target digit was randomly 
selected and continuously displayed on the right side of the screen. In the centre a series of 
rapidly changing digits was displayed. Participants were required to press the space bar 
button as quickly as possible, whenever the digit in the centre matched the target digit. The 
task lasted for 10 minutes. Reaction times (milliseconds), percentage accuracy and number 
of false alarms were recorded. 
 




A list of 20 words matched for frequency, concreteness and imagery is presented on the 
monitor at the rate of 1 every 2 seconds for participants to remember. During encoding, 
participants were required to perform two complex hand-movement sequences (Sünram-
Lea et al., 2001). Each sequence was performed using both hands and contains three 
movements: fist – chop – slap and back-slap – chop – fist. Participants were told to 
alternate the sequence every fifth word and they were not informed when to change, only 
that they had to keep track of this themselves. Hand-movements were performed 
continually during word presentation. 
Distractor Task 
After viewing the words participants engaged in an arithmetic task, which serves to 
prevent the rehearsal of items in working memory. The participants completed a short 
computerised Serial Threes Subtraction task, this was the same as the Serial Sevens 
subtraction task except it required the serial subtraction of 3s. The distracter task lasted for 
30 seconds. 
Immediate word recall 
Immediately after the words were presented participants were given 60-seconds to write 
down as many words as they can from the list they have just seen. Participants’ responses 
are marked according to total number of errors and number of words recalled correctly. 
Rapid Visual Information Processing (RVIP) 
A series of numbers between 1 and 9 will appeared one at a time in quick succession. 
Participants were asked to press the space bar whenever they saw three odd or three even 
numbers in a row. The numbers were presented at the rate of 100/min. The task lasts for 10 




Participants were presented with a series of letters one at a time. For each letter they had to 
decide if it was the same as one presented 3 letters previously in the series and then press 
the ‘m’ key for ‘yes or the ‘z’ key for ‘no’ on their keyboard. The task lasted for 5 minutes. 
Percentage accuracy and reaction times for both distractors and targets were recorded in 
addition to overall reaction times. 
Delayed word recall  
Participants were given 60-seconds to write as many words as they could remember from 
the list they have seen at the beginning of the battery. Participant’s responses were marked 
according to total number of errors and number of words recalled correctly. 
Delayed word recognition  
The 20 original words and 20 distractor words were presented individually in a randomised 
order. Participants were asked to indicate whether each word had been in the original list 
or not by using the ‘m’ key for ‘yes’ or the ‘z’ key for ‘no’ on their keyboard. The 
percentage accuracy and reaction times for both distractors and targets were recorded in 
addition to overall reaction times. 
 
Subjective Mood 
The Bond and Lader visual analogue scales (VAS; Bond & Lader, 1974) 
Visual Analogue Scales were presented on the screen immediately after the cognitive tests. 
Participants used the mouse to position a cross at the point on the scale that represented 
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their feelings at that moment. The 16 scales were combined as recommended by Bond and 
Lader (1974) to form three mood factors: ‘alertness’, ‘calmness’ and ‘contentment’. 
Mood, alertness and physical symptoms questionnaire (MAPS) (Rogers et al., 2008)  
This computerised questionnaire consisted of seven unipolar and four bipolar visual 
analogue scales adapted from a similar questionnaire used in previous research on caffeine 
(e.g. Rogers et al., 2005). ‘Headache’, ‘heart pound’, jittery/shaky’, ‘light-headed/feeling 
faint/dizzy’, ‘hands trembling’, ‘scared’ and ‘feeling hot/sweating (not due to heat)’ were 
rated on unipolar scales labelled ‘I don’t have this feeling at all’ (left-hand end=0) and ‘I 
have this feeling strongly (right-hand end=100). The bipolar scales were Relaxed (labelled 
‘anxious/tense/nervous/on edge’=0 and ‘relaxed/calm’=100), Clearheaded (labelled 
‘muzzy/dazed’=0, and ‘clearheaded’=100), Happy (labelled ‘sad/gloomy/miserable’=0 and 
‘happy/cheerful/light-hearted’=100), and Alert (labelled 
‘drowsy/sluggish/tired/fatigued’=0 and ‘alert/energetic/lively’=100). Instructions asked 
participants to rate ‘how you feel RIGHT NOW’. Scores for each item were obtained. 
Blood glucose measurement 
Blood glucose readings were obtained using the ExacTech® blood glucose monitoring 
equipment (supplied by MediSense Britain Ltd, 16/17 The Courtyard, Gorsey Lane, 
Coleshill, Birmingham B46 1JA), following the recommended procedure: The researcher 
swabbed the finger of the volunteer with a Sterets Isopropyl Alcohol BP Pre-injection swab 
(Seton Healthcare Group, Oldham, UK) and allowed the skin to air dry. The skin was 
punctured using an automatic lancing devise and a drop of blood was collected onto the 
analytical test strip. The volunteer applying a tissue blotted any excess blood. Ambidex-HG 
powder free polymer bonded latex examination gloves were worn by the experimenter at all 
times during the procedure. Each lancet and cap was only used once and then disposed of 
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into a sharps container. Swabs, test strips, tissues and gloves were placed in a clinical waste 
sack.   
For performance characteristics of ExacTech® blood glucose monitoring equipment see 
Chapter 2.   
 
6.2.6 Statistical Analysis 
 
The absolute pre and post mental fatigue scores from the Resource Depletion Battery 
analysed using a linear mixed model. Treatment, period and time were added as fixed 
effects and subject as a random effect to the model. The primary efficacy analysis was 
attention mentioned by accuracy on the RVIP task. The secondary analyses were; attention 
(measured by speed and false alarms on the RVIP), memory (measured by immediate 
word recall correct and errors, delayed word recall correct and errors, word recognition 
accuracy and speed and 3-Back accuracy and speed) and mood (measured by Bond-Lader 
and MAPS). All these behavioural and mood variables were transformed into change from 
baseline scores. Using IBM SPSS Statistics Version 22, the change from baseline scores 
within each group (No Depletion/Depletion) were analysed using a linear mixed model. 
Treatment and period were added as fixed effects and subject as a random effect to the 
model. Baseline average for each individual task were added as a covariate to the model. 
The Estimates of Fixed Effects were used to compare each active treatment with placebo. 
For glycaemic treatment comparisons were performed on the blood glucose levels using a 
linear mixed model. The model included a random effect for subject and fixed effects for 
period, treatment and time. The Estimates of Fixed Effects were used to compare each active 





6.3.1 Demographics, means and standard deviations 
 
 











































Independent samples t tests showed there were no significant differences between the 
groups in terms of their age, t (57) = -1.47, p = .148; BMI, t (57) = 0.82, p = .41; years in 
full time education, t (57) = -1.29, p = .20; and average caffeine consumption, t (57) = 
1.93, p = .06. 
 
6.3.2 Blood Glucose Results 
 
No Depletion Group  
There was a significant main effect of the treatments on blood glucose, F (2, 83.64) = 
212.22, p < .001. There was a significant effect of time, F (2, 86.63) = 106.32, p < .001 
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and treatment x time interaction F (4, 64.08) = 80.27, p < .001 were observed. 
Comparisons showed blood glucose levels did not differ significantly across any of the 
time points within the placebo treatment. Following the moderate dose treatment blood 
glucose levels differed significantly from baseline (M = 4.82) at the second post dose time 
point (M = 7.43), p < .001, but not at the first post dose time point (M  = 6.15) compared to 
the second post dose time point, p = .17. Following the high dose treatment blood glucose 
levels differed significantly from baseline (M = 4.86) at the second post dose time point (M 
= 8.26), p < .001, and at the first post dose time point (M  = 6.80) compared to the second 
post dose time point, p = .004 (see Figure 6.1 for glycaemic response as a function of 
treatment and time). 
 
 










Placebo Moderate High 
Baseline 4.86 (0.11) 4.82 (0.12) 4.86 (0.11) 
1
st
 Post Dose 4.31 (0.12) 6.15 (0.25) 6.80 (0.22) 
2
nd
 Post Dose 4.33 (0.12) 7.43 (0.29) 8.26 (0.25) 
 
Depletion Group 
There was a significant main effect of the low dose treatments on blood glucose, F (2, 
103.81) = 184.52, p < .001. There was a significant effect of time, F (2, 98.57) = 98.05, p 
< .001 and treatment x time interaction F (4, 79.57) = 62.05, p < .001 were observed. 
Comparisons showed blood glucose levels did not differ significantly across any of the 
time points within the placebo treatment. Following the moderate dose treatment blood 
glucose levels differed significantly from baseline (M = 5.08) at the second post dose time 
point (M = 7.55), p < .001, but not at the first post dose time point (M  = 6.64) compared to 
the second post dose time point, p = .28. Following the high dose treatment blood glucose 
levels differed significantly from baseline (M = 5.10) at the second post dose time point (M 
= 8.43), p < .001, but not at the first post dose time point (M  = 7.09) compared to the 
second post dose time point, p = .73, (see Figure 6.2 for glycaemic response as a function 





Figure 6.3 Glycaemic response in the Depletion Group as a function of drink and 
time 




Placebo Moderate High 
Baseline 5.03 (0.08) 5.08 (0.13) 5.10 (0.11) 
1
st
 Post Dose 4.43 (0.10) 6.64 (0.21) 7.09 (0.26) 
2
nd
 Post Dose 4.66 (0.10) 7.55 (0.22) 8.43 (0.28) 
 
 
6.3.3 Cognitive Performance Results  
Only participants who had not completed the tasks correctly were removed from the 
analyses for each individual task. In the No Depletion group one participant’s scores from 
the 3 Back task were removed across all study days due to the incorrect completion of the 
task. In the Depletion group one participant’s scores on all outcomes of the RVIP were 




Resource Depletion Battery 
The mental fatigue ratings scales completed before and after the Resource Depletion 
Battery show that the battery was successful in mentally fatiguing the participants, F (1, 
133.73) = 30.78, p < .001. 
 
Table 6.3 Mental Fatigue ratings pre and post Resource Depletion Battery, means 




Pre-RDB 50.0 (2.0) 
Post-RDB 61.9 (2.2) 
 
 
No Depletion Group 
 
6.3.3.1 Primary Outcome  
 
RVIP Accuracy 
There was no significant main effect of treatment on the correct responses on the RVIP 
task, F (2, 49.10) = 0.74, p = .48. There was a significant main effect of period, F (2, 
38.63) = 7.02, p = .003, there was a trend for participants to perform better on study day 1 
(period 1) compared to on study day 3 (period 3), p = .09. There was no interaction effect, 
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F (4, 38.12) = 2.36, p = .07. There were no significant differences observed following 
administration of treatment drinks compared to placebo. 
 




There was no significant main effect of treatment on the correct responses on the reaction 
time of responses on the RVIP task, F (2, 41.57) = 0.70, p = .50; or period, F (2, 40.53) = 
2.71, p = .08; or their interaction, F (4, 29.51) = 0.61, p = .66. Significant differences 
following administration of active treatment drinks compared to placebo were not 
identified. 
 
RVIP False Alarms 
There was no main effect of treatment on the on the false alarm rate on the RVIP task, F 
(2, 44.92) = 0.51, p = .61; or period, F (2, 48.30) = 0.25, p = .78; or their interaction, F (4, 
41.03) = 0.09, p = .90. There were no significant differences observed following 








































Change from baseline; covariates appearing in the model for treatments are evaluated at the following average baseline 
values: 146.34; 2524.7;32.84. 
*Significant compared to placebo at p < .05 
 
6.3.3.3 Secondary Outcomes - Memory  
 
Immediate Word Recall Correct 
There was no significant main effect of treatment on the correctly recalled words in the 
immediate word recall task, F (2, 53.74) = 0.27, p = .77. There was a significant main 
effect of period, F (2, 44.42) = 3.96, p = .03, with participants performing significantly 
better at study day 1 (period 1) compared to study day 3 (period 3), p = .005. There was no 
significant interaction effect between treatment and period, F (4, 34.97) = 1.02, p = .41. 
There were no significant differences were observed following administration of any of the 
active treatment drinks compared to placebo. 
 
Immediate Word Recall Incorrect 
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There was no significant main effect of treatment on the incorrectly recalled words in the 
immediate word recall task, F (2, 46.96) = 0.04, p = .96; or period, F (2, 41.02) = 0.04, p = 
.97; or their interaction, F (4, 38.56) = 0.79, p = .54; There were no significant differences 
observed following administration of any of the active treatment drinks compared to 
placebo. 
 
Delayed Word Recall Correct 
There was no main effect of treatment on the correct words recall on the Delayed Word 
Recall task, F (2, 45.46) = 0.09, p = .92; or period, F (2, 48.01) = 2.44, p = .10; or their 
interaction, F (4, 34.76) = 0.20, p = .94. There were no significant differences observed 
following administration of treatment drinks compared to placebo. 
 
Delayed Word Recall Incorrect 
There was no significant main effect of treatment on the incorrect words recall on the 
Delayed Word Recall task, F (2, 28.79) = 0.18, p = .84; or period, F (2, 39.79) = 0.11, p = 
.89; or their interaction, F (4, 26.88) = 0.98, p = .43. Comparison of the active drinks with 
placebo showed an advantage of the placebo drink compared to the high dose treatment 

























































Change from baseline; covariates appearing in the model for treatments are evaluated at the following average baseline 
values: 15.74; 20.92; 34.72; 41.35. 
*Significant compared to placebo at p < .05 
 
Word Recognition Accuracy 
The effect of the active treatments on the percentage correct responses on the Delayed 
Word Recognition failed to reach significance, F (2, 45.07) = 2.10, p = .13. There was no 
main effect of period, F (2, 36.15) = 0.69, p = .51; or the interaction effect between 
treatment and period, F (4, 34.21) = 0.52, p = .73. There were no significant differences 
observed following administration of treatment drinks compared to placebo, but a greater 
decline in performance was sees following the high treatment drink compared to placebo 
(p = .10). 
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Word Recognition Speed 
There was no main effect of treatment on the correct reaction time response on the 
Delayed Word Recognition task, F (2, 44.15) = 0.97, p = .39; or period, F (2, 34.95) = 
1.69, p = .20; or their interaction, F (4, 34.43) = 1.19, p = .33. There were no significant 
differences observed following administration of treatment drinks compared to placebo. 
 

























Change from baseline; covariates appearing in the model for treatments are evaluated at the following average baseline 
values: 168.68; 2833.3 
*Significant compared to placebo at p < .05 
 
3 Back Accuracy 
There was no significant main effect of treatment on the correct scores on the 3 Back task, 
F (2, 33.87) = 2.04, p = .15; or period, F (2, 33.67) = 2.31, p = .12; or interaction effect, F 
(4, 36.95) = 1.53, p = .21. There were no significant differences observed following 




3 Back Speed 
There was no significant main effect of treatment on the correct reaction time on the 3 
Back task, F (2, 39.89) = 1.26, p = .30; or period, F (2, 42.52) = 1.28, p = .29; or their 
interaction, F (4, 38.81) = 1.35, p = .27. There were no significant differences observed 
following administration of treatment drinks compared to placebo. 
 























Change from baseline; covariates appearing in the model for treatments are evaluated at the following average baseline 
values: 186.83; 2783.0. 
*Significant compared to placebo at p < .05 
 
6.3.3.4 Secondary Outcomes - Mood 
 
Bond and Lader Visual Analogue Scale 
Alert 
There was no significant main effect of treatment on the participants’ ratings of alertness 
on the Bond-Lader VAS, F (2, 44.20) = 2.08, p = .14; or period, F (2, 48.68) = 1.14, p = 
.33. There was a significant interaction effect, F (4, 38.29) = 3.52, p = .02. Following the 
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moderate dose drink participants rated themselves as significantly more alert on study day 
3 (period 3), compared to on study day 1 (period 1) and study day 2 (period 2), p = .01 and 
p = .02 respectively. Comparison of the active drinks to placebo showed that participants 
rated themselves as more alert following the moderate treatment drink compared to 
placebo (p = .002). 
 
Calm 
There was no significant main effect of treatment on the participants’ ratings of calmness 
on the Bond-Lader VAS, F (2, 45.76) = 0.30, p = .75; or period, F (2, 36.24) = 0.10, p = 
.91; or their interaction, F (4, 37.88) = 0.90, p = .47. There were no significant differences 
observed following administration of treatment drinks compared to placebo. 
 
Content 
There was no significant main effect of treatment on the participants’ ratings of feeling 
content on the Bond-Lader VAS, F (2, 36.37) = 1.02, p = .37; or period, F (2, 46.53) = 
1.04, p = .36; or their interaction, F (4, 34.62) = 0.53, p = .72. There were no significant 
comparisons between the active drinks and placebo. 
 
Table 6.8 Bond and Lader Visual Analogue Scales, means and standard errors for 
the No Depletion Group 
Task 
Treatment 

































Change from baseline; covariates appearing in the model for treatments are evaluated at the following average baseline 
values: 142.3; 263.1; 355.6. 
*Significant compared to placebo at p < .05 
 
Mood, Alertness and Physical Symptoms Questionnaire (MAPS) 
 
Headache 
There was no significant main effect of treatment on participants’ ratings of headache on 
the VAS, F (2, 34.23) = 0.13, p = .88; or period, F (2, 37.46) = 0.99, p = .38; or their 
interaction, F (4, 36.11) = 0.65, p = .63. There were no significant differences observed 
following administration of treatment drinks compared to placebo. 
 
Heart Pound 
There was no significant main effect of treatment on participants’ ratings of heart 
pounding on the VAS, F (2, 43.04) = 0.43, p = .65; or period, F (2, 47.05) = 0.09, p = .92; 
or the interaction effect between treatment and period, F (4, 34.84) = 0.86, p = .50. No 






There was no significant main effect of treatment on the participants’ ratings of 
jitteriness/shakiness, F (2, 40.05) = 1.98, p = .15; or period, F (2, 41.09) = 0.12, p = .89. 
There was a significant interaction, F (4, 36.80) = 2.91, p = .03, participants rated 
themselves as significantly less jittery following the high dose drink at study day 3 (period 
3) compared to study 1 (period 1), p = .05. No significant comparisons were found 
between active drinks and placebo. 
 
Light-headed/Feeling faint/Dizzy 
There was a significant main effect of treatment on the participants’ ratings of light-
headedness/feeling faint/dizziness on the VAS, F (2, 37.33) = 4.08, p = .03. There was no 
main effect of period, F (2, 35.24) = 2.70, p = .08; or interaction effect, F (4, 26.73) = 
1.15, p = .36. Comparisons of the means did not reveal any significant differences; 
however examination of the means shows that participants rated themselves as less light-
headed/feeling faint/dizzy after the high dose treatment drink. 
 
Hands-trembling 
There was no significant main effect of treatment on the participants’ ratings of hands-
trembling on the VAS, F (2, 36.94) = 0.12, p = .88; or period, F (2, 34.08) = 0.66, p = .52; 
or their interaction, F (4, 29.45) = 2.18, p = .10. There were no significant differences 





There was no significant main effect of treatment on the participants’ ratings of sacredness 
on the VAS, F (2, 43.58) = 0.69, p = .51; or period, F (2, 46.63) = 0.69, p = .51; or their 
interaction, F (4, 44.99) = 0.59, p = .67. There were no significant comparisons between 
any of the active drinks compared to placebo.  
 
Feeling hot/sweating (not due to heat) 
There was no significant main effect of treatment on the participants’ ratings of feeling 
hot/sweating (not due to heat) on the VAS, F (2, 45.87) = 0.59, p = .56; or period, F (2, 
37.06) = 0.35, p = .71; or their interaction, F (4, 34.03) = 0.72, p = .59. There were no 




There was no significant main effect of treatment on the participants’ ratings of feeling 
relaxed on the VAS, F (2, 40.12) = 0.64, p = .53; or period, F (2, 30.18) = 0.23, p = .80; or 
their interaction, F (4, 32.46) = 0.76, p = .56. There were no significant differences 
observed following administration of treatment drinks compared to placebo. 
 
Clearheaded 
There was no significant main effect of treatment on the participants’ ratings of feeling 
clearheaded on the VAS, F (2, 44.60) = 1.65, p = .20; or period, F (2, 43.33) = 0.12, p = 
216 
 
.88. There was a significant interaction effect between treatment and period, F (4, 37.51) = 
5.08, p = .002. Participants rated themselves as more clearheaded following the moderate 
drink on study day 3 (period 3) compared to on study day 1 (period 1) and study day 2 
(period 2), p = .005 and p = .03 respectively. Participants rated themselves as more 
clearheaded after the moderate dose drink compared to placebo, p = .005. 
 
Happy 
There was no significant main effect of treatment on the participants’ ratings of feeling 
happy on the VAS, F (2, 39.07) = 0.91, p = .41; or period, F (2, 35.38) = 1.03, p = .37; or 
their interaction, F (4, 32.91) = 1.51, p = .22. Compared to placebo participants rated 
themselves as happier after the moderate dose drink, p = .04. 
 
Alert 
There was no significant main effect of treatment on the participants’ ratings of feeling 
alert on the VAS, F (2, 39.30) = 1.89, p = .16; or period, F (2, 44.76) = 2.45, p = .10. 
There was a significant interaction effect between treatment and period, F (4, 35.20) = 
5.28, p = .002, whereby participants rated themselves as significantly more alert after the 
moderate dose treatment on study day 3 (period 3) compared to on study day 1 (period 1). 
Compared to placebo participants rated themselves as more alert following the moderate 




Table 6.9 Mood, Alertness and Physical Symptoms Questionnaire (MAPS), means 
and standard errors for the No Depletion Group 
Task 
Treatment 








































































































Change from baseline; covariates appearing in the model for low dose treatments are evaluated at the following average 
baseline values: 1Headache = 26.3; 2Heart pound = 15.2; Jittery/shaky3 = 15.4; Light-headed/feeling faint/dizzy4 = 24.4; 
Hands trembling5 = 16.3; Scared6 = 14.5; Feeling hot/sweating (not due to heat)7 = 11.7; Relaxed8 = 63.0; Clearheaded9 
= 41.3; Happy10 = 51.2; Alert11 = 36.4. 






6.3.3.5 Primary Outcome 
 
RVIP Accuracy 
There was no significant main effect of treatment on the correct responses on the RVIP 
task, F (2, 52.01) = 1.21, p = .31; or period, F (2, 44.14) = 0.44, p = .64; or their 
interaction, F (4, 38.58) = 1.22, p = .32. There were no significant differences observed 
following administration of treatment drinks compared to placebo. 
 




There was no significant main effect of treatment on the Correct Reaction Time scores on 
the RVIP task, F (2, 21.35) = 0.35, p = .71; or period, F (2, 23.24) = 0.29, p = .75; or their 
interaction, F (4, 21.66) = 0.77, p = .56. There were no significant differences observed 
following administration of treatment drinks compared to placebo. 
 
RVIP False Alarms 
The main effect of treatment on the false alarm responses on the RVIP task failed to reach 
significance, F (2, 55.38) = 2.43, p = .10. There was no main effect of visit, F (2, 41.46) = 
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2.15, p = .13; or their interaction, F (4, 38.16) = 1.70, p = .17. Comparison of the active 
treatment drinks with placebo found no significant differences. 
 
Table 6.10 RVIP performance, means and standard errors for the Depletion Group 
Task 
Treatment 





























Change from baseline; covariates appearing in the model for treatments are evaluated at the following average baseline 
values: 139.92; 2546.0; 32.73. 
*Significant compared to placebo at p < .05 
 
6.3.3.7 Secondary Outcomes - Memory 
 
Immediate Word Recall Correct 
The main effect of treatment on the correct score of the Immediate Word Recall task just 
reached significance level, F (2, 36.85) = 3.25, p = .05. There was a main effect of period, 
F (2, 39.04) = 3.47, p = .04, with participants’ performance being worse at their last visit 
compared to visit 1; however, no treatment x visit interaction was observed, F (4, 45.42) = 
1.28, p = .29. Participants performed better following the placebo drink compared to after 
the moderate drink, p = .01.  
 
Immediate Word Recall Incorrect 
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There was no significant main effect of treatment on the incorrect score of the Immediate 
Word Recall task, F (2, 34.14) = 1.86, p = .17; or period, F (2, 37.47) = 0.30, p = .74; or 
their interaction, F (4, 32.98) = 0.12, p = .97. There were no significant differences 
observed following administration of treatment drinks compared to placebo. 
 
Delayed Word Recall Correct 
There was no main effect of treatment on the correct responses on the Delayed Word 
Recall task, F (2, 47.83) = 0.34, p = .72. There was no main effect of visit, F (2, 46.70) = 
1.16, p = .32; or the interaction effect between treatment and visit, F (4, 34.58) = 1.76, p = 
.16.  
 
Delayed Word Recall Incorrect 
There was no main effect of treatment on the incorrect responses on the Delayed Word 
Recall task, F (2, 44.55) = .97, p = .39; or period, F (2, 49.45) = 0.92, p = .41; or their 
interaction, F (4, 41.90) = 1.64, p = .18. There were no significant differences observed 
following administration of treatment drinks compared to placebo. 
 




















































Change from baseline; covariates appearing in the model for treatments are evaluated at the following average baseline 
values: 16.06; 20.57; 34.96; 40.86. 
*Significant compared to placebo at p < .05 
 
Word Recognition Accuracy 
There was no significant main effect of treatment on the correct responses on the Word 
Recognition task, F (2, 30.96) = 0.21, p = .82; or period, F (2, 30.14) = 1.20, p = .31; or 
their interaction, F (4, 35.08) = 1.22, p = .32. Comparison of the active treatment drinks 
with placebo revealed no significant differences. 
 
Word Recognition Speed  
There was no significant main effect of treatment on the correct reaction time scores on the 
Word Recognition task, F (2, 41.27) = 0.92, p = .41; or period, F (2, 44.90) = 1.98, p = 
.15; or their interaction, F (4, 30.66) = 0.83, p = .52. Comparison of the active treatment 





























Change from baseline; covariates appearing in the model for treatments are evaluated at the following average baseline 
values: 172.31; 2838.6 
*Significant compared to placebo at p < .05 
 
3 Back Accuracy 
There was no significant main effect of treatment on accuracy on the 3 Back task, F (2, 
32.68) = 0.26, p = .77. There was a significant main effect of visit, F (2, 34.79) = 5.83, p = 
.007, with participants performing on study day 1 (period 1) compared to study day 3 
(period 3), p = .15. There was no interaction effect between treatment and visit, F (4, 
38.58) = 2.06, p = .10. Comparison of the active treatment drinks with placebo revealed no 
significant differences. 
 
3 Back Speed 
There was no significant main effect of treatment on the correct reaction time for the 3 
Back task, F (2, 41.11) = 1.34, p = .27; or period, F (2, 39.97) = 1.34, p = .27; or their 
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interaction, F (4, 32.53) = 2.18, p = .09. Comparison of the active treatment drinks with 
placebo revealed no significant differences. 
 
Table 6.13 3 Back performance, means and standard errors for the Depletion Group 
Task 
Treatment 



















Change from baseline; covariates appearing in the model for treatments are evaluated at the following average baseline 
values: 183.71; 2872.8. 
*Significant compared to placebo at p < .05 
 
6.3.3.8 Secondary Outcomes - Mood 
 
Bond-Lader Visual Analogue Mood Scales 
Alert  
There was no significant main effect of treatment on the participants’ ratings of alertness 
on the Bond-Lader VAS, F (2, 43.68) = 0.13, p = .88. There was a significant main effect 
of visit, F (2, 38.33) = 3.30, p = .05, whereby participants rated themselves as more alert at 
study day 1 (period 1) compared to study day 3 (period 3), p = .13, and less alert on study 
day 2 (period 2) compared to study day 3, p = .11. There was no significant interaction 
effect between treatment and visit, F (4, 43.75) = 1.45, p = .23. Participants rated 
themselves as more alert following the moderate dose treatment drink (M = 6.98), 





There was no significant main effect of treatment on the participants’ ratings of calmness 
on the Bond-Lader VAS, F (2, 41.63) = 0.75, p = .48; or period, F (2, 36.71) = 0.84, p = 
.44; or the interaction effect between treatment and visit, F (4, 33.22) = 0.44, p = .78. 




There was no significant main effect of treatment on the participants’ ratings of feeling 
content on the Bond-Lader VAS, F (2, 35.26) = 0.66, p = .52; or period, F (2, 51.52) = 
0.64, p = .53. There was a significant interaction effect between treatment and period, F (4, 
38.53) = 3.37, p = .02, participants rated themselves as significantly more content after the 
moderate drink on study day 3 (period 3) compared to on study day 2, p = .002. Post hoc 
comparison revealed no significant differences compared to placebo. 
 
Table 6.14 Bond and Lader, means and standard errors for the Depletion Group 
Task 
Treatment 






















 1.3  1.7  3.0  
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(1.4) (1.2) (1.0) 
Change from baseline; covariates appearing in the model for treatments are evaluated at the following average baseline 
values: 139.7; 263.8; 352.1. 
*Significant compared to placebo at p < .05 
 
Mood, Alertness and Physical Symptoms Questionnaire (MAPS) 
Headache 
There was no significant main effect of treatment on the participants’ ratings of headache, 
F (2, 38.14) = 0.09, p = .91; or period, F (2, 34.47) = 0.61, p = .55; or the interaction effect 
between treatment and visit, F (4, 31.02) = 0.55, p = .70. There were no significant 
differences observed following administration of treatment drinks compared to placebo. 
 
Heart pound 
There was no significant main effect of treatment on the participants’ ratings of heart 
pounding, F (2, 30.17) = 1.32, p = .28; or period, F (2, 31.23) = 0.32, p = .73; or their 
interaction, F (4, 29.01) = 0.23, p = .92.Compared to placebo, those receiving the moderate 
treatment drink felt less of an increase in heart pound compared to placebo (p = .03).  
 
Jittery/Shaky 
There was no significant main effect of treatment on the participants’ ratings of feeling 
jittery/shaky, F (2, 45.44) = 1.18, p = .32; or period, F (2, 47.87) = 2.26, p = .12. There 
was a significant interaction effect between treatment and period, F (4, 39.20) = 4.77, p = 
.003, participants rated themselves as significantly less jittery following the moderate dose 
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drink on study day 3 (period 3), compared to a study day 1 (period 1), and this just failed 
to reach significance compared to study day 2 (period 2), p = .001 and p = .05 respectively. 
Post hoc comparisons of the active drinks with placebo revealed no significant differences. 
 
Light-headed/Feeling faint/Dizzy 
There was no significant main effect of treatment on the participants’ ratings of feeling 
light-headed/feeling faint/dizziness, F (2, 44.10) = 0.51, p = .61; or period, F (2, 50.47) = 
0.04, p = .96; or their interaction, F (4, 40.45) = 1.99, p = .12. Participants rated 
themselves as less light-headed/feeling faint/dizzy following the moderate dose treatment 
(M = -8.47), compared to placebo (M = -4.00), p = .006. 
 
Hands-trembling 
There was no significant main effect of treatment on the participants’ ratings of hands-
trembling, F (2, 38.63) = 0.57, p = .57; or period, F (2, 38.57) = 0.53, p = .59; or their 
interaction, F (4, 36.29) = 1.29, p = .29; no effect of the baseline average covariate, F (1, 
79.23) = 2.26, p = .18. No significant differences were observed following administration 
of active treatment drinks compared to placebo. 
 
Scared 
There was no significant main effect of treatment on the participants’ ratings of scared, F 
(2, 29.72) = 0.81, p = .45; or period, F (2, 31.49) = 0.39, p = .68; or their interaction, F (4, 
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28.64) = 0.43, p = .79. There were no significant differences observed following 
administration of treatment drinks compared to placebo. 
 
Feeling hot/sweating (not due to heat) 
There was no significant main effect of treatment on the participants’ ratings of feeling 
hot/sweating, F (2, 23.17) = 0.78, p = .47; or period, F (2, 37.05) = 0.12, p = .88; or their 
interaction, F (4, 35.00) = 2.19, p = .09. There were no significant differences observed 
following administration of treatment drinks compared to placebo. 
 
Relaxed 
There was no significant main effect of treatment on the participants’ ratings of feeling 
relaxed, F (2, 39.37) = 0.03, p = .97; or period, F (2, 36.27) = 0.24, p = .79; or their 
interaction, F (4, 30.61) = 1.29, p = .29. Comparisons of active drinks with placebo 
revealed no significant differences. 
 
Clearheaded 
There was no significant main effect of treatment on the participants’ ratings of feeling 
clearheaded, F (2, 47.15) = 1.04, p = .36. There was a significant main effect of period, F 
(2, 40.35) = 4.70, p = .02. There was no significant interaction effect between treatment 
and period, F (4, 41.12) = 0.84, p = .51. Comparisons of active drinks with placebo 





There was no significant main effect of treatment on the participants’ ratings of feeling 
happy, F (2, 36.58) = 1.27, p = .29. There was no main effect of visit, F (2, 36.41) = 1.27, 
p = .29; or the interaction effect between treatment and visit, F (4, 32.26) = 1.09, p = .38. 
Comparisons of active drinks with placebo revealed no significant differences. 
 
Alert 
There was no significant main effect of treatment on the participants’ ratings of feeling 
alert, F (2, 45.13) = 0.29, p = .75; or period, F (2, 39.53) = 3.07, p = .06; or their 
interaction, F (4, 39.72) = 0.70, p = .59. There were no significant differences observed 
following administration of treatment drinks compared to placebo. 
 
Table 6.15 Mood, Alertness and Physical Symptoms Questionnaire (MAPS), means 
and standard errors for the Depletion Group 
Task 
Treatment 






























































































Change from baseline; covariates appearing in the model treatments are evaluated at the following average baseline 
values: 1Headache = 19.4; 2Heart pound = 11.8; Jittery/shaky3 = 17.5; Light-headed/feeling faint/dizzy4 = 25.3; Hands 
trembling5 = 14.0; Scared6 = 8.9; Feeling hot/sweating (not due to heat)7 = 9.9; Relaxed8 = 57.6; Clearheaded9 = 35.1; 
Happy10 = 47.6; Alert11 = 31.9. 






The aim of this study was to examine whether the effects of glucose and caffeine on 
cognition and mood would be greatest when cognitive resources were in a sub-optimal 
state due to prior depletion. In addition to manipulation of participants’ state prior to drink 
administration and behavioural assessment, longer and more demanding working memory 
and attention tasks were used to help tease out the effects of these substances. 
Participants’ ratings of their mental fatigue before and after the Resource Depletion 
Battery showed that the manipulation was successful as participants reported feeling 
significantly more mentally fatigued. This demonstrates that it is possible to deplete the 
cognitive resources of participants via the completion of a demanding battery. Therefore it 
is possible manipulate participants into a sub-optimal state using this method.  
With regards to the blood glucose findings, these followed the expected pattern. Following 
treatment, only the two active treatment drinks increased blood glucose levels. Once raised 
however, blood glucose did not significantly differ from the first post-dose time-points 
(pre-post dose completion of the cognitive tasks) compared to the second post-dose time-
points (at the end of the study); except for after the ‘high dose’ combination drink in the 
No Depletion group where blood glucose was significantly raised again at the second post-
dose time-point compared to the first post-dose time-point. 
Overall, the active drink effects for both the No Depletion Group and Depletion were 
limited almost exclusively to effects on mood. This study therefore does not provide 
support for the notion that the effects of the active treatment drinks would be most 
beneficial on cognitive performance when participants are in a sub-optimal state, and does 
not support the literature on combined administration where the most robust effects have 
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been found on participants who are in a sub-optimal state (Alford, Cox & Wescott, 2001; 
Horne & Reyner, 2001; Kennedy & Scholey, 2004; Sünram-Lea, Owen-Lynch, Robinson, 
Jones & Hu, 2012). 
There were no beneficial effects of the active treatment drinks on the accuracy 
performance on the RVIP task for either the Depletion or the No Depletion Group. There 
were no effects of any of the active treatment drinks on the other measures of attention. 
Combined administration of glucose and caffeine has previously been shown to improve 
performance on attention tasks (Adan & Serra-Grabulosa, 2010; Kennedy & Scholey, 
2004; Rao, Henglong & Nobre, 2005; Scholey & Kennedy, 2004). Dose may be an 
important factor here as beneficial effects on attention have been observed after 
administration of drinks which contained 75mg caffeine (Adan & Serra-Grabulosa, 2010; 
Scholey & Kennedy, 2004) suggesting that effects on attention might only be observed at 
higher doses of caffeine. However, Rao et al., (2005) found that a combination of 40mg 
caffeine and 60g glucose improved performance on a sustained selective attention task 
both in terms of accuracy and speed. Kennedy and Scholey (2004) also found that 3 
‘energy drinks’ which contained 38mg, 46mg and 33mg of caffeine and 68g, 68g and 60g 
glucose respectively, improved performance accuracy on an attention task across a 
cognitively demanding battery. Smit et al., (2006) found that drinks containing 30mg 
caffeine and 58g glucose were also able to improve performance on attention tasks relative 
to placebo. However, these beneficial effects were found on tasks that had a much longer 
duration, and therefore a more demanding period of sustained attention. In Rao et al.,’s 
(2005) study the task lasted for 45mins and in Smit et al.,’s (2006) study the attention tasks 
were repeated over the course of a task battery which lasted for 1.5hrs. Indeed, Kennedy 
and Scholey (2004) did not find any improvements on attention until the later stages of 
their cognitively demanding battery, until after at least 35mins. Therefore, whilst the task 
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in this study was of a longer duration (10mins), compared to the attention tasks in study 1 
(Chapter 2) (2mins), it is likely that it is still not sustained enough to elucidate the 
beneficial effects of glucose and caffeine at these lower doses. Another potential 
explanation might be that in order for cognitive and/or physiological depletion to occur, 
consecutive tasks need to pertain to similar domains and structures. Similar to the 
‘multiple resource’ theory which suggests that tasks can be completed simultaneously, 
unless they are dependent on the same energy resources (Ruiter, Lorist & Snel, 1999).  
Consequently, it could be argued that for the initial demanding tasks to impact on 
subsequent performance, tasks need to rely on the same underlying processes in order for 
these to be fully depleted. The digit vigilance task and the RVIP may be relying on 
different underlying processes. Whilst the digit vigilance task only requires maintaining 
attention, the RVIP battery also requires an element of working memory for its successful 
completion. Apart from the significant drink effects on mood in the No Depletion group, 
the only other effect was on long-term memory where it was found that performance was 
better following placebo rather than the high dose drink. A contrasting pattern of results 
were also seen in the Depletion Group, here only immediate  memory was impaired 
following the moderate dose drink compared to placebo. These findings are in contrast to 
previous research which has found that an ‘energy drink’ containing 75mg caffeine and 
75g glucose was effective in improving learning/immediate memory as well as long term 
memory (Adan and Serra-Grabulosa, 2010). These findings are also in contrast to previous 
literature where 25g has been found to be the most optimal dose for improving verbal 
declarative memory (Foster et al., 1998; Sünram-Lea, Foster, Durlach & Perez, 2002; 
Sünram-Lea et al., 2011).  
In the Depletion Group, there was no effect of either doses on working memory. The doses 
may not have been optimal to see these effects. Sünram-Lea et al., (2011) found that dose-
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response curves differed across memory domains and were also influenced by participants’ 
individual characteristic e.g. height and weight and suggested that the optimal dose for 
enhancing performance is task dependent.  
In terms of mood effects, both active drinks were able to elicit beneficial effects in both the 
Depletion and No Depletion groups. These results fit with previous findings in the 
literature that glucose and caffeine in combination have positive effects on mood 
(Gershon, et al., 2009; Howard & Marczinski, 2010; Kennedy & Scholey, 2004; Mets et 
al., 2010; Smit & Rogers, 2002; Sünram-Lea et al., 2012). The moderate drink improved 
ratings of alertness, across both groups and content/happiness and clearheaded in the No 
Depletion group. In the Depletion group it also improved ratings of aspects of mood 
associated with anxiety and light-headedness. The high dose drink had more limited effects 
only showing some beneficial effects on anxiety and light-headedness in the Depletion 
group and only improvements in light-headedness in the No Depletion group. The caffeine 
content in the two drinks was the same but the effects were mainly seen with the moderate 
dose treatment which contained 25g glucose compared to the high dose treatment which 
contained 60g glucose. Therefore the amount of glucose must have some moderating or 
additive effect. This may be related to the inverted U-shaped dose response of glucose 
(Gold, Vogt, & Hall, 1986), as it may be that 60g is too high to see beneficial effects on 
some aspects of mood. 
Ideally it would have been beneficial to examine each of the constituents of the active 
treatments in isolation as well as in combination. However, given the primary aim of the 
study was to compare the effects of depletion versus no depletion on subsequent cognitive 
performance using accuracy on the RVIP task as the primary measure, this would have 
resulted in an increase in number of study arms, which would most certainly have 
impacted on participant recruitment and retention. With regards to the Resource Depletion 
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Battery itself, it would be useful to ask participants to rate how cognitively demanding 
they found each task, as well as how mentally fatigued they felt prior to and after the 
battery. This would be useful if the tasks were also manipulated to see which are most 
effective at depleting participants’ cognitive resources to see if a manipulation of the 
battery could increase its cognitive demand, thereby elucidating the effects of caffeine and 
glucose on cognitive function. For example, in this study there were no effects on 
attention, however it may be that this could be achieved with a more demanding attention 
task completed in the Resource Depletion Battery. It would also have been useful to have 
participants rate how mentally fatigued they were prior to and after the DVD, to ensure 
that they didn’t feel significantly more mentally fatigued following this and to ensure it 
acted as an adequate control. 
This study was unable to demonstrate that it is possible to manipulate participants into a 
sub-optimal state using a cognitively demanding battery. Subsequent to this it has shown 
that glucose and caffeine administered in combination have greater effects on cognitive 
performance when the participant is in a sub-optimal state. However, the state of the 
participant may still be crucial to any enhancing effects of these substances. In this sense 
their effects could be looked on as restorative, rather than enhancing performance where it 























Previous studies reported in this thesis have focused on the behavioural effects of glucose, 
caffeine and their combination. These studies identified beneficial effects on aspects of 
long-term declarative memory following caffeine administration and combined 
administration of caffeine and glucose has led to improved aspects of long-term memory 
performance and attention. In addition, improvements on aspects of working memory have 
been observed. These results lend support for previous research findings to a certain extent 
(see for example Smith et al., 1999; Kelman & Creeley, 2001 for effects of caffeine on 
long-term memory; Alford et al.,, 2001; Horne & Reyner, 2000 for effects of combined 
administration on long-term memory and attention; and Kennedy & Scholey, 2004 for 
effect on working memory). However, none of the studies reported showed strong 
evidence for glucose facilitation of memory performance or enhanced level of attention 
following caffeine administration (Foster et al., 1998; Meikle et al., 2005; Smith, 2002; 
Sünram-Lea et al., 2001). 
One reason for the discrepancies in the findings could be due to the sensitivity of the tasks, 
especially as the population under study are healthy young adults, who are already 
performing well on these tasks. However, it is also important to note that behavioural 
measures only provide indirect information on underlying neuro-cognitive processes 
(Lorist & Tops, 2003). To help gain a more complete picture of the effects of caffeine and 
glucose, both alone and in combination the current study aimed to examine the underlying 
neural mechanisms mediating the behavioural effects. This research used a convergent 
operations approach that combined cognitive (behavioural) testing with brain imaging 
using event-related potentials (ERPs). Event-related potentials are voltage fluctuations in 
the ongoing electroencephalogram (EEG) that are time-locked to an event, such as the 
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onset of a stimulus or the execution of a manual response. The observed ERP waveform is 
a depiction of the changes in scalp-recorded voltage over time that reflect the sensory, 
cognitive, affective, and motor processes elicited by a stimulus. The ERP peak can be 
defined as a reliable local positive or negative maximum in the observed ERP waveform 
(Kappenman & Luck, 2011). This approach will inform our theoretical understanding of 
the cognitive and physiological mechanisms involved in the effects of glucose and caffeine 
administration. 
It may be that whilst the effects of these substances cannot be reliably seen behaviourally 
that they are having effects on the neurocognitive processes in the brain e.g. making 
performance more efficient so that fewer neural resources are used. Event-related 
potentials (ERPs) were used as the primary tool to investigate the neural correlates of 
glucose and caffeine-mediated cognitive processes. In brief, ERPs are a measure of neural 
activity (derived from EEG, the electroencephalogram, recorded from scalp electrodes) 
that can be recorded non-invasively from humans whilst performing cognitive tasks. It is a 
reliable and cost-effective means of tracking mental chronometry in response too various 
cognitive events. It offers excellent temporal resolution in the order of milliseconds, 
whereas functional magnetic resonance imaging (fMRI) is much slower (in the order of 
seconds), and much more costly. ERPs allow the investigation of the organisation and 
timing carried out, and these measures may be more sensitive to the effects of glucose and 
caffeine (Lorist & Tops, 2003). 
ERP components are defined by their polarity (positive or negative going voltage), timing, 
scalp distribution, and sensitivity to task manipulations. The P300 component (central to 
the proposed investigation) has provided a wealth of information on normal and 
dysfunctional cognition over the last 40 years (see Bashore & van der Molen, 1991 for a 
review). Early P300 experiments focused on a large positive peak elicited approximately 
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300-500 ms, maximal over parietal sites.  This component follows the presentation of a 
rare target stimulus, embedded in a train of background stimuli, the so-called oddball task. 
This deflection, now referred to as the P3b, is widely thought to index memory storage 
operations. P3b amplitudes are considered to reflect the maintenance in working memory 
of a stimulus when the mental representation of the stimulus context is updated (Donchin 
et al., 1986; Polich, 2003), and is closely associated with episodic memory. It is 
acknowledged that several brain regions contribute to the generation of the P3b, including 
frontal areas, hippocampal areas of the medial temporal lobe and the parietal cortex 
(Polich, 2003). Extensive intracranial recordings have also revealed a widespread network 
of activation for the P3b, with generators in the ventrolateral prefrontal, superior temporal 
sulcus and posterior superior parietal cortical areas, and hippocampal and perirhinal 
regions (Halgren et al., 1998). An earlier deflection, with a more fronto-central 
distribution, is elicited during the oddball task where an additional novel or distracter 
stimulus is inserted into the background and target sequence. This is referred to as the P3a 
and is thought to reflect frontal lobe function and orienting of attention (Knight, 1997). 
Frontal lesion patients exhibit diminished P3a amplitudes (Knight, 1984), and it is 
therefore considered that frontal lobe engagement is necessary for P3a generation and 
contributes to attentional control. Intracranial recordings have also implicated the 
dorsolateral prefrontal cortex as the principle generator, with contributions from the 
supramarginal gyrus, and the cingulate gyrus (Halgren et al., 1998). The P3a and P3b are 
characterised as distinct components elicited by the interaction between frontal lobe 
attentional control over the contents of working memory and the subsequent long-term 
storage operations (Polich, 2003). These two components are therefore appropriate to 
investigate the effects of glucose administration on different aspects of attention and 
memory in older adults.   
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Indeed, previous research has found that glucose and caffeine alone and in combination 
affect ERPs (Brown & Riby, 2003; Dixit et al., 2006; Kawamura et al., 1996; Lorist et al., 
1994a&b; Lorist et al., 1995; Lorist et al., 1996; Lorist et al.,, 2004a; Rao et al., 2005; 
Riby et al., 2008; Ruijter et al., 2000a&b; Smith et al., 2009). Riby et al., (2008) 
administered 25g of glucose to participants prior to them completing the Oddball Task. 
They found that compared to placebo, glucose modulated the P3b component which is the 
memory updating component of the P300, by reducing the amplitude, latency and duration. 
They concluded that glucose may enhance memory by reducing the resources needed for 
memory updating. They also found there was a trend for glucose to enhance the P3a and 
earlier P2 components, which are associated with novelty detection and orientation of 
attention. Brown and Riby (2013) again looked at the effects of 25g glucose on episodic 
memory and attention. They found that compared to placebo, glucose enhances the left 
parietal old/new effect which is a measure of verbal episodic memory, in particular 
recollection memory. They also found a trend for glucose to facilitate attentional processes 
as measured by the frontal-central negativity component. 
Caffeine has been found to have effects on the early exogenous N1 component, which is 
elicited by visual stimuli (Lorist et al., 1994a&b; Lorist et al., 1995). Caffeine affected 
both the latency and amplitude of the N1 (activity related to perceptual processing) and 
Lorist et al., (1994a) concluded that it increased the participants’ receptivity to external 
stimuli and increases perceptual processing. However even using ERPs as the measure, the 
results are still equivocal, with Ruijter et al., (2000a&b), not finding any effects of caffeine 
on the N1 component. Caffeine also positively modulates the N2b component, which is 
associated with object recognition and catgorisation, suggesting that caffeine leads to a 
more effective selection mechanism (Lorist et al., 1994b, 1995, 1996; Ruijter et al., 
2000a). Research has also found that 250mg of caffeine can positively modulate P3 
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amplitude (potentially an indicator for the amount of energy that is used), but not affect 
latency, which is said to reflect stimulus evaluation time (Lorist et al., 1994; Lorist et al., 
1995). Kawamura et al., (1996) found that 500mg caffeine significantly increased the 
amplitude and area of the P300, but did not reduce latency in response to an auditory 
stimulus. Dixit et al., (2006) administered 3mg/kg (210mg for a 70kg individual) caffeine 
and also found it increased the amplitude of the P300, as well as significantly reducing 
reaction time on the behavioural task and causing a non-significant decrease in latency. 
Rao et al., (2005) evaluated the effects of combined caffeine and glucose administration 
compared to placebo. In their study participants consumed either an energising drink 
containing 60g glucose and 40mg caffeine or a placebo. Participants then performed a 
behavioural task where they detected visual targets and the C1, P1, N1, N2 and P3 ERP 
components were measured throughout the task. The C1 and P1 components reflect early 
visual cortical processing. The N1 is a visual component, whilst the N2 component is 
believed to reflect the evaluation of stimuli and the P3 component reflects decision-making 
and updating. They found that the energising drink lead to a significantly diminished N1 
component, although this interacted with scalp hemisphere and was larger over the 
posterior occipital lobes. The N2 component was also significantly larger over the frontal-
central scalp following the energising drink. Finally the P3 component, at the midline sites, 
was enhanced following the active treatment drink. 
Taking that the previous behavioural work reported in this thesis identified more robust 
effects on memory performance, this study aimed to investigate the effects on the P300 
component. The primary outcome measures in this current study was the P3b component 
for evaluation of memory storage operations was also carried out as well and the P3a 
components for assessment of fontal lob engagement (secondary outcome measure).  
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The current study specifically examined the effects of 25g glucose and 40mg caffeine, as 
these dosage levels have formed the main doses of interest in the previous studies reported 
in this thesis. Moreover -as outlined above- previous studies have beneficial effects on 
long-term memory performance following administration of 40mg caffeine, both in 
isolation and in combination with glucose. In addition, 25g glucose has been shown to 
modulate ERPs in previous research (Brown & Riby, 2013; Riby et al., 2008). Therefore it 
seems reasonable to predict that this dosage combination may have effects on these 
neurocognitive measures. 
As prior cognitive depletion and more general the activation state prior to drink 
administration are still considered to be an important effect moderator (see Chapter 6), all 
participants completed a series of cognitive tasks prior to drink administration and 








In total, 34 subjects were screened and recruited via the Online Research Participation 
System (SONA) at Lancaster University. 33 subjects were randomised, received study 
product and included in the Safety and Intent to Treat (ITT) populations. Thirty (30) 
subjects completed all four study periods. Based on the data observed in previous studies, 
a sample size of 30 participants completing all four treatment periods will have >80% 
power to detect a difference of 3.0 units in mean amplitude for P3b (memory updating 
component using target stimuli) as assessed at the parietal region (Pz site), between each of 
the three active treatments (glucose, caffeine, combination) versus placebo. The standard 
deviation (SD) of the paired differences is assumed to be 4.7 units, derived from the mean 
squared error 11.2 units, which was reported by Riby (2008).  
The age range was 18-35 years (mean age 21.53 years). They all consumed at least 120mg 
caffeine per day, (average consumption was 225.75mg). Inclusion criteria included; 
Compliance (understand and is willing, able and likely to comply with all study procedures 
and restrictions); Good general and mental health, with a) no clinically significant and 
relevant abnormalities of medical history or physical examination, b) absence of any 
condition that would impact on the subjects’ safety or wellbeing or affect the individual’s 
ability to understand and follow study procedures and requirements; Self-assessed as 
healthy, confirmed by medical questionnaire during screening; A native English speaker. 
Exclusion criteria included; individuals who regularly consume less than 120mg/day of 
caffeine or excessive consumers (>600mg/day) caffeine; a diagnosis of Diabetes Mellitus 
Types 1 or 2; allergy/intolerance, known or suspected intolerance or hypersensitivity to the 
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study materials (or closely related compounds) or any of their stated ingredients; any 
intolerance or allergic reaction to substances that contain phenylalamine and/or caffeine; 
clinical study/experimentation, a) participation in another clinical study or receipt of an 
investigational drug within 30 days of the screening visit, b) previous participation in this 
study; Personnel, an employee of the sponsor or the study site or members of their 
immediate family; having a history of neurological or psychiatric illness (excluding 
depression or anxiety); history of heart disease or high blood pressure (≥140/90 BPM) as 
measured at screening;  having a current diagnosis of neurological or psychiatric illness 
(including depression or anxiety); currently taking medication or nutritional supplements 
(including vitamins) other than the contraceptive pill and/or asthma inhalers; being 
pregnant, seeking to become pregnant or breastfeeding; having a history of or currently 
abusing drugs or alcohol; currently smoke or using nicotine replacement products (i.e. 
those attempting to quit smoking with the aid of nicotine supplementation. The study was 
approved by the Department of Psychology Ethics Committee at Lancaster University. 
Participants gave their signed informed consent prior to taking part and a Clinical Records 




This was a randomised, double blind, placebo-controlled, repeated measures design to 
examine event-related potentials, cognitive performance and glycaemic response under 4 
different drink conditions [glucose (25g), caffeine (40mg), glucose/caffeine (25g/40mg), 
and placebo]. Participants were randomly allocated to a treatment regime according to a 
Williams square, for a 4 by 4 crossover study. Within the randomisation list, each 





The treatments were supplied by Suntory Food and Beverage Europe in 380ml solutions. 
There were three active drinks; glucose containing 25g glucose, caffeine containing 40mg 
caffeine and a glucose and caffeine combination containing 25g glucose and 40mg 
caffeine. A taste matched placebo was also utilised.  
Participants were instructed to consume one drink per test session within 5 min. Cognitive 
testing started 20 minutes after drink administration. A twenty-minute delay was chosen as 
peak plasma caffeine concentration is reached between 15 to 120 min after oral ingestion 
and brain levels remain stable for at least one hour following peak plasma levels (Nehlig, 
1999; Nehlig & Boyet, 2000). Also this time frame is similar to the procedure of previous 
glucose studies (Foster et al., 1998) in order to ensure successful transfer of plasma 




Participants attended the laboratory on five different days. Their first visit was a screening 
session and the other four visits were for study visits. The study visits took place between 
9am and 4pm, but each participant took part in the study at the same time of day for all 
their visits. Participants attended the study visits following a 2 hour fast (i.e. no food or 
drink except water). The participants were instructed to abstain from drinking caffeine 
containing drinks and food for 12 hours and abstain from alcohol for 24 hours prior to the 
start of the study visit. Participants were also instructed not to take part in any strenuous 
physical activity until after their testing session had been completed each day. 
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Initial screening was done during sign-up using the Lancaster University recruitment on-
line system (SONA). Participants were informed about the inclusion and exclusion criteria 
and lifestyle restrictions and self-assessed their eligibility to take part in the study. 
At their first screening visit, following a discussion between the participant and the 
researcher about the requirements of the study, voluntary written informed consent was 
provided by all participants prior to any procedures being performed. All participants then 
completed the caffeine consumption questionnaire and were screened by the researcher 
using the completion of the CRF to ensure that they met the inclusion and exclusion 
criteria. The CRF captured personal demographic information and relevant medical history 
(including height, weight and confirmation of screening criteria). Participants also had 
their blood pressure checked to ensure they were not in the hypertensive range (≥140/90). 
Each participant also completed a training session in order to familiarise them with the 
cognitive tasks used. They were given instructions for each of the cognitive task 
assessments. No treatment drinks were administered during the screening session and 
performance data from those sessions was not included in the analysis. 
Once the screening session was successfully completed there were four experimental test 
sessions (active study days). The first session took place within 14 days of the screening 
session. Participants were randomised on arrival at the laboratory. All subsequent visits 
took place a minimum of 48 hours apart. 
Upon arrival at the study session the participant gave a blood sample (finger prick) for the 
measurement of blood glucose, these confirmed their compliance with the 2 hour fasting 
for food. If baseline glucose was ≤6mmol/L, participants completed the first set of 
cognitive tasks (Resource Depletion Battery including Serial Sevens task and Digit 
Vigilance task). The participants then provided a saliva sample to measure their caffeine 
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levels. Participants then consumed their treatment drink for the day (following a double-
blind procedure) in a maximum time of 5 minutes. The post-drink cognitive test session 
commenced 20 minutes after treatment drink consumption. Whilst the participants 
consumed their treatment, and during the first 15 minutes of the absorption period, the 
researcher capped up the participant ready for the EEG recording. After the full 20 minutes 
absorption period, participants were given a short practice of the next cognitive task (Odd 
ball task). They then completed the cognitive task whilst the EEG was recording. A further 
saliva sample was taken at 25 and 55 minutes after the intake of the treatment drink and 
measuring blood glucose levels was also repeated at 25 and 55 minutes post-intake. All 



















































Figure 7.1 Schematic of the study day procedure 
 





Computerised Serial Sevens Task – Evaluates working-memory performance (Hayman, 
1942). Participants were required to compute a running subtraction of 7, starting from a 
randomly generated number. Participants were given 5 minutes to complete this task. 
Numbers of responses, number of correct responses and number of incorrect responses 
were recorded. 
Digit Vigilance – Measures sustained attention (Lewis, 1995). A single target digit was 
randomly selected and continuously displayed on the right side of the screen. In the centre 
a series of rapidly changing digits were displayed. Participants were required to press the 
space bar button as quickly as possible, whenever the digit in the centre matches the target 
digit. The task lasted for 10 minutes. Reaction times (milliseconds), percentage accuracy 
and number of false alarms were recorded. 
These tasks were administered using the Computerised Mental Performance Assessment 
System (COMPASS), a purpose designed software for the flexible delivery of randomly 
generated parallel versions of standard and novel cognitive assessment tasks. All responses 
were made using the computer keyboard and mouse. 
 
Odd Ball Task 
The task followed the same procedure as described in Riby et al., (2008). The task was 
administered via a personal computer on a 14’ monitor. Participants were seated 1.5 m 
from the computer screen in a semi-darkened room. Three versions of the task were 
presented in a counterbalanced order in the session. Participants were instructed to press a 
keyboard every time they identified the designated target stimulus, but that they should 
ignore all other stimuli. The experimental task comprised of 350 stimuli, with a probability 
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of 0.8 for the standard stimulus (a large blue square of 16 cm
2
 in area), 0.1 for the target 
stimulus (a smaller blue square 12.82 cm
2
 in area), 0.1 for the irrelevant stimuli (neutral 
photographs selected from the International Affective Picture System, Lang et al., 1988). 
The stimuli remained on the screen for 100 ms. The inter-stimulus interval was 2000 ms. 
Prior to the experimental blocks, a practice block of 15 items was administered without the 
irrelevant stimuli. The Odd Ball task was administered using E-Prime. All the responses 
were made using the computer keyboard and mouse.   
 
Event-related Potential (ERP) recording 
EGI (Electrical Geodesics Incorporated, Eugene, OR) Geodesic EEG System (GES) 250 
EEG system with Net Amps 200 amplifier and 128 channel HydroCel Geodesic Sensor 
Net (HCGSN) were used for EEG recordings. The EEG was recorded and analysed using 
NetStation software (Electrical Geodesics Incorporated, Eugene, OR). Impedances were 
kept below 50 kOhm. During the recording, the EEG was referenced to vertex (Cz). The 
sampling rate was 1000 Hz. Horizontal and vertical eye movements were recorded from 
around the eyes (channels 8 and 25, 125 and 128 on HCGSN net). Time windows of 320-
430ms and 380-700ms was used to capture the P3a and P3b ERP components respectively. 
Automatic eye-blink correction, artefact rejection (trials where ERPs are outside the range 
-75uV to +75uV) and ERP averaging were carried out offline using Edit 4.3 (Neuroscan). 
 
Blood Glucose Measurement 
Blood glucose readings were obtained using the ExacTech® blood glucose monitoring 
equipment (supplied by MediSense Britain Ltd, 16/17 The Courtyard, Gorsey Lane, 
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Coleshill, Birmingham B46 1JA), following the recommended procedure: The researcher 
swabbed the finger of the volunteer with a Sterets Isopropyl Alcohol BP Pre-injection 
swab (Seton Healthcare Group, Oldham, UK) and allowed the skin to air dry. The skin was 
punctured using an automatic lancing devise and a drop of blood was collected onto the 
analytical test strip. The volunteer applying a tissue blotted any excess blood. Ambidex-
HG powder free polymer bonded latex examination gloves were worn by the experimenter 
at all times during the procedure. Each lancet and cap were only used once and then 
disposed of into a sharps container. Swabs, test strips, tissues and gloves will be placed in 
a clinical waste sack.   
For performance characteristics of ExacTech® blood glucose monitoring equipment see 
chapter 2.   
 
Quantification of Caffeine in Saliva 
Caffeine saliva concentrations were obtained through saliva samples, which were collected 
using the salivette saliva sampling device (Sarstedt LTD, Leicester, UK). These consist of 
a small test tube fitted with an inner receptacle containing a sterile cotton wool bud. 
Participants were required to remove the cotton wool bud and give unstimulated saliva 
samples by placing the cotton wool under the tongue for a timed two-minute period and 
then replacing it in the test tube. Ambidex-HG powder free polymer bonded latex 
examination gloves were worn by the experimenter at all times during saliva sampling. 
Excess saliva was removed using Sterets Isopropyl Alcohol BP Pre-injection swabs (Seton 
Healthcare Group, Oldham, UK). All saliva contaminated waste was placed in a yellow 
bio hazard bag and disposed of via Lancaster University’s Biology Autoclave system. Test 
tubes were sent to the School of Applied Sciences, University of Huddersfield within 24 
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hours of collections. There the saliva-cotton wool was analysed and levels of caffeine were 
determined by high performance liquid chromatography (HPLC) following the procedure 
described in Child and de Wit (2006).  
 
7.2.6 Statistical Analysis 
 
P3b Memory Component 
The primary efficacy variable was the mean amplitude for P3b (memory updating 
component using target stimuli) as assessed at the parietal region (Pz site). To investigate 
the effect of glucose and caffeine administration on the P3b component related to memory 
updating, average amplitude in the 380-700ms region for correct responses to the target 
were analysed using a linear mixed model. Terms in the model were treatment, period, site 
(Pz. Cz) and treatment by site interaction as fixed effects and subject as a random effect. 
Since each participant had multiple measures (i.e. at the different regions of the brain), the 
mixed model was set up using a repeated measures framework, in order that to take into 
account the inherent correlation between the repeat measures on the same participant. An 
unstructured covariance pattern was used. All active treatment drinks were compared with 
the placebo drink using two-sided testing and implementing the Dunnett’s method to 
ensure a family wise significance level of 5%. Adjusted 95% confidence intervals are 
presented for pairwise differences. 
The secondary variables were; mean amplitude for P3b (using target stimuli; memory 
updating component) as assessed at the central region (Cz site); peak latency data for P3b 
(using target stimuli; memory updating component) as assessed the Pz and Cz sites; mean 
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amplitude and peak latency data for P3a (using target stimuli; orientation of attention 
component) as assessed at the frontal and central scalp regions (Fz and Cz sites); Odd Ball 
task performance, performance are percentage accuracy (%) and reaction time 
(milliseconds); blood glucose levels (mmol/L) at 0 (baseline), 25 and 55 min, and salivary 
caffeine levels (µg/ml) at 0 (baseline), 25 and 55 min. 
 
Descriptive summaries and statistical comparisons between study groups were performed 
for the following secondary parameters: 
P3a Attention Component 
To investigate the effect of glucose administration on the P3a component related to 
memory updating, average amplitude in the 320-340ms region for correct responses to the 
target were analysed using a linear mixed model. Terms in the model were treatment, 
period, site (Fz,Cz) and treatment by site interaction as fixed effects and participant as a 
random effect. In addition, an analysis of the repeat latency data using the same mixed 
model was performed. 
Odd Ball Task 
Percentage accuracy (data collapsed across experimental blocks) was analysed using a 
linear mixed model. Terms in the model were treatment and period as fixed effects and 
participant as random effect. Two measures from the resource depletion task were included 
as covariates; the percentage accuracy on the Serial Sevens task and percentage accuracy 
on the Digit Vigilance task. 
In addition, an analysis of reaction time using a linear mixed model was performed. Terms 
in the model were treatment and period as fixed effects and participant as a random effect. 
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One measure from the Resource Depletion task was included as a covariate; reaction time 
on the Digit Vigilance task. 
For the analyses of the secondary parameters, all active treatment drinks were compared 
with the placebo drink using two-sided testing and implementing the Dunnett’s method to 
ensure a family wise significance level of 5%. Adjusted confidence intervals are presented 






7.3.1 Glycaemic response 
 
Linear mixed model analysis revealed a significant effect of time, F (2, 194.14) = 36.86, p 
< .001 was observed, but no significant effect of treatment, F (3, 95.82) = 1.37; p =.26, or 
treatment x time interaction, F (6, 95.93) = 0.61, p = .73. No effect of period was 
observed, F (3, 68.86) = 0.54, p = .66.  
Inspection of the means showed that as expected, blood glucose levels were highest in the 
test drinks containing glucose. Glucose levels peaked at between 7.25 and 7.50 mmol/l at 
25mins for the glucose and glucose & caffeine test drinks (see figure 7.1 for glycaemic 
response). 
 




Table 7.1 Glycaemic response to treatments, means and standard deviations 
Time Point 
Treatment 
Placebo Glucose (40g) Caffeine (40mg) Caffeine 
(40mg)/Glucose 
(40g) 
Baseline 4.77 (0.16) 4.87 (0.12) 5.03 (0.18) 4.83 (0.11) 
1
st
 Post Dose 4.89 (0.16) 7.24 (0.27) 4.73 (0.17) 7.5 (0.26) 
2
nd
 Post Dose 4.95 (0.12) 6.4 (0.28) 4.80 (0.16) 6.99 (0.31) 
 
7.3.2 Salivary caffeine concentration 
 
For caffeine levels, mixed model analysis revealed a significant effect of treatment, F (3, 
61.61) = 18.9, p < .001, time, F (2, 59.45) = 6.69; p < .01, but no significant treatment x 
time interaction, F (6, 34.49) = 1.98, p = .10. No effect of period was observed, F (3, 
236.37) = 1.08, p = .36.  
Salivary caffeine levels were highest following ingestion of caffeine containing drinks. 
More specifically, caffeine levels peaked at 1240.3 ng/ml at 55 mins for the glucose and 
caffeine treatment drink. Following the caffeine treatment drink, caffeine levels peaked at 
1260.4 ng/ml at 25 mins and then reduced to 746 ng/ml by 55 mins (see figure 7.3 for 




Figure 7.3 Time-caffeine concentration profiles for different drink conditions 
 




Placebo Glucose (40g) Caffeine (40mg) Caffeine 
(40mg)/Glucose 
(40g) 
Baseline 655.6 (243.10) 760.9 (224.85) 708.8 (299.46) 501.3 (122.58) 
1
st
 Post Dose 376.5 (78.81) 465 (67.78) 1240.9 (70.65) 1111.4 (80.28) 
2
nd
 Post Dose 380.9 (60.74) 359.4 (106.11) 745.9 (262.86) 1237.6 (142.68) 
 
 




7.3.3.1 Mixed model results 
 
P3b: Mixed linear model analysis showed no significant effect of treatment drink on the 
mean P3b amplitude, F (3, 75.2) = 0.64, p = .59. No effect of period, F (3, 82.5) = 0.56, p 
= .64, but a treatment x site interaction, F (4, 115) = 9.45, p < .001. For P3b peak latency, 
no significant effect of treatment drink, F (3, 88.3) = 0.82, p = .45, but a significant effect 
of period was observed, F (3, 82.2) = 2.81, p = .05, but no  significant site x treatment 
interaction, F (4,115) = 2.37, p = .06. 
P3a: Mixed model analysis no significant effect of treatment drink on the mean amplitude 
for P3a, F (3, 71.5) = 1.08, p = .36. In addition, no significant effects of period, F (3, 81.4) 
= 0.72, p = .55, or treatment x site interaction, F (4, 115) = 0.69. p = .60 were observed. 
There was no significant effect of treatment on the peak latency for P3a, F (3, 73.6) = 0.28, 
p = .84, period, F (3, 83.4) = 2.24, p = .09, or treatment x site interaction, F (4, 115) = 
0.83, p = .51. 
 
7.3.3.1 Comparison with placebo based on results from linear model 
 
Mean amplitude for P3b as assessed at the parietal region (Pz site) 
No statistically significant differences versus placebo for any of the 3 active treatment 
drinks were observed for target specific amplitude at parietal region (see table 7.3).  
 
Peak latency for P3b as assessed at the parietal region (Pz site) 
No statistically significant differences were observed for any of the three active treatments 





Mean amplitude and peak latency for P3b as assessed at the central region (Cz site) 
Mean amplitude values for each of the three active drinks were not statistically significant 
(see table 7.3). 
 
Table 7.3 P3b mean amplitude and latency as a function of drink 
 
Region  Glucose Caffeine Combined Placebo 








0.29 (0.44)  
p = .10 
-0.14 (0.45) 






p = .39 
446.7 (11.2) 
p = .99 
428.9 (11.3) 
p = .24 
449.9  
(11.2) 
Central  Amplitude 
(µV) 
1.76 (0.38)  
p = .93 
1.67 (0.38)  
p = .98 







p = .61 
452.0 (16.1) 
p = .72 
475.9 (16.4) 
p = .94 
469.9  
(16.1) 
†Adjusted mean (SE) from linear mixed model with terms for treatment, period, site (Pz, Cz) and treatment by site 
interaction as fixed effects and subject as a random effect. 
‡Comparison with placebo; results from linear model, p-value adjusted according to Dunnett’s for multiple comparisons 
 
Mean amplitude and peak latency for P3a as assessed at the frontal region (Fz site) 
None of the differnces in the mean amplitude values following the three active drinks were 
statistically significant. In addition there was no significant difference between the Peak 
latency values following any of the three active treatments (see table 7.4).  
 
Mean amplitude and peak latency for P3a as assessed at the central region (Cz site) 
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The Mean amplitude was no statistically significant following any of the three treatment 
drinks.  There were also no statistically significant differences between the Peak latency 
values following any of the three active treatment drinks (see table 7.4).  
 
Table 7.4 P3a mean amplitude and latency as a function of drink 
Region  Glucose Caffeine Combined Placebo 
Frontal  Amplitude 
(µV) 
1.57 (0.47) †  
p = .86‡ 
1.24 (0.47)  
p = .95 
1.83 (0.48)  





387.7 (11.9)  
p = .96 
399.6 (12.0)  
p =  .96 
398.3 (12.1) 
p = .98 
393.7  
(12.0) 
Central  Amplitude 
(µV) 
2.09 (0.36)  
p = .41 
2.21 (0.36)  
p =  .27 
1.70 (0.37)  





373.2 (11.6)  
p = .85 
380.4 (11.7)  
p = .99 
385.7 (11.8)  
p = .99 
382.4  
(11.7) 
†Adjusted mean (SE) from linear mixed model with terms for treatment, period, site (Fz, Cz) and treatment by site 
interaction as fixed effects and subject as a random effect. 
‡Comparison with placebo; results from linear model, p-value adjusted according to Dunnett’s for multiple comparisons 
 
7.3.4 Behavioural Performance Data 
 
Odd Ball Task Percentage Accuracy 
There was no significant effect of treatment drink on the percentage accuracy of the Odd 
/ball task, F (3, 86.3) = 1.55, p = .21. There was evidence of a notable difference in the 
percentage accuracy across study days, F (3, 93.6) = 30.45, p <.001. More specifically, 
performance on study day 1 was significantly lower compared to study days 2 to 4. This is 
259 
 
illustrated in Figure 7.4, which presents the mean percentage accuracy for each group by 
the study day. 
 
 
Figure 7.4 Oddball task percentage accuracy as a function of period and drink 
 
In terms of drink effects, percentage accuracy ranged from adjusted means of 77.6% 
(glucose and caffeine in combination) to 83.59% (caffeine). However, there were no 
significant differences between any of the active treatment drinks and placebo (see table 
7.5). 
 
















Glucose Caffeine Glucose	+	Caffeine Placebo
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There was a significant effect of treatment on the reaction time on the Odd /ball task, F (3, 
78.4) = 2.91, p = .04. No effect of period was evident, F (3, 79.4) = 0.99, p = .40.  
Reaction time was numerically faster in all three active treatment drinks compared to 
placebo. Following the caffeine treatment drink participants were significantly faster (M = 
541.39) compared to after the placebo drink (M = 567.02), p = .03. The glucose (M = 
544.86) and glucose and caffeine combination (M = 545.02) treatment drinks failed to 
reach significance compared to placebo, p = .08 and p = .07 respectively. 
 















p = .59 
79.95 (2.72) 






p = .08 
541.0 (13.9) 
p = .03* 
546.0 (13.9) 
p = .07 
567.4  
(13.9) 
†Adjusted mean (SE) from linear mixed model with terms for treatment, period, site (Fz, Cz) and treatment by site 
interaction as fixed effects and subject as a random effect. 
‡Comparison with placebo; results from linear model, p-value adjusted according to Dunnett’s for multiple comparisons, 







The aim of this study was to investigate the effects of glucose and caffeine on the P300 
component. The primary outcome measure was the P3b component which relates to 
memory storage operations, but the P3a component which assesses frontal lobe 
engagement was also assessed.  
For the P3b component, none of the active drinks containing caffeine or glucose had a 
statistically significant effect on ERPs which reflect memory processes (P3b using the 
target stimuli) as assessed by mean amplitude at the parietal region (Pz site). There were 
also no effects of the active drinks on any of the secondary ERP outcomes. The active 
drinks containing caffeine and/or glucose did alter the behavioural performance on the 
Odd-ball task. Specifically, reaction time was numerically faster following all 3 active 
drinks compared to placebo, with participants who received the caffeine drink achieving 
significantly faster reaction times compared to those on placebo. There were no effects of 
any of the active drinks on the accuracy outcome on the Odd-ball task. 
The lack of active treatment effects does not support previous literature which has found 
glucose and caffeine to affect the P300 component (Brown & Riby, 2003; Dixit et al., 
2006; Kawamura et al., 1996; Lorist et al., 1994a&b; Lorist et al., 1995; Lorist et al., 
1996; Lorist et al., 2004a; Rao et al., 2005; Riby et al., 2008; Smith et al., 2009). 
Administration of 25g glucose has been found to reduce amplitude, latency and duration of 
the P3b component (Riby et al., 2008) and enhanced the left parietal old/new effect, which 
is a measure of verbal memory (Brown & Riby, 2013). Caffeine at doses of 250mg (Lorist 
et al., 1994; Lorist et al., 1995), 500mg (Kawamura et al., 1996) and 3mg/kg 
(approximately 210mg for a 70kg individual) (Dixit et al., 2006) has been found to 
increase the amplitude of the P300, but not to reduce latency. 
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Whilst the dose of glucose previously found to elicit an effect on the P300 component is 
the same as used in this task, the caffeine dose was much lower at 40mg than the 
efficacious doses administered in previous studies. It may be therefore that the dose 
administered in this study was too low to elicit an effect. However the caffeine drink was 
the only active drink to improve behavioural performance, specifically decreasing reaction 
time on the Odd-ball task. Potentially, whilst this task elicits a memory updating ERP 
component, modulation of this particular behaviour outcome, increased speed, could be 
modulated by a more basic psychomotor process that was not assessed in this study.  
In terms of the pharmacokinetics of caffeine, estimated from salivary caffeine samples, the 
levels of caffeine followed the expected pattern, with the highest levels following the 
caffeine containing drinks. However, when caffeine was administered in isolation, salivary 
caffeine levels peaked at 25mins, before declining at 55mins. Conversely, when 
administered with glucose, salivary caffeine levels peaked at 55 mins. The caffeine results 
suggest that salivary caffeine peaked later following the combination drink compared to 
the caffeine drink. These results are similar to findings by Adan and Serra-Grabulosa 
(2010) whereby they found that the salivary caffeine increase was greater for the caffeine 
group compared to the caffeine plus glucose group. Rather than the caffeine plus glucose 
group’s salivary caffeine peaking at a lower level however, it may be the same as the 
finding in the current study, where the peak is just shifted. This is because they only 
sampled at baseline and 30mins post drink consumption whereas in the current study 
salivary caffeine was sampled at baseline, 25mins post drink and 55mins post drink. 
Numerically both the caffeine and caffeine and glucose group reached the same salivary 
caffeine levels, the caffeine group just did so 25mins post drink and the caffeine and 
glucose group did so at 55mins post drink. Previous research has found that caffeine can 
increase glucose uptake and/or release (Graham et al., 2001; Greer et al.,, 2001; Keijzers et 
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al.,, 2002; Lee et al., 2005; Petrie et al., 2004; Pizziol et al., 1998; Thong et al., 2002), and 
affect the intestinal absorption of glucose (Van Nieuwenhoven et al., 2000). However, 
effects on caffeine absorption by co-administration with glucose has not been explored 
(Adan & Serra-Grabulosa, 2010). 
The potential modulation of glucose on caffeine absorption may impact on the timing of 
the physiological measurements and cognitive tasks. The task timing is based on the 
premise that peak plasma concentration is reached around 15 to 120 min after ingestion 
(Nehlig, 1999; Nehlig & Boyet, 2000). However it may be that when co-administered with 
glucose this profile is altered and therefore the window of opportunity for the greatest 
effects of glucose and caffeine in combination may be missed. 
This study found that, unlike in previous research glucose, caffeine or their combination 
did not modulate any parameters of the P300 component despite evidence of beneficial 
behavioural effects. The concurrent finding that caffeine absorption could be altered when 
in combination with caffeine leads to the suggestion that perhaps the timing of the tasks 


















The experiments reported in this thesis were designed to systematically evaluate the effects 
of combined glucose and caffeine administration in comparison to either glucose or 
caffeine in isolation in healthy young adults. This was done by examination of dose-
response, cognitive domains, evaluation of neural mechanisms and biochemical effects. 
The following chapter will summarise the findings by discussing cognitive domains 
affected, summarising effects on biochemical and neurocognitive measures and exploring 
the effects of different dosages used.  Potential moderating and mediating factors will be 
discussed. Implications and potential methodological issues will be addressed and 
suggestions for future research directions made.  
 
8.1 Effects on Memory 
 
The first experimental study (as described in chapters 2 and 3), aimed to compare the 
effects of two dosing regimens, a ‘low’ dose (15g glucose and 20mg caffeine), and a 
‘moderate’ dose of glucose and caffeine (25g glucose and 40mg caffeine). The active 
doses of glucose and caffeine were administered in isolation and alone and compared to a 
placebo drink. Cognitive performance, mood and hormonal responses were assessed. A 
wide range of cognitive tasks were included to elucidate the cognitive domains most 
susceptible to modulation by glucose and caffeine in combination. Whilst evidence of 
improved performance was limited across all cognitive domains for both dosing regimens, 
there was some evidence of beneficial effects on memory, specifically verbal declarative 
memory. There were no beneficial effects on working memory. 
The second experimental study (as reported in chapter 4) aimed to specifically explore the 
effects on memory performance when the active drinks (40g glucose and 40mg caffeine) 
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were administered prior to memory retrieval. There was however no beneficial effect of 
glucose and caffeine administered in isolation or in combination. 
Given the equivocal findings of the research in the series so far, besides temporal relation 
of drink administration, another aspect of the methodology was of interest: the importance 
of participants’ state before drink administration and testing. Based on previous research, it 
is possible that a sub-optimal state, i.e. being tired, fatigued might be critical to obtaining 
an effect. This might suggest that manipulation of participants into a sub-optimal state 
would provide clearer results. Unfortunately the Resource Depletion battery that was 
utilized, failed to tease out any effects related to participants potentially altered state. 
In general, the findings on memory, in particular verbal declarative memory are equivocal. 
There is some support for previous research which has found beneficial effects of glucose 
and caffeine in combination on memory (Adan & Serra-Grabulosa, 2010; Alford et al., 
2001; Sünram-Lea et al., 2012). Taken as a whole, the results from this series of studies 
suggest that caffeine and glucose alone and in combination may preferentially benefit 
recognition performance rather than recall. The recall and recognition aspects of memory 
are theorised to be related but separate processes (Flexser & Tulving, 1978; Gillund & 
Shiffrin, 1984). Whilst by no means exclusive, most of the tasks where no improvements 
following the active treatments were observed, or where performance was even impaired, 
were recall tasks. The hippocampus has been most strongly implicated in long-term 
memory performance (Aggleton & Brown, 1999). More specifically, the hippocampal-
diencephalic system has been postulated as important for item recognition during 
recollection of stimuli; conversely the recognition process suggested to be independent of 
the ‘extended hippocampal system’ and related to stimulus familiarity (Aggleton & 
Brown, 1999). Therefore the modulation of specific memory processes could be facilitated 
by different mechanisms of action. However, there is evidence to suggest that in 
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recognition memory itself there are different processes at work. Sünram-Lea et al., (2008) 
utilised a ‘remember-know’ paradigm to assess recollection and familiarity components of 
recognition memory. They found that recognition responses that were based on 
recollection (remembering responses) were sensitive to beneficial modulation by glucose 
administration. In contrast responses based on familiarity (know responses) were no 
sensitive to facilitation by glucose. This suggests that memory processes should be 
considered in finer detail as indeed should the potential modulation of these processes by 
glucose and caffeine. These different aspects of memory and their potentially different 
underlying mechanisms may go some way towards explaining the equivocal findings in 
this domain of cognition.  
With regards to working memory, no supporting evidence was found. This is in support of 
the previous literature (Aden & Serra-Grabulosa, 2010; Scholey & Kennedy, 2004; 
Urquiza& Vieyra (2015), which found no effects on working memory.  
 
8.2 Effects on Attention 
 
In the first study (chapter 2) there were no benefits on attention seen following either the 
low or moderate treatment regimes. Chapter 5 reported the findings of a study which 
examined the effects of glucose and caffeine administered in isolation and combination on 
attention. The study utilised the testing paradigm of study 2 (chapter 4), but the task of 
interest was one which specifically assessed three separate attention networks; alerting, 
orienting and executive control. These studies also served to examine the effects of 
caffeine and glucose in a more realistic testing paradigm which had greater ecological 
validity as testing took place in the afternoon following a 2hr fast. This is more 
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representative of a typical consumption time as the substances may be consumed in order 
to provide an afternoon pick-me-up following a slump in performance and/or energy. 
However, no effects of glucose, caffeine or their combination were found on any of the 
attention networks. Study 4 (chapter 6) found no beneficial effects on attention following 
either the ‘moderate’ or ‘high’ treatment regime. Behavioural measures in study 5 (chapter 
7) found that participants performed significantly faster on the Odd-ball task following 
40mg caffeine. 
Overall, whilst the effects on attention were very limited they provide some support for 
previous research that caffeine has a beneficial effect on attention (Brice & Smith, 2001b; 
Chubley et al., 1979; Hindmarch, et al., 2000; Smith et al., 1997; Smith et al., 1994; Smith 
et al., 1992). In comparison with the effects on memory, beneficial effects were found 
following the moderate dosing regimens (40mg caffeine). With the moderate 40mg dose 
beneficial for decreasing reaction time. It appears that caffeine is responsible for the 
modulation of attention and that there is no evidence from the current research series to 
suggest that glucose beneficially modulates attention performance. This is because there 
were no beneficial effects seen following the combination drinks or glucose alone. 
Previous research for the effect of glucose on attention is limited, although Giles et al., 
(2012) did find a beneficial effect of 50g glucose on the orienting network, this was in 
conjunction with taurine administration.  
Attention tasks can be divided into simple information processing tasks which merely 
require a response to a stimulus and have an element of automaticity, and more complex 
ones which involve executive control (Enother & Giesbrecht, 2013). It has been suggested 
that simple tasks are more sensitive to effects of pharmacological interventions, in 
particular on psychomotor components (Enother & Giesbrecht, 2013), and caffeine has 
previously been found to have its most robust effects on simple attention processes (for 
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reviews see Glade, 2010; Smith, 2002). As caffeine is the main driver behind the attention 
result seen here, this could provide an explanation as most of the tasks that have shown 
beneficial effects are simple attention tasks and no effects were seen on the more complex 
Attention Network Task. Effects on the more complex attention tasks may be difficult to 
elucidate due to the myriad of factors e.g. personality and time of day that could influence 
performance (Smith, 2002).  
 
8.3 Effects on Mood 
 
In terms of mood effects, in the first study (chapter 2) positive modulation of mood was 
found, although this was almost exclusively limited to the moderate dose regimen, with 
each of the active treatments improving various self-rated aspects of mood. In the fourth 
study (chapter 6) both active drinks were able to elicit beneficial effects on mood 
irrespective whether participants started the session in a state of cognitive depletion or not. 
In terms of dose, the moderate dose of 25g glucose and 40mg caffeine was more 
efficacious in eliciting mood effects. Across both studies 40mg caffeine and 25g glucose 
were found to increase level of alertness, calmness, contentedness/happiness, arousal and 
reduce anxiety. It also improved ratings on the more physiological based feelings such as 
reducing light-headedness and increasing clear-headedness. The only negative effect was 
for the 40mg caffeine and 25g glucose combination treatment to increase one rating of 
tense arousal. Consequently the studies reported here support previous research findings 
that consumption of glucose and caffeine engenders mainly beneficial effects on mood 
(Gershon, et al., 2009; Howard & Marczinski, 2010; Kennedy & Scholey, 2004; Mets et 
al., 2010; Smit & Rogers, 2002; Sünram-Lea et al., 2012). 
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Although in one of the two studies in this thesis which assessed mood, glucose and 
caffeine were only administered in combination, the almost complete absence of any mood 
effects following administration of either glucose or caffeine in isolation suggests that it is 
the combination which is responsible for the modulation of mood. Whether this is a truly 
synergistic effect remains to be elucidated. However, as the findings in this thesis reflect 
the mood changes found previously following consumption of either caffeine or glucose in 
isolation, then it is likely that these findings reflect some level of additive effect of each 
substance at the doses utilised here (Benton & Owens, 1993; Brice & Smith 2001a; 
Haskell et al., 2005; Hindmarch et al., 2000; Kennedy et al., 2008; Owens, et al., , 1997; 
Smith et al., 1999). 
Previously it has been proposed that mood effects only follow on from changes in 
cognitive performance (Rusted, 1999). However, given that the cognitive effects found in 
the current studies were limited, the mood outcomes found would not support this as being 
a necessity. Yet, emotional arousal state might have mediated some effects. Improvements 
on memory were seen when administration was prior to encoding, but not when 
administered prior retrieval.  This might be due to specific effects on encoding and storage, 
or could be explained via state dependent state-dependent memory effects (Bruins Slot & 
Colpaert, 1999; Ceretta et al., 2008), as in this case the substances (caffeine and glucose) 
would have been present for both encoding and retrieval. Sanday et al., (2013) suggests 
that it may be related to the anxiogenic effects of caffeine that modulate the participants’ 
emotional state and thereby elicit a state dependent learning effect.  
 




In order to assist with elucidating the underlying mechanisms of action of glucose and 
caffeine we also investigated the neuroendocrine response to drinks (as reported in chapter 
3). Both the hypothalamic-anterior pituitary-adrenocortical axis (HPA axis) and sympatho-
adrenomedullary axis (SAM axis) response were examined by measuring both salivary 
cortisol and alpha amylase. However no effects of the active drinks were found on these 
mechanisms. Whilst the findings from this study do no support some previous research 
which has found effects on neuroendocrine responses  after glucose and caffeine ingestion 
(Bergendahl et al., 1996; 2000; Gonzalez-Bono et al., 2002; Graham et al., 1994; 
Kirschbaum et al., 1997; Vance & Thorner, 1989; James, 2004; Lovallo et al., 2006; 
Lovallo et al., 2005; Robinson et al., 2004), there are other reports in the literature of a 
failure to observe effects on these hormonal systems  (Klein et al., 2014; Sünram-Lea et 
al., 2012).   
In the study reported in this thesis beneficial effects of the active drinks were found 
without any concomitant changes in hormonal response. Therefore, our data does not 
provide evidence that the beneficial effects were elicited via underlying neuroendocrine 
mechanism.  
 
8.5 Neurocognitive effects 
 
The final study (chapter 7) in the thesis examined the neurocognitive effects of glucose 
and caffeine. Doses of 25g glucose and 40mg caffeine (chosen as they have been the main 
doses of interest throughout this thesis), were administered in isolation and combination 
and their effects on the P3b component of the P300 ERP were examined. This component 
reflects the memory updating component as improvements in memory have been found 
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across this programme of studies. The P3a which assesses frontal lobe engagement was 
also evaluated. No effects of any of the active treatment drinks were found on any of the 
EEG measures. There was however evidence that the active treatments had a beneficial 
effect on behavioural performance.  
The findings of this study did not support previous research which has found effects of 
both caffeine and glucose on the P300 component (Brown & Riby, 2003; Dixit et al., 
2006; Kawamura et al., 1996; Lorist et al., 1994a&b; Lorist et al., 1995; Lorist et al., 
1996; Lorist et al.,, 2004a; Rao et al., 2005; Riby et al., 2008; Smith et al., 2009). 
However, it is important to note that the doses used in this study were much lower than 
those used previously and this may explain the lack of effects. Alternatively it may be that 
other factors such as task timings affected the results. Concomitant measurement of 
salivary caffeine suggested that caffeine absorption was modulated by co-administration 
with glucose and this may have affected the pharmacokinetic profile of caffeine. Therefore 
the tasks may have been administered when the ingested caffeine was unable to be utilised 
fully. 
Table 8.1 Summary of the effects on caffeine and glucose administered in 
combination on outcome measures in this study series 
Domain Evidence Found for 
Benefits 
Evidence Found for 
Negative Effects 
Summary of Evidence 
Immediate Memory No evidence found No evidence found No evidence that 
caffeine and glucose 
in combination have a 
beneficial effect on 
Immediate Memory. 
Some evidence that 
Caffeine and glucose 








No evidence found 
Working Memory No evidence found No evidence found No evidence that 
caffeine and glucose 
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in combination have a 
beneficial effect on 
Working memory. 
Attention No evidence found No evidence found No evidence that 
caffeine and glucose 
in combination have a 
beneficial effect on 
Attention. 
Improvement in Mood More alert* 
Calmer* 






More tense* Moderate evidence to 
support that caffeine 
and glucose in 
combination have 
beneficial effects on 




No evidence found No evidence found No evidence that 
caffeine and glucose 
in combination have a 
beneficial effect on 
Neuro-cognitive 
effects. 
Hormonal Effects No evidence found No evidence found No evidence that 
caffeine and glucose 
in combination have a 
beneficial effect on 
Hormonal response. 
* 40 mg Caffeine and 25g Glucose 
 
8.6 Dose effects 
 
Another important aim of this research was to identify the most effective dose. Overall the 
25g glucose and 40mg caffeine doses appeared to be the most effective across memory, 
attention and mood outcomes. These doses are in line with previous research which has 
found 25g glucose to be effective at beneficially modulating cognitive performance 
(Kennedy & Scholey, 2000; Scholey et al., 2001; Sünram-Lea et al., 2002a; Sünram-Lea 
et al., 2004); and that 50-75mg of caffeine has beneficial effects (Messier, 2004), with 
evidence of a flat dose response profile at lower doses (Smit & Rogers, 2000). However 
these doses of caffeine and glucose are lower than those previously found to affect mood 
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ratings (Benton & Owens, 1993; Haskell et al., 2005; Owens, Parker & Benton, 1997). 
There is no strong evidence from the current studies of a synergistic effect as often it was 
found that either caffeine or glucose in isolation also had the same effects as the 
combination drink.   
As found previously for glucose, the results also suggest that the specific dose-response 
profile is task specific (Sünram-Lea et al., 2011). A lower dose (20mg) of caffeine was 
more effective at improving performance on attention tasks compared to its ability to 
modulate memory performance. Equally preferential improvement on recognition 
performance by 25g glucose and 40mg caffeine compared to their effects on recall 
performance again is supportive of a different dose-response profile for these aspects of 
memory. 
The salivary caffeine findings from study 5 (chapter 7) provide evidence that the 
pharmacokinetic profile of caffeine absorption is attenuated by glucose. Specifically it was 
found that the salivary caffeine peaked later following consumption of a combined glucose 
(25g) and caffeine (40mg) drink. This finding requires further exploration as little research 
has examined the effects of glucose on caffeine absorption (Adan & Serra-Grabulosa, 
2010). This attenuation of caffeine absorption by glucose could be influential on the most 
effective doses required when the substances are co-administered. 
 
8.7 Moderating effects 
 
Several factors may be responsible for moderating the effects of glucose and caffeine in 
the studies conducted in this thesis. 
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One factor which was the subject of examination in the thesis was the activation state of 
the participants. Earlier study findings in this thesis of the effects of caffeine and glucose 
on cognitive performance and mood were equivocal. Previous research had found the most 
robust effects of these substances in participants who were performing at a sub-optimal 
level (Alford, Cox & Wescott, 2001; Horne & Reyner, 2001; Kennedy & Scholey, 2004; 
Sünram-Lea, Owen-Lynch, Robinson, Jones & Hu, 2012). It was postulated that glucose 
and caffeine may be more effective at ameliorating the decrements in performance of 
participants in this state, rather than increasing the performance of participants who were 
already performing at a high level. Study 4 (chapter 6) aimed to examine whether 
participants activation state would elucidate beneficial effects of caffeine and glucose on 
performance and also to determine if it was possible to modulate this state using a 
demanding cognitive battery. The Resource Depletion Battery was found to increase 
participants’ ratings of mental fatigue. However in comparison to a group who did not 
complete the battery, the active combination treatment drinks were not found to have 
greater beneficial effects across memory, attention and mood measures.  
These findings provide a proof of concept that participants can be cognitively depleted by 
a demanding task and provides an alternative to fatiguing participants via exercise or sleep 
restriction that is easier to administer in a laboratory setting. Further work needs to be done 
to establish the parameters for the task to engender a depletion effect more reliably. The 
Resource Depletion Battery was also utilised in study 5 (chapter 7) to help elucidate the 
effects of caffeine and glucose on neurocognitive processes, however only limited 
behavioural effects of the active treatments were found. The concept is flexible and 
potentially different tasks could be utilised within the battery depending on the domain 




8.8 Methodological Considerations and Future Research Directions 
 
There are several methodological considerations that should be taken into account when 
interpreting the findings of this thesis and that warrant further investigation.  
Firstly a consideration that should be given is to the length of the testing batteries utilised 
in this research; in particular the length of the testing battery in the first study (chapter 2). 
The total length of the battery was quite long at around 30mins and this may be a factor in 
the limited modulating effects of caffeine and glucose, especially as the tasks were always 
carried out in the same order. Ullrich et al., (2015) suggest that the lack of effects in their 
study of 25g glucose and 200mg caffeine on cognitive performance was due to the 
extensive test battery which lasted for 2hrs as the cognitive resources of the participants 
may have already been depleted by the time they completed the final task. The effects of 
this on task outcomes could be moderated by counter-balancing the order of task 
presentation.  
As described above in study 5 (chapter 7), salivary caffeine levels were found to peak later 
following the caffeine and glucose combined drink in comparison to the caffeine drink. 
Whilst caffeine has been found to attenuate glucose uptake, release and absorption 
(Graham et al., 2001; Greer et al., 2001; Keijzers et al., 2002; Lee et al., 2005; Petrie et 
al., 2004; Pizziol et al., 1998; Thong et al., 2002; Van Nieuwenhoven et al., 2000), to date 
little research has examined the effect of glucose on caffeine absorption (Adan & Serra-
Grabulosa, 2010). The findings from this thesis suggest that further investigation into this 
effect is warranted. There are implications for the timings of the tasks as the different 
pharmacokinetic profile in comparison to that expected when caffeine is administered 
alone (Nehlig, 1999; Nehlig & Boyet, 2000), means that potentially the tasks are 
completed too early, before the combination of caffeine and glucose is at its most 
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effective. The salivary caffeine level measured at 55mins post caffeine drink also drop off 
sharply at the time when the salivary caffeine levels are just peaking following the 
combination drink. What is unknown, due to the measurement times in this study, is how 
long it takes before the salivary caffeine levels begin to decline following the combined 
drink. It is possible that the levels of caffeine remain elevated for a sustained period of 
time and therefore it may be that if you were to compare cognitive performance after a 
longer interval that the beneficial effects of combined administration may be greater and 
therefore elucidated more clearly. Modulation of glucose by caffeine and the effect on the 
time course of the physiological response should also be investigated further. Young and 
Benton (2013) found that, compared to administration without caffeine, when 80mg 
caffeine was administered with either 39g glucose or a yoghurt drink with a low GL (3-6) 
interstitial glucose levels were increased. The peak of the response was delayed by 10mins 
and the response was increased and prolonged for 90mins post-drink 
Another consideration is an area which has received much attention in the caffeine 
literature and relatively little in the combination literature and that is whether any 
beneficial effects seen are due to reversal of caffeine withdrawal rather than any net 
benefits of caffeine and glucose consumption (James, 1994; James, 1998; James & Rogers, 
2005; Rogers & Dernoncourt, 1998; Yeomans, Ripley, Davies, Rusted & Rogers, 2002). In 
all the studies in this thesis participants were withdrawn from caffeine for at least 12hrs. 
Previous studies which have investigated this when examining the benefits of combined 
administration have found mixed results. Warburton et al., (2001) considered the potential 
effect of withdrawal from caffeine and imposed an abstinence period of only 1hr. They 
found that administration of a combination drink (80mg caffeine and 26g glucose) had 
beneficial effects on attention and verbal reasoning in the absence of caffeine withdrawal. 
Conversely Ullrich et al., (2015) found no effects of 25g glucose and 200mg caffeine in 
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combination on cognitive performance (logical thinking, processing speed, numeric and 
verbal memory, attention and ability to concentrate) when participants continued with their 
habitual caffeine intake prior to the study. They did however find effects of caffeine alone 
on self-ratings of mental energy and these effects were following a 24hr period of caffeine 
abstinence. In this study though participants also continued to consume their usual sugar 
intake and therefore this may also have a separate or possibly combined effect on the 
findings. Future research should examine the potential for withdrawal reversal effects on 
co-administration of caffeine and glucose.   
Related to the above is the finding that caffeine consumer status of the participant does 
alter caffeine’s effects (Haskell & Kennedy, 2011; Rogers et al., 2013). Differences in 
cognitive performance, mood and physiological responses have been found between 
consumers and low/non-consumers of caffeine. The participants who took part in this 
research were all regular caffeine consumers (at least 120mg per day), and therefore the 
effects of consumer status on these findings were mitigated. However, future research 
should explore the combined effects of caffeine and glucose in consumers and non-
consumers of caffeine in a more systematic way to elucidate the moderating effects. The 
differing physiological responses to caffeine in consumers and non-consumers (Haskell & 
Kennedy, 2011) may provide further information about the underlying mechanisms of 
action of these substances in combination. 
Similarly a moderating factor found in the glucose literature has not been examined here, 
and that is the effect of participants’ glucoregulation. In those with poor glucoregulation 
(associated with both older adults and high BMI), administration of glucose was associated 
with impaired cognitive performance (Donohoe & Benton, 1999a; Messier, et al., 2003; 
Sünram-Lea et al., 2011). Whilst the participants utilised in the current research were all 
young, healthy adults, the effects of individual glucoregulation cannot be ruled out. As 
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discussed previously (chapter 1), the effects of glucoregulation have not been examined in 
the combined literature and therefore further evaluation of its potential mediating effects is 
warranted. A related point is that individual glucoregulation, and the speed at which 
individuals metabolise glucose, may make detecting an effect of glucose more difficult 
when testing takes place shortly after consumption as some participants may not have 
metabolised it sufficiently (Sünram-Lea et al., 2002) 
It is also worth noting that in female participants, both the stage of their menstrual cycle 
and/or the use of the contraceptive pill, can affect their response to caffeine as estrogen 
inhibits metabolism and the pharmacokinetics of caffeine (Lane, Steege, Rupp & Kuhn, 
1992).  
Caveats should also be placed when assessing mood, as this is a subjective measure and 
therefore interpretations should be made cautiously as it could be affected by a number of 
external factors. Controlling for baseline mood in the studies reported here goes some way 
towards protecting pre-existing mood states from carrying over into the study. As 
discussed earlier in this chapter, the mood effects found in this research were also 
reasonably consistent and in agreement with previous findings in both the single and 
combined administration literature, demonstrating reliability and therefore strengthens 
their meaning. 
Whilst the above methodological considerations are of note and worthy of further 
exploration, it must be remembered that if the findings from research are to be ecologically 
valid, then it is unlikely that all the potential mediating factors can be controlled. Indeed, if 
the effects of these substances cannot be found in more naturalistic and realistic settings 




Moving away from participant characteristics, as described above, further exploration into 
individual aspects of tasks should be further investigated. As discussed, it appears that 
individual aspects of the memory process may be preferentially enhanced by glucose, 
caffeine and their combination. Teasing apart these more detailed effects may help to 
further elucidate the mechanisms that underlie the effects of these substances. 
 
8.9 General summary 
 
In conclusion this research has found some evidence of beneficial effects of caffeine, 
glucose and their combination on cognitive performance, mood and physiological 
response. However, no effects were found on neurocognitive measures or neuroendocrine 
response. The effects found are on the whole supportive of previous findings; in terms of 
improvements on memory, attention and mood, at doses found previously to be effective, 
both alone and in combination. The effects of the combined substances appear to be driven 
by the effects of one or other of the individual substances, depending on the outcome 
measure and so truly synergistic effects are not seen. Many potential moderating factors 
and specific cognitive domain effects are yet to be fully explored. Further investigation 
into these will further elucidate the effects of these substances and their underlying 
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